Document:

EX-4.2

 Exhibit 4.2 

DOORDASH, INC. 
 SEVENTH
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 
 June 17, 2020 

 SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of June 17, 2020 by and
among DoorDash, Inc., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively as the “Investors”.

 RECITALS 

WHEREAS, certain of the Investors (the “Existing Investors”) hold shares of the Company’s Series A Preferred
Stock, par value $0.00001 per share (the “Series A Preferred Stock”), Series A-1 Preferred Stock, par value $0.00001 per share (the “Series A-1
Preferred Stock”), Series B Preferred Stock, par value $0.00001 per share (the “Series B Preferred Stock”), Series C Preferred Stock, par value $0.00001 per share (the “Series C Preferred Stock”), Series D
Preferred Stock, par value $0.00001 per share (the “Series D Preferred Stock”), Series E Preferred Stock, par value $0.00001 per share (the “Series E Preferred Stock”), Series F Preferred Stock, par value $0.00001
per share (the “Series F Preferred Stock”), Series G Preferred Stock, par value $0.00001 per share (the “Series G Preferred Stock”) and/or shares of Common Stock issued upon conversion thereof and possess
registration rights, information rights, rights of first offer and other rights pursuant to that certain Sixth Amended and Restated Investors’ Rights Agreement dated as of May 21, 2019 by and among the Company and such Existing Investors
(the “Prior Agreement”); 
 WHEREAS, the Prior Agreement may be amended, and any provision therein waived, with the
consent of the Company and the Required Majority (as defined in the Prior Agreement, the “Prior Agreement Required Majority”); 

WHEREAS, the undersigned Existing Investors, representing the Prior Agreement Required Majority, desire to terminate the Prior
Agreement and to accept the rights created pursuant hereto in lieu of the rights granted to them under the Prior Agreement; and 

WHEREAS, certain Investors are parties to that certain Series H Preferred Stock Purchase Agreement of dated as of June 17, 2020 by
and among the Company and certain of the Investors (as may be amended from time to time, the “Series H Agreement”), which provides that as a condition to the closing of the sale of the Series H Preferred Stock, par value $0.00001
per share (the “Series H Preferred Stock” and collectively with the Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred
Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock, the “Preferred Stock”), this Agreement must be executed and delivered by such Investors, the Prior Agreement Required Majority and the Company.

 NOW, THEREFORE, BE IT RESOLVED, in consideration of the mutual promises and covenants set forth herein, the Company and the
Existing Investors hereby agree that the Prior Agreement shall be amended and replaced in its entirety by this Agreement, and the parties hereto further agree as follows: 

1. Definitions. For purposes of this Agreement: 

(a) The term “1934 Act” means the Securities Exchange Act of 1934, as amended. 

(b) The term “Act” means the Securities Act of 1933, as amended. 

 (c) The term “Affiliate” means, with respect to any Person, any other
Person who or which, directly or indirectly, controls, is controlled by, or is under common control with such specified Person, including, without limitation, any general partner, officer, director or manager of such Person and any venture capital
fund or other investment fund now or hereafter existing that is controlled by one or more general partners or managing members of, or is under common investment management with, or shares the same investment adviser with, such Person. For the
avoidance of doubt, SoftBank Vision Fund L.P., a limited partnership formed under the laws of Jersey (“SVF”), SoftBank Group Corp. and all persons or entities controlling, controlled by or under common control with either SVF or
SoftBank Group Corp. are Affiliates of each other. For the avoidance of doubt, an Affiliate with respect to Dahlia Investments Pte Ltd. (“Temasek”) shall mean Temasek’s ultimate holding company, Temasek Holdings (Private)
Limited (“Temasek Holdings”), and Temasek Holdings’ direct and indirect wholly owned companies whose boards of directors or equivalent governing bodies are comprised solely of nominees or employees of (i) Temasek Holdings;
(ii) Temasek Pte. Ltd; and/or (iii) wholly owned direct or indirect subsidiaries of Temasek Pte. Ltd. 
 (d) The term
“Board” means the Company’s Board of Directors, as constituted from time to time. 
 (e) The term
“Competitor” means any Person who, in the reasonable good faith determination of the Board, carries on any business that is substantially similar to the Company’s business. 

(f) The term “Disallowed SPV Entity” means any SPV Entity (i) (x) whose terms permit the distribution of shares of the
Company’s capital stock prior to the expiration of the applicable lockup period with respect to the Initial Offering or (y) whose terms permit the direct or indirect Transfer of such SPV Entity’s ownership interests to any party that
is not Affiliated with an Investor and (ii) that is not controlled or managed by an Investor or an Affiliate of such Investor. Notwithstanding the foregoing, the term “Disallowed SPV Entity” shall not include any Investor
listed on Schedule A hereto as of the date of this Agreement. 
 (g) The term “Form
S-3” means such form under the Act as in effect on the date hereof or any registration form under the Act subsequently adopted by the SEC that permits inclusion or incorporation of substantial
information by reference to other documents filed by the Company with the SEC. 
 (h) The term “Free Writing Prospectus”
means a free-writing prospectus, as defined in Rule 405. 
 (i) The term “Holder” means any Person owning or having the
right to acquire Registrable Securities or any assignee thereof in accordance with Section 2.10 of this Agreement. 
 (j) The term
“Initial Offering” means the Company’s first firm commitment underwritten public offering of its Common Stock under the Act. 

(k) The term “Major Investor” means any Investor (or transferee of an Investor) that, individually or collectively with its
Affiliates, holds at least 525,000 shares of Registrable Securities (as adjusted for any stock splits, stock dividends, combinations, subdivisions, recapitalizations or the like); provided that any Disallowed SPV Entity shall not constitute
an Affiliate of such Investor for the purposes of qualifying as a Major Investor. 
 (l) The term “Person” means any
individual, corporation, partnership, trust, limited liability company, association or other entity. 
 (m) The term “Preferred
Directors” means the Series A Director, Series B Director and Series D Director (each as defined in the Restated Certificate). 

  
 2 

 (n) The terms “register,” “registered,” and
“registration” refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or
document. 
 (o) The term “Registrable Securities” means (i) the Common Stock issuable or issued upon conversion of
the Preferred Stock, (ii) any Common Stock, or any Common Stock issued or issuable (directly or indirectly) upon conversion and/or exercise of any other securities of the Company, acquired by the Investors after the date hereof, and
(iii) any Common Stock of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution with respect to, or in exchange for, or in replacement of,
the shares referenced in (i) and (ii) above, excluding in all cases, however, any Registrable Securities sold by a Person in a transaction in which his rights under Section 2 of this Agreement are not assigned. In addition, the number of
shares of Registrable Securities outstanding shall equal the aggregate of the number of shares of Common Stock outstanding that are, and the number of shares of Common Stock issuable pursuant to then exercisable or convertible securities that are,
Registrable Securities. 
 (p) The term “Restated Certificate” means the Company’s Restated Certificate of
Incorporation, as amended and/or restated from time to time. 
 (q) The term “Rule 144” means Rule 144 under the Act. 

(r) The term “Rule 144(b)(1)(i)” means subsection (b)(1)(i) of Rule 144 under the Act as it applies to Persons who have held
shares for more than one (1) year. 
 (s) The term “Rule 405” means Rule 405 under the Act. 

(t) The term “SEC” means the Securities and Exchange Commission. 

(u) The term “SPV Entity” means any entity that (i) is formed for the specific purpose of acquiring shares of the
Company’s capital stock and/or (ii) has assets, a majority of which (by value) consist of shares of the Company’s capital stock as of immediately following such entity’s acquisition of shares of the Company’s capital stock.

 2. Registration Rights. The Company covenants and agrees as follows: 

2.1 Request for Registration. 

(a) Subject to the conditions of this Section 2.1, if the Company shall receive at any time after the earlier of (i) five (5) years
after the date of this Agreement or (ii) six (6) months after the effective date of the Initial Offering, a written request from the Holders of at least fifty percent (50%) of the Registrable Securities then outstanding (for purposes of this
Section 2.1, the “Initiating Holders”) that the Company file a registration statement under the Act covering the registration of Registrable Securities with an anticipated aggregate offering price of at least $15,000,000, then
the Company shall, within twenty (20) days of the receipt thereof, give written notice of such request to all Holders, and subject to the limitations of this Section 2.1, use its commercially reasonable efforts to effect, as soon as
practicable, the registration under the Act of all Registrable Securities that the Holders request to be registered in a written request received by the Company within twenty (20) days of the mailing of the Company’s notice pursuant to
this Section 2.1(a). 

  
 3 

 (b) If the Initiating Holders intend to distribute the Registrable Securities covered by
their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 2.1, and the Company shall include such information in the written notice referred to in Section 2.1(a).
In such event the right of any Holder to include its Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the
underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an
underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting by the Company (which underwriter or underwriters shall be reasonably acceptable to those Initiating Holders holding a majority of the
Registrable Securities then held by all Initiating Holders). Notwithstanding any other provision of this Section 2.1, if the underwriter advises the Company that marketing factors require a limitation on the number of securities underwritten
(including Registrable Securities), then the Company shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and the number of shares that may be included in the underwriting shall be allocated to
the Holders of such Registrable Securities pro rata based on the number of Registrable Securities held by all such Holders (including the Initiating Holders). In no event shall any Registrable Securities be excluded from such underwriting unless all
other securities are first excluded. Any Registrable Securities excluded or withdrawn from such underwriting shall be withdrawn from the registration. 

(c) Notwithstanding the foregoing, the Company shall not be required to effect a registration pursuant to this Section 2.1: 

(i) in any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such
registration, unless the Company is already subject to service in such jurisdiction and except as may be required under the Act; or 
 (ii)
after the Company has effected two (2) registrations pursuant to this Section 2.1, and such registrations have been declared or ordered effective; or 

(iii) during the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of the filing
of and ending on a date one hundred eighty (180) days following the effective date of a Company-initiated registration subject to Section 2.2 below, provided that the Company is actively employing in good faith its commercially
reasonable efforts to cause such registration statement to become effective; or 
 (iv) if the Initiating Holders propose to dispose of
Registrable Securities that may be registered on Form S-3 pursuant to Section 2.3 hereof; or 

(v) if the Company shall furnish to Holders requesting a registration statement pursuant to this Section 2.1 a certificate signed by the
Company’s Chief Executive Officer or Chairman of the Board stating that in the good faith judgment of the Board, it would be seriously detrimental to the Company and its stockholders for such registration statement to be effected at such time,
in which event the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders; provided that such right shall be exercised by the Company not
more than once in any twelve (12) month period; and provided further that the Company shall not register any securities for the account of itself or any other stockholder during such ninety (90) day period (other than a registration
relating solely to the sale of securities of participants in a Company stock plan, a registration relating to a corporate reorganization or transaction under Rule 145 of the Act, a registration on any form that does not include substantially the
same information as would be required to be included in a registration statement covering the sale of the Registrable Securities, or a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt
securities that are also being registered). 

  
 4 

 2.2 Company Registration. 

(a) If (but without any obligation to do so) the Company proposes to register (including for this purpose a registration effected by the
Company for stockholders other than the Holders) any of its stock or other securities under the Act in connection with the public offering of such securities (other than (i) a registration relating to a demand pursuant to Section 2.1 of
this Agreement or (ii) a registration relating solely to the sale of securities of participants in a Company stock plan, a registration relating to a corporate reorganization or transaction under Rule 145 of the Act, a registration on any form
that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities, or a registration in which the only Common Stock being registered is Common
Stock issuable upon conversion of debt securities that are also being registered), the Company shall, at such time, promptly give each Holder written notice of such registration. Upon the written request of each Holder given within twenty
(20) days after mailing of such notice by the Company in accordance with Section 4.7 of this Agreement, the Company shall, subject to the provisions of Section 2.2(c) of this Agreement, use its commercially reasonable efforts to cause
to be registered under the Act all of the Registrable Securities that each such Holder requests to be registered. 
 (b) Right to
Terminate Registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2.2 prior to the effectiveness of such registration whether or not any Holder has elected to include
securities in such registration. The expenses of such withdrawn registration shall be borne by the Company in accordance with Section 2.6 hereof. 

(c) Underwriting Requirements. In connection with any offering involving an underwriting of shares of the Company’s capital
stock, the Company shall not be required under this Section 2.2 to include any of the Holders’ securities in such underwriting unless they accept the terms of the underwriting as agreed upon between the Company and the underwriters
selected by the Company (or by other Persons entitled to select the underwriters) and enter into an underwriting agreement in customary form with such underwriters, and then only in such quantity as the underwriters determine in their sole
discretion will not jeopardize the success of the offering by the Company. If the total amount of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds the amount of securities sold other
than by the Company that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable
Securities, that the underwriters determine in their sole discretion will not jeopardize the success of the offering. In the event that the underwriters determine that less than all of the Registrable Securities requested to be registered can be
included in such offering, then the Registrable Securities that are included in such offering shall be apportioned pro rata among the selling Holders based on the number of Registrable Securities held by all selling Holders or in such other
proportions as shall mutually be agreed to by all such selling Holders. Notwithstanding the foregoing, in no event shall (i) any Registrable Securities be excluded from such offering unless all other stockholders’ securities have been
first excluded from the offering and (ii) the amount of securities of the selling Holders included in the offering be reduced below twenty-five percent (25%) of the total amount of securities included in such offering, unless such offering is
the Initial Offering, in which case the selling Holders may be excluded if the underwriters make the determination described above and no other stockholder’s securities are included in such offering. For purposes of the preceding sentence
concerning apportionment, for any selling stockholder that is a Holder of Registrable Securities and that is a venture capital fund, partnership or corporation, the affiliated venture capital funds, partners, members, retired partners and
stockholders of such Holder, or the estates and family members of any such partners, members and retired partners and any trusts for the benefit of any of the foregoing Persons shall be deemed to be a single “selling Holder,” and any pro
rata reduction with respect to such “selling Holder” shall be based upon the aggregate amount of Registrable Securities owned by all such related entities and individuals. 

2.3 Form S-3 Registration. In case the Company shall receive from the Holders of at least
thirty percent (30%) of the Registrable Securities (for purposes of this Section 2.3, the “S-3 Initiating Holders”) a written request or requests that the Company effect a registration on
Form S-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, the Company shall: 

(a) promptly give written notice of the proposed registration, and any related qualification or compliance, to all other Holders; and 

  
 5 

 (b) use its commercially reasonable efforts to effect, as soon as practicable, such
registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holders’ Registrable Securities as are specified in such request,
together with all or such portion of the Registrable Securities of any other Holders joining in such request as are specified in a written request given within fifteen (15) days after receipt of such written notice from the Company;
provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 2.3: 

(i) if Form S-3 is not available for such offering by the Holders; 

(ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to
sell Registrable Securities and such other securities (if any) at an aggregate price to the public (net of any underwriters’ discounts or commissions) of less than $5,000,000; 

(iii) if the Company shall furnish to all Holders requesting a registration statement pursuant to this Section 2.3 a certificate signed
by the Company’s Chief Executive Officer or Chairman of the Board stating that in the good faith judgment of the Board, it would be seriously detrimental to the Company and its stockholders for such registration statement to be effected at such
time, in which event the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the S-3 Initiating Holders; provided that
such right shall be exercised by the Company not more than once in any twelve (12) month period; and provided further that the Company shall not register any securities for the account of itself or any other stockholder during such
ninety (90) day period (other than a registration relating solely to the sale of securities of participants in a Company stock plan, a registration relating to a corporate reorganization or transaction under Rule 145 of the Act, a registration
on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities, or a registration in which the only Common Stock being registered
is Common Stock issuable upon conversion of debt securities that are also being registered); 
 (iv) if the Company has, within the twelve
(12) month period preceding the date of such request, already effected two (2) registrations on Form S-3 pursuant to this Section 2.3; 

(v) in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to
service of process in effecting such registration, qualification or compliance; 
 (vi) if the Company, within thirty (30) days of
receipt of the request of such S-3 Initiating Holders, gives notice of its bona fide intention to effect the filing of a registration statement with the SEC within one hundred twenty (120) days of receipt
of such request (other than a registration effected solely to qualify an employee benefit plan or to effect a business combination pursuant to Rule 145), provided that the Company is actively employing in good faith its commercially
reasonable efforts to cause such registration statement to become effective; or 

  
 6 

 (vii) during the period starting with the date thirty (30) days prior to the
Company’s good faith estimate of the date of the filing of and ending on a date ninety (90) days following the effective date of a Company-initiated registration subject to Section 2.2 of this Agreement, provided that the
Company is actively employing in good faith its commercially reasonable efforts to cause such registration statement to become effective. 

(c) If the S-3 Initiating Holders intend to distribute the Registrable Securities covered by their
request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 2.3 and the Company shall include such information in the written notice referred to in Section 2.3(a). The
provisions of Section 2.1(b) of this Agreement shall be applicable to such request (with the substitution of Section 2.3 for references to Section 2.1). 

(d) Subject to the foregoing, the Company shall file a registration statement covering the Registrable Securities and other securities so
requested to be registered as soon as practicable after receipt of the request or requests of the S-3 Initiating Holders. Registrations effected pursuant to this Section 2.3 shall not be counted as
requests for registration effected pursuant to Section 2.1 of this Agreement. 
 2.4 Obligations of the Company. Whenever
required under this Section 2 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 

(a) prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable
efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for a period of up to one hundred
twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed; 
 (b) prepare
and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition
of all securities covered by such registration statement; 
 (c) furnish to the Holders such number of copies of a prospectus, including a
preliminary prospectus and any Free Writing Prospectus, in conformity with the requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

(d) use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other
securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions; 
 (e) in the event of any underwritten public offering, enter
into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering; 

(f) notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus or Free Writing
Prospectus (to the extent prepared by or on behalf of the Company) relating thereto is required to be delivered under the Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, and, at the request
of any such Holder, the Company will, as soon as reasonably practicable, file and furnish to all such Holders a supplement or 

  
 7 

 
amendment to such prospectus or Free Writing Prospectus (to the extent prepared by or on behalf of the Company) so that, as thereafter delivered to the purchasers of such Registrable Securities,
such prospectus will not contain an untrue statement of a material fact or omit to state any fact necessary to make the statements therein not misleading in light of the circumstances under which they were made; 

(g) cause all such Registrable Securities registered pursuant to this Section 2 to be listed on a national exchange or trading system
and on each securities exchange and trading system on which similar securities issued by the Company are then listed; and 
 (h) provide a
transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration. 

Notwithstanding the provisions of this Section 2, the Company shall be entitled to postpone or suspend, for a reasonable period of time,
the filing, effectiveness or use of, or trading under, any registration statement if the Company shall determine that any such filing or the sale of any securities pursuant to such registration statement would in the good faith judgment of the
Board: 
 (i) materially impede, delay or interfere with any material pending or proposed financing, acquisition, corporate reorganization
or other similar transaction involving the Company for which the Board has authorized negotiations; 
 (ii) materially and adversely impair
the consummation of any pending or proposed material offering or sale of any class of securities by the Company; or 
 (iii) require
disclosure of material nonpublic information that, if disclosed at such time, would be materially harmful to the interests of the Company and its stockholders; provided, however, that during any such period all executive officers and
directors of the Company are also prohibited from selling securities of the Company (or any security of any of the Company’s subsidiaries or affiliates). 

In the event of the suspension of effectiveness of any registration statement pursuant to this Section 2.4, the applicable time period
during which such registration statement is to remain effective shall be extended by that number of days equal to the number of days the effectiveness of such registration statement was suspended. 

2.5 Information from Holder. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this
Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such
securities as shall be reasonably required to effect the registration of such Holder’s Registrable Securities. 
 2.6 Expenses of
Registration. All expenses other than underwriting discounts and commissions incurred in connection with registrations, filings or qualifications pursuant to Sections 2.1, 2.2 and 2.3 of this Agreement, including, without limitation, all
registration, filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company and the reasonable fees and disbursements of one counsel for the selling Holders (not to exceed $50,000) shall be
borne by the Company. Notwithstanding the foregoing, the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 2.1 or Section 2.3 of this Agreement if the registration request is
subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all participating Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to
be included in the withdrawn registration) unless, in the case of a registration requested 

  
 8 

 
under Section 2.1 of this Agreement, the Holders of a majority of the Registrable Securities agree to forfeit their right to one demand registration pursuant to Section 2.1 of this
Agreement and; provided, however, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business or prospects of the Company from that known to the Holders at the time of their
request and have withdrawn the request with reasonable promptness following disclosure by the Company of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to
Sections 2.1 and 2.3 of this Agreement. 
 2.7 Delay of Registration. No Holder shall have any right to obtain or seek an injunction
restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.8 Indemnification. In the event any Registrable Securities are included in a registration statement under this Section 2: 

(a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, the partners, members, officers, directors and
stockholders of each Holder, legal counsel, accountants and investment advisers for each Holder, any underwriter (as defined in the Act) for such Holder and each Person, if any, who controls such Holder or underwriter within the meaning of the Act
or the 1934 Act, against any losses, claims, damages or liabilities (joint or several) to which they may become subject under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any
state securities laws, insofar as such losses, claims, damages, or liabilities (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon any of the following statements, omissions or violations
(collectively, a “Violation”): (i) any untrue or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus, final prospectus, or Free Writing Prospectus contained
therein or any amendments or supplements thereto, any issuer information (as defined in Rule 433 of the Act) filed or required to be filed pursuant to Rule 433(d) under the Act or any other document incident to such registration prepared by or on
behalf of the Company or used or referred to by the Company, (ii) the omission or alleged omission of a material fact required to be stated in such registration statement, or necessary to make the statements therein not misleading or
(iii) any violation or alleged violation by the Company of the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws, and the Company will reimburse each such
Holder, underwriter, controlling Person or other aforementioned Person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability, action or proceeding as such
expenses are incurred; provided, however, that the indemnity agreement contained in this Section 2.8(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, action or proceeding if such
settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld, conditioned or delayed), nor shall the Company be liable in any such case for any such loss, claim, damage, liability, action or proceeding
to the extent that it arises out of or is based upon a Violation that occurs in reliance upon, and in conformity with, written information furnished expressly for use in connection with such registration by any such Holder, underwriter, controlling
Person or other aforementioned Person. 
 (b) To the extent permitted by law, each selling Holder, severally and not jointly, will
indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each Person, if any, who controls the Company within the meaning of the Act, legal counsel and accountants for the
Company, any underwriter, any other Holder selling securities in such registration statement and any controlling Person of any such underwriter or other Holder, against any losses, claims, damages or liabilities (joint or several) to which any of
the foregoing Persons may become subject, under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws, insofar as such losses, claims, damages or liabilities
(or actions or 

  
 9 

 
proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in
reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration; and each such Holder will reimburse any Person intended to be indemnified pursuant to this Section 2.8(b)
for any legal or other expenses reasonably incurred by such Person in connection with investigating or defending any such loss, claim, damage, liability, action or proceeding as such expenses are incurred; provided, however, that the
indemnity agreement contained in this Section 2.8(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, action or proceeding if such settlement is effected without the consent of the Holder (which consent
shall not be unreasonably withheld, conditioned or delayed), and provided that in no event shall any indemnity under this Section 2.8(b), when combined with any amounts paid by such Holder pursuant to Section 2.8(d), exceed the net
proceeds from the offering received by such Holder. 
 (c) Promptly after receipt by an indemnified party under this Section 2.8 of
notice of the commencement of any action or proceeding (including any governmental action or proceeding) for which a party may be entitled to indemnification, such indemnified party will, if a claim in respect thereof is to be made against any
indemnifying party under this Section 2.8, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in and, to the extent the indemnifying party so desires,
jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties
that may be represented without conflict by one counsel) shall have the right to retain one (1) separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel
retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the
indemnifying party within a reasonable time of the commencement of any such action or proceeding, if prejudicial to its ability to defend such action or proceeding, shall relieve such indemnifying party of liability to the indemnified party under
this Section 2.8 to the extent of such prejudice, but the omission to so deliver written notice to the indemnifying party will not relieve such indemnifying party of any liability that it may have to any indemnified party otherwise than under
this Section 2.8. 
 (d) If the indemnification provided for in this Section 2.8 is held by a court of competent jurisdiction to
be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or
payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and the indemnified party on the other hand
in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable considerations; provided, however, that (i) no contribution by any Holder,
when combined with any amounts paid by such Holder pursuant to Section 2.8(b), shall exceed the net proceeds from the offering received by such Holder and (ii) no Person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation; and provided further that in no event shall a Holder’s liability pursuant to this
Section 2.8(d), when combined with the amounts paid or payable by such Holder pursuant to Section 2.8(b), exceed the proceeds from the offering received by such Holder (net of any expenses paid by such Holder). The relative fault of the
indemnifying party and the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 

  
 10 

 (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

(f) The obligations of the Company and Holders under this Section 2.8 shall survive the completion of any offering of Registrable
Securities in a registration statement under this Section 2 and otherwise. 
 2.9 Reports Under the 1934 Act. With
a view to making available to the Holders the benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on
Form S-3, the Company agrees to: 
 (a) make and keep adequate current public information
available, as those terms are understood and defined in Rule 144, at all times after the effective date of the Initial Offering; 
 (b)
file with the SEC in a timely manner all reports and other documents required of the Company under the Act and the 1934 Act; and 
 (c)
furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of Rule 144 (at any time after ninety
(90) days after the effective date of the first registration statement filed by the Company), the Act and the 1934 Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose
securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the
Company and (iii) such other information as may be reasonably requested to avail any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration or pursuant to such form. 

2.10 Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities pursuant to this
Section 2 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such securities that (a) is an Affiliate (other than an Affiliate that is a Competitor or an Affiliate that is a Disallowed
SPV Entity), subsidiary, parent, partner, limited partner, retired partner, member or stockholder of a Holder, (b) is a Holder’s family member or trust for the benefit of an individual Holder or any of such Holder’s family members or
(c) after such transfer or assignment, holds at least 100,000 shares of Registrable Securities (subject to appropriate adjustment for stock splits, stock dividends, combinations and other recapitalizations), provided: (i) the
Company is, within a reasonable time after such transfer or assignment, furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned;
(ii) such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement, including, without limitation, the provisions of Section 2.12 of this Agreement; (iii) such assignment shall
be effective only if immediately following such transfer the further disposition of such securities by the transferee or assignee is restricted under the Act and (iv) such transferee or assignee is not a Disallowed SPV Entity. 

2.11 Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without the prior
written consent of the Holders holding a majority of the Registrable Securities then held by all Holders (the “Required Majority”), enter into any agreement with any holder or prospective holder of any securities of the Company that
would allow such holder or prospective holder (a) to include any of such securities in any registration filed under Section 2.1, Section 2.2 or Section 2.3 of this Agreement, unless under the terms of such agreement, such holder
or prospective holder may include such securities in any such registration only to the extent that the inclusion of such securities will not reduce the amount of the Registrable Securities of the Holders that are included or (b) to demand
registration of their securities. 

  
 11 

 2.12 “Market
Stand-Off” Agreement. 
 (a) Each Holder hereby agrees that it will not,
without the prior written consent of the managing underwriter, during the period commencing on the date of the public filing of a registration statement on Form S-1 in connection with the Initial Offering and
ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days from the date of the final prospectus relating to the registration by the Company of shares of Common Stock or any
other equity securities under the Act on a registration statement on Form S-1 in connection with the Initial Offering), (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable
(directly or indirectly) for Common Stock held immediately prior to the effectiveness of the Registration Statement for the Initial Offering, or (ii) enter into any hedging, swap or other arrangement that transfers to another, in whole or in
part, any of the economic consequences of ownership of such securities or that is otherwise based in whole or in part on the price or value of the securities, whether any such transaction described in clause (i) or (ii) above is to be settled
by delivery of Common Stock or other securities, in cash or otherwise. The foregoing provisions of this Section 2.12 shall apply only to the Initial Offering, shall not apply to the sale of any shares to an underwriter pursuant to an
underwriting agreement or shares acquired in the Initial Offering or in the secondary market following effectiveness of the registration statement relating to the Initial Offering, and shall only be applicable to the Holders if all officers,
directors and greater than one percent (1%) stockholders of the Company enter into similar agreements. The underwriters in connection with the Initial Offering are intended third-party beneficiaries of this Section 2.12 and shall have the
right, power and authority to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in the Initial Offering that are consistent with
this Section 2.12 or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters with respect to the officers, directors and
greater than one percent (1%) stockholders of the Company shall apply to all Holders subject to such agreements pro rata based on the number of shares subject to such agreements. The provisions of the previous sentence will not apply, however, if
(i) (a) the waiver or termination is effected solely to permit a transfer not for consideration and (b) the transferee agrees to be bound in writing by the restrictions set forth in this Section 2.12 and any lock-up agreement with the underwriters or (ii) the waiver or termination is granted in connection with a follow-on public offering of the Company’s securities
pursuant to a registration statement on Form S-1 that is filed with the SEC and the applicable Holder (a) has been given an opportunity to participate with the other selling stockholders in such public
offering on a pro rata basis in accordance with this Agreement and (b) has declined to so participate. 
 In order to enforce the
foregoing covenant, the Company may impose stop-transfer instructions and may stamp each such certificate or book-entry notation with the legend set forth in Section 2.12(b) with respect to the Registrable Securities of each Holder (and the
shares or securities of every other Person subject to the foregoing restriction) until the end of such period. 

  
 12 

 (b) Each Holder agrees that a legend reading substantially as follows shall be placed on
all certificates representing all shares or securities of the Company of each Holder (and the shares or securities of every other Person subject to the restriction contained in this Section 2.12): 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD AFTER THE EFFECTIVE DATE
OF THE ISSUER’S REGISTRATION STATEMENT FILED UNDER THE ACT, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES. 
 2.13 Termination of Registration
Rights. No Holder shall be entitled to exercise any right provided for in this Section 2: (a) after five (5) years following the consummation of the Initial Offering, (b) as to any Holder, such earlier time after the Initial
Offering at which such Holder (i) can sell all shares held by it in compliance with Rule 144(b)(1)(i) or (ii) holds one percent (1%) or less of the Company’s outstanding Common Stock and all Registrable Securities held by such Holder
(together with any Affiliate of the Holder with whom such Holder must aggregate its sales under Rule 144) can be sold in any three (3) month period without registration in compliance with Rule 144 or (c) after the consummation of a
Liquidation Event (as defined in the Restated Certificate). 
 3. Covenants of the Company. 

3.1 Delivery of Financial Statements. 

(a) The Company shall, upon request, deliver to each Major Investor: 

(i) as soon as practicable, but in any event within one hundred eighty (180) days after the end of each fiscal year of the Company, an
income statement for such fiscal year, a balance sheet of the Company and statement of stockholders’ equity as of the end of such year, and a statement of cash flows for such year, such year-end financial
reports to be in reasonable detail, prepared in accordance with generally accepted accounting principles (“GAAP”), and audited and certified by independent public accountants of nationally recognized standing selected by the
Company; 
 (ii) as soon as practicable, but in any event within forty-five (45) days after the end of each of the first three
(3) quarters of each fiscal year of the Company, an unaudited income statement and statement of cash flows for such fiscal quarter and an unaudited balance sheet and a statement of stockholders’ equity as of the end of such fiscal quarter,
all prepared in accordance with GAAP (except that such financial statements may (A) be subject to normal year-end audit adjustments and (B) not contain all notes thereto that may be required in
accordance with GAAP); 
 (iii) within thirty (30) days of the end of each month, an unaudited income statement and statement of cash
flows for such month, and an unaudited balance sheet and statement of stockholders’ equity as of the end of such month, all prepared in accordance with GAAP (except that such financial statements may (A) be subject to normal year-end audit adjustments and (B) not contain all notes thereto that may be required in accordance with GAAP); 

(iv) as soon as practicable, but in any event at least thirty (30) days before the end of each fiscal year, a budget and business plan
for the next fiscal year, prepared on a monthly basis, including balance sheets, income statements, and statements of cash flow for such months and, promptly after prepared, any other budgets or revised budgets prepared by the Company; 

(v) as soon as practicable upon request by a Major Investor (but in any event no later than fifteen (15) days after such request), a
statement showing the number of shares of each class and series of capital stock and securities convertible into or exercisable for shares of capital stock outstanding, the Common Stock issuable upon conversion or exercise of any outstanding
securities convertible or exercisable for Common Stock and the exercise price applicable thereto, and the number of shares of issued stock options and stock options not yet issued but reserved for issuance, if any, all in sufficient detail as to
permit such Major Investor to calculate its percentage equity ownership in the Company; and 

  
 13 

 (vi) such other information relating to the financial condition, business or corporate
affairs of the Company as the Major Investor may from time to time reasonably request; provided, however, that the Company shall not be obligated under this subsection (vi) or any other subsection of Section 3.1 to provide
information (A) that it deems in good faith to be a trade secret or similar highly confidential information (excluding, for the sake of clarity, the financial statements and reports to be delivered pursuant to Section 3.1(i) – (v) to
the extent such information is deemed a trade secret), (B) that the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel or (C) to any Major Investor whom the Board determines to be a
Competitor or an officer, employee, director or holder of more than ten percent (10%) of a Competitor; and 
 (b) If, for any period, the
Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial
statements of the Company and all such consolidated subsidiaries. Notwithstanding anything else in this Section 3.1 to the contrary, the Company may cease providing the information set forth in this Section 3.1 during the period starting
with the date thirty (30) days before the Company’s good-faith estimate of the date of filing of a registration statement if it reasonably concludes it must do so to comply with the SEC rules applicable to such registration statement and
related offering; provided that the Company’s covenants under this Section 3.1 shall be reinstated at such time as the Company is no longer actively employing its commercially reasonable efforts to cause such registration statement
to become effective. 
 3.2 Inspection. The Company shall permit each Major Investor, at such Major Investor’s expense, to visit
and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers, all at such reasonable times as may be requested by the Major Investor;
provided, however, that the Company shall not be obligated pursuant to this Section 3.2 to provide access to any information that (A) it deems in good faith to be a trade secret or similar highly confidential information or
(B) the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel, or if the Company reasonably believes that providing access to such information creates or poses a conflict of interest;
provided that providing a Major Investor access to such information subject to the provisions of Section 3.3 shall not be deemed to create or pose a conflict of interest, notwithstanding such Major Investor’s or its Affiliates’
ownership of equity interests in any Competitor. 
 3.3 Confidentiality. Notwithstanding anything in this Agreement to the contrary,
no Investor shall have access to any trade secrets of the Company (excluding, for the sake of clarity, the financial statements and reports to be delivered pursuant to Section 3.1(i) – (v) to the extent such information is deemed a trade
secret). Further, each Investor acknowledges and agrees that such Investor will keep confidential and will not disclose, divulge or use for any purpose other than the Purpose (as defined below) (i) the existence of this Agreement, the Series H
Agreement and the other Ancillary Agreements (as defined in the Series H Agreement) and the transactions contemplated hereby and thereby and (ii) any business, technical, financial or other information or materials (whether written, oral or in
any other form) provided to or learned by such Investor (whether by the Company or its advisors or other representatives), together with all derivative works prepared by such Investor or its Permitted Disclosees (as defined below) which contain or
otherwise reflect such information or materials or such Investor’s review of, or interest in, the Company or any of the foregoing (collectively, the “Confidential Information”), unless such Confidential Information (a) is
known or becomes known to the public in general (other than as a result of a breach of this Section 3.3 by such Investor); (b) is or has been made known or disclosed to such Investor by a third party without restriction and without a breach of
any confidentiality obligations with respect thereto; (c) is already in Investor’s possession free of any 

  
 14 

 
confidentiality obligations with respect thereto at the time of disclosure; (d) is or has been independently developed or conceived by such Investor without use of or reference to any
Confidential Information, as shown by written records and other competent evidence prepared contemporaneously with such independent development; (e) is approved for release or disclosure by the Company without restriction or (f) is
required to be disclosed by law, court order or subpoena, or pursuant to the request of a governmental or regulatory authority; provided, however, that an Investor may disclose Confidential Information to officers, directors, members,
Affiliates or limited partners or their respective general partners, employees and legal, tax and accounting advisors of such Investor who have a need to know such information for the Purpose (and/or advising such Investor in connection with such
Purpose) and who have expressly agreed, or are bound by similar obligations, to treat such Confidential Information confidentially in accordance with, or substantially similar to, this Agreement (collectively, the “Permitted
Disclosees”). For the avoidance of doubt, such Investor shall not be permitted to disclose or divulge any Confidential Information to any Person (whether orally or in writing) or use any Confidential Information (1) in connection
with or to solicit any interest in any proposed sale, assignment, encumbrance, pledge, gift or other transfer or disposition of any kind of any of its Shares (as hereinafter defined) or any of such Investor’s rights held thereunder or
(2) if such Person is or could possibly be a Competitor. Each Investor further agrees to protect and maintain, and to cause each Permitted Disclosee to protect and maintain, the confidentiality and security of, and to exercise the same standard
of care it exercises to prevent the unauthorized disclosure or unauthorized use of its own proprietary information, which shall be no less than reasonable care, with respect to, the Confidential Information. Each Investor shall be liable for any
disclosure or unauthorized use by the Permitted Disclosees or other representatives of such Investor in contravention of this Section 3.3, and shall take reasonably appropriate steps to safeguard the Confidential Information from disclosure,
misuse, espionage, loss and theft. Each Investor further agrees to notify the Company in writing of any actual or suspected misuse, misappropriation or unauthorized disclosure of the Confidential Information, which may come to its attention. In the
event that an Investor or any of its Permitted Disclosees receives a request or is required by a governmental authority to disclose all or any Confidential Information, such Investor or its Permitted Disclosees, as the case may be, agree to
(A) promptly notify the Company of the existence, terms and circumstances surrounding such request to the extent permissible, (B) to the extent permissible and reasonably practicable, consult with the Company on the advisability of taking
legally available steps to resist or narrow such request and (C) to the extent permissible and reasonably practicable and at the request and expense of the Company, assist the Company in seeking a protective order or other appropriate remedy.
In the event that such protective order or other remedy is not obtained or that the Company waives compliance with the provisions hereof, such Investor or its Permitted Disclosees, as the case may be, may disclose to any governmental authority only
that portion of the Confidential Information which such Investor is advised by counsel is legally required to be disclosed, and such Investor shall exercise its best reasonable efforts to obtain assurance that confidential treatment will be accorded
such Confidential Information. Nothing in this Section 3.3 shall in any way limit or otherwise modify any confidentiality covenants entered into by any Investor pursuant to any other agreement entered into with the Company. Notwithstanding
anything to the contrary herein, the Company acknowledges and agrees that each Investor may disclose such information in respect of the Company and the Investor’s interest therein as is required under applicable securities laws, rules or
regulations or rules of a national securities exchange, including in response to routine examinations, demands, requests or reporting requirements. The Company consents in advance to such disclosure and any such disclosure shall not constitute a
breach of this Section 3.3. For purposes of this Agreement, the “Purpose” shall mean to monitor and evaluate Investor’s investment in the Company and to assist and advise the Company in the Company’s conduct of its
business. 
 3.4 Termination of Information and Inspection Covenants. The covenants set forth in Sections 3.1 and 3.2 shall terminate
and be of no further force or effect upon the earlier to occur of (a) the consummation of the Initial Offering, (b) when the Company first becomes subject to the periodic reporting requirements of Sections 12(g) or 15(d) of the 1934 Act,
whichever event shall first occur and (c) the consummation of a Liquidation Event. 

  
 15 

 3.5 Right of First Offer. Subject to the terms and conditions specified in this
Section 3.5, the Company hereby grants to each Major Investor a right of first offer with respect to future sales by the Company of its Shares. For purposes of this Section 3.5, the term “Major Investor” includes any
general partners and Affiliates (other than an Affiliate that is a Competitor or an Affiliate that is a Disallowed SPV Entity) of a Major Investor. A Major Investor shall be entitled to apportion the right of first offer hereby granted it among
itself and its partners and Affiliates (other than an Affiliate that is a Competitor or an Affiliate that is a Disallowed SPV Entity) in such proportions as it deems appropriate. 

Each time the Company proposes to offer any shares of, or securities convertible into or exchangeable or exercisable for any shares of, its
capital stock (including, without limitation, any such shares or securities issued in connection with debt securities) (“Shares”), the Company shall first make an offering of such Shares to each Major Investor in accordance with the
following provisions: 
 (a) The Company shall deliver a notice in accordance with Section 4.7 (“Notice”) to the
Major Investors stating (i) its bona fide intention to offer such Shares, (ii) the number of such Shares to be offered and (iii) the price and terms upon which it proposes to offer such Shares. 

(b) By written notification received by the Company within twenty (20) calendar days after the giving of Notice, each Major Investor may
elect to purchase, at the price and on the terms specified in the Notice, up to that portion of such Shares that equals the proportion that the number of shares of Registrable Securities issued and held by such Major Investor (assuming full
conversion and exercise of all convertible and exercisable securities then outstanding) bears to the total number of shares of Common Stock of the Company then outstanding (assuming full conversion and exercise of all convertible and exercisable
securities then outstanding). At the expiration of such twenty (20) calendar day period, the Company shall promptly, in writing, notify each Major Investor that elects to purchase all the shares available to it (a “Fully-Exercising
Major Investor”) of any other Major Investor’s failure to do likewise. During the ten (10) calendar day period commencing after the Company has given such notice to the Fully-Exercising Major Investors, each Fully-Exercising Major
Investor may elect to purchase that portion of the Shares for which Major Investors were entitled to subscribe, but which were not subscribed for by the Major Investors, that is equal to the proportion that the number of shares of Registrable
Securities issued and held by such Fully-Exercising Major Investor bears to the total number of shares of Common Stock of the Company then outstanding (assuming full conversion and exercise of all convertible and exercisable securities then
outstanding). 
 (c) If all Shares that Major Investors are entitled to obtain pursuant to Section 3.5(b) of this Agreement are not
elected to be obtained as provided in Section 3.5(b) of this Agreement, the Company may, during the ninety (90) day period following the expiration of the period provided in Section 3.5(b) of this Agreement, offer the remaining
unsubscribed portion of such Shares to any Person or Persons at a price not less than that, and upon terms no more favorable to the offeree than those, specified in the Notice. If the Company does not enter into an agreement for the sale of the
Shares within such period, or if such agreement is not consummated within sixty (60) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Shares shall not be offered unless first reoffered to the
Major Investors in accordance herewith. 
 (d) The right of first offer in this Section 3.5 shall not be applicable to (i) any
equity securities described in Article IV, Section 4(d)(ii)(A) through (I) of the Restated Certificate, (ii) the issuance and sale of Series H Preferred Stock pursuant to the Series H Agreement, or (iii) the issuance and sale of
securities that are not offered to any existing stockholder (or any Affiliate thereof) of the Company, if such issuance and sale has been unanimously approved by the Board as being exempt from this Section 3.5. In addition to the foregoing, the
right of first offer in this Section 3.5 shall not be applicable with respect to any Major Investor in any subsequent offering of Shares if (A) at the time of such offering, the Major Investor is not an “accredited investor,” as
that term is then defined in Rule 501(a) of the Act and (B) such offering of Shares is otherwise being offered only to accredited investors. 

  
 16 

 (e) The rights provided in this Section 3.5 may not be assigned or transferred by any
Major Investor; provided, however, that a Major Investor that is a venture capital fund may assign or transfer such rights to its Affiliates (other than an Affiliate that is a Competitor or an Affiliate that is a Disallowed SPV
Entity). For the avoidance of doubt SoftBank Vision Fund (AIV M2) L.P. (“SBVF”), Coatue US 11 LLC (“Coatue”), DST Global VI, L.P. (“DST”), Doorstep DF Holdings, LP (“Dragoneer”),
Darsana Master Fund LP (“Darsana”) and Temasek and each of their Affiliates (other than an Affiliate that is a Competitor or an Affiliate that is a Disallowed SPV Entity) shall be deemed to be a venture capital fund. 

(f) The covenants set forth in this Section 3.5 shall terminate and be of no further force or effect upon the consummation of
(i) the Initial Offering or (ii) a Liquidation Event. 
 3.6 Directors’ and Officers’
Insurance. The Company has as of the date hereof from financially sound and reputable insurers directors and officers liability insurance in an amount and on terms and conditions satisfactory to the Board (including each of the Preferred
Directors), and will use its commercially reasonable efforts to cause such insurance policy to be maintained until such time as the Board (including a majority of the Preferred Directors) determines that such insurance should be discontinued. 

3.7 Proprietary Information and Inventions Agreements. The Company shall require all employees and consultants with access to
confidential information to execute and deliver a Proprietary Information and Inventions Agreement in substantially the form approved by the Board or a consulting agreement containing substantially similar proprietary rights assignment and
confidentiality provisions. 
 3.8 Employee Agreements. Unless approved by the Board, all future employees of the Company who shall
purchase, or receive options to purchase, shares of Common Stock following the date hereof shall be required to execute stock purchase or option agreements providing for (a) vesting of shares over a four (4) year period with the first
twenty five percent (25%) of such shares vesting following twelve (12) months of continued employment or services, and the remaining shares vesting in equal monthly installments over the following thirty six (36) months thereafter and
(b) a one hundred and eighty (180)-day lockup period (plus an additional period of up to eighteen (18) days) in connection with the Initial Offering. The Company shall retain a right of first refusal
on transfers until the Initial Offering and the right to repurchase unvested shares at cost. 
 3.9 Corporate Opportunities and
Information Use. The Company acknowledges that the Investors and their affiliates, members, equity holders, director representatives, partners, employees, agents and other related persons are engaged in the business of investing in private and
public companies in a wide range of industries, including the industry segment in which the Company operates (the “Company Industry Segment”). Accordingly, the Company and the Investors hereby acknowledge and agree that a Covered
Person (as that term is defined in the Restated Certificate) shall: 
 (a) have no obligation or duty (contractual or otherwise) to the
Company to refrain from participating as a director, investor or otherwise with respect to any company or other person or entity that is engaged in the Company Industry Segment or is otherwise competitive with the Company, and 

(b) in connection with making investment decisions, to the fullest extent permitted by law, have no obligation or duty (contractual or
otherwise) to the Company to refrain from using any information, including, but not limited to, market trend and market data, which comes into such Covered Person’s possession, whether as a director or, or investor in, the Company or otherwise.

  
 17 

 3.10 Foreign Corrupt Practices Act. The Company represents that it shall not, and
shall not permit any of its subsidiaries or Affiliates or any of its or their respective directors, officers, managers, employees, independent contractors, representatives or agents to, promise, authorize or make any payment to, or otherwise
contribute any item of value, directly or indirectly, to any third party, including any Non-U.S. Official (as defined in the Foreign Corrupt Practices Act (the “FCPA”)), in each case, in
violation of the FCPA, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law. The Company further represents that it shall, and shall cause each of its subsidiaries and Affiliates to, cease all of its or their respective
activities, as well as remediate any actions taken by the Company, its subsidiaries or Affiliates, or any of their respective directors, officers, managers, employees, independent contractors, representatives or agents in violation of the FCPA, the
U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law. The Company further represents that it shall, and shall cause each of its subsidiaries and Affiliates to, maintain systems of internal controls (including, but not
limited to, accounting systems, purchasing systems and billing systems) designed to ensure compliance with the FCPA, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law. 

3.11 Indemnification Matters. The Company hereby acknowledges that one (1) or more of the directors nominated to serve on the
Board by the Investors (each a “Fund Director”) may have certain rights to indemnification, advancement of expenses and/or insurance provided by one or more of the Investors and certain of their affiliates (collectively, the
“Fund Indemnitors”). The Company hereby agrees (a) that it is the indemnitor of first resort (i.e., its obligations to any such Fund Director are primary and any obligation of the Fund Indemnitors to advance expenses or to
provide indemnification for the same expenses or liabilities incurred by such Fund Director are secondary), (b) that it shall be required to advance the full amount of expenses incurred by such Fund Director and shall be liable for the full amount
of all expenses, judgments, penalties, fines and amounts paid in settlement by or on behalf of any such Fund Director to the extent legally permitted and as required by the Restated Certificate or Bylaws of the Company (or any agreement between the
Company and such Fund Director), without regard to any rights such Fund Director may have against the Fund Indemnitors, and, (c) that it irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all claims against the Fund
Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of any such Fund Director with respect to any claim for which
such Fund Director has sought indemnification from the Company shall affect the foregoing and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery
of such Fund Director against the Company. 
 3.12 United States Real Property Holding Company. Upon the request of any Investor, the
Company shall provide (a) a statement (in such form as may be reasonably requested by such Investor) conforming to the requirements of Section 1.897-2(h)(1)(i) and
1.1445-2(c)(3)(i) of the Treasury Regulations certifying that interests in the Company do not constitute “United States real property interests” under Section 897(c) of the Internal Revenue Code
of 1986, as amended, and (b) evidence in form and substance satisfactory to such Investor that the Company has delivered to the Internal Revenue Service the notification required under
Section 1.897-2(h)(2) of the Treasury Regulations. 
 3.13 Termination of Certain
Covenants. The covenants set forth in Sections 3.6, 3.7, 3.8, 3.9, 3.10, 3.11 and 3.12 shall terminate and be of no further force or effect upon the consummation of (a) the Initial Offering or (b) a Liquidation Event. 

4. Miscellaneous. 
 4.1
Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties (including transferees of any
shares of Registrable Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or
by reason of this Agreement, except as expressly provided in this Agreement. 

  
 18 

 4.2 Further Limitations on Disposition. Each Investor agrees not to make any
disposition of all or any portion of the Registrable Securities unless and until: 
 (a) There is then in effect a registration statement
under the Act covering such proposed disposition and such disposition is made in accordance with such registration statement; or 
 (b) (i)
Such Investor shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and (ii) if reasonably requested by the Company,
such Investor shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the Company that such disposition will not require registration of such shares under the Act. It is agreed that the Company will not require
opinions of counsel for transactions made pursuant to Rule 144 except in unusual circumstances. 
 (c) Notwithstanding the provisions of
subsections (a) and (b) above, no such registration statement or opinion of counsel shall be necessary for a transfer by an Investor (1) that is a partnership to a partner of such partnership or a retired partner of such partnership who
retires after the date hereof, or to the estate of any such partner or retired partner or the transfer by gift, will or intestate succession of any partner to his or her spouse or to the siblings, lineal descendants or ancestors of such partner or
his or her spouse or (2) to an Affiliate, in each case if the prospective transferee agrees in all such instances in writing to be subject to the terms hereof to the same extent as if he, she or it were an Investor hereunder. 

4.3 Restrictions on Transfer. Without limitation of any other restriction on transfer set forth in this Agreement or the Bylaws of the
Company, each Investor shall be bound by each of the following restrictions until the earlier to occur of (i) the closing of a Liquidation Event, (ii) immediately prior to the Initial Offering or (iii) May 21, 2024: 

(a) No Investor may sell, transfer, distribute, assign, pledge, or otherwise dispose of or encumber (including transfer by gift or operation
of law) (“Transfer”) any securities of the Company without the prior written consent of the Board, unless such Transfer is to an Affiliate of such Investor that is not a Disallowed SPV Entity. 

(b) No Investor shall Transfer any securities of the Company at any time to any Disallowed SPV Entity unless such Transfer has been approved
by the Board. 
 (c) No Investor shall Transfer any securities of the Company, if as a result of such Transfer, the Company would have
outstanding any class of equity securities held of record by (i) two thousand (2,000) or more persons or (ii) five hundred (500) or more persons who are not accredited investors (as such term is defined in Rule 501 of Regulation D
promulgated under the Act), as described in Section 12(g) of the 1934 Act and Rule 12g5-1 promulgated thereunder, as determined by the Board. 

(d) As a condition to any Transfer of the Company’s securities to a proposed transferee by any Investor, such proposed transferee shall
agree to be bound by the restrictions set forth in this Agreement. 
 (e) No Investor may list, sell or offer to sell or otherwise trade in
Company securities on any private market place or securities exchange, including without limitation on Nasdaq Private Market or SharesPost (each, a “Private Market Exchange”), until such time that a court of competent jurisdiction
or appropriate regulatory authority has issued a ruling or endorsed the activities of such Private Market Exchange as compliant with applicable securities law to the Company’s reasonable satisfaction. 

  
 19 

 4.4 Governing Law. This Agreement shall be governed by and construed under the laws
of the State of California as applied to agreements among California residents entered into and to be performed entirely within California. THE PARTIES TO THIS AGREEMENT HEREBY WAIVE THEIR RIGHT TO A TRIAL BY JURY WITH RESPECT TO DISPUTES ARISING
UNDER THIS AGREEMENT AND CONSENT TO A BENCH TRIAL WITH THE APPROPRIATE JUDGE ACTING AS THE FINDER OF FACT. 
 4.5 Counterparts;
Facsimile. This Agreement may be executed by electronic signature and in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one (1) and the same instrument. Counterparts
may be delivered by facsimile, electronic mail (including pdf) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

4.6 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement. 
 4.7 Notices. All notices and other communications given or made pursuant hereto shall
be in writing and shall be deemed effectively given upon the earlier to occur of actual receipt or: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal
business hours of the recipient; if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally
recognized overnight courier, specifying next day delivery, with written verification of receipt. All notices and other communications shall be sent to the Company at the address set forth on the signature page hereto, Attention: Chief Executive
Officer, and to the other parties at the addresses set forth on the applicable signature pages hereto (or at such other addresses as shall be specified by notice given in accordance with this Section 4.7). 

4.8 Expenses. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party
shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. 

4.9 Entire Agreement; Amendments. This Agreement (including Exhibits and Schedules hereto, if any) constitutes the full and entire
understanding and agreement among the parties with regard to the subjects hereof and thereof. Upon the effectiveness of this Agreement, the Prior Agreement shall be amended and replaced in its entirety by this Agreement and shall be of no further
force or effect. Any term of this Agreement (other than Sections 1(k), 3.1, 3.2, 3.4 and 3.5) may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or
prospectively) only with the written consent of the Company and the Required Majority. The provisions of Section 1(k), 3.1, 3.2, 3.4 and 3.5 may be amended or waived (either generally or in a particular instance and either retroactively or
prospectively) only with the written consent of the Company and the Major Investors holding a majority of the Registrable Securities then held by all of the Major Investors, including the written consent of Darsana, Coatue, DST, Dragoneer, Temasek
and SBVF, as applicable, with respect to any amendment of Section 1(k) to the extent that any such amendment would result in Darsana, Coatue, DST, Dragoneer, Temasek or SBVF failing to qualify as a Major Investor; provided further that
any amendments or waivers that disproportionately affect the rights of a particular Major Investor shall require the written consent of such affected Major Investor(s). Notwithstanding anything herein to the contrary, if a Major Investor consents to
a waiver of the right of first offer contained in Section 3.5 and then purchases any Shares, then each other non-participating Major Investor who did not consent to such waiver (each a “Non-Consenting Major  

  
 20 

 
Investor”) shall be permitted to purchase Shares on a pro rata basis in proportion to the number of Shares purchased by such consenting Major Investor, or the full pro rata
amount of such Non-Consenting Major Investor as calculated in accordance with Section 3.5, whichever is less. Any amendment or waiver effected in accordance with this paragraph shall be binding upon
each holder of any Registrable Securities, each future holder of all such Registrable Securities and the Company. 
 4.10
Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement shall be held to be prohibited by or invalid under
applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Agreement. 

4.11 Aggregation of Stock. All shares of Registrable Securities held or acquired by affiliated entities (including affiliated venture
capital funds or venture capital funds under common investment management) or Persons shall be aggregated together for the purpose of determining the availability of any rights under this. For the avoidance of doubt, any Disallowed SPV Entity shall
not constitute an Affiliate of an Investor for the purposes of this aggregation provision and the capital stock held by the Disallowed SPV Entity shall not be aggregated with the capital stock held by another Investor. 

4.12 Additional Investors. Notwithstanding anything to the contrary contained herein, if the Company issues additional shares of the
Company’s Preferred Stock after the date hereof, any purchaser of such shares of Preferred Stock may become a party to this Agreement by executing and delivering an additional counterpart signature page to this Agreement, and thereafter shall
be deemed an “Investor” for all purposes hereunder. No action or consent by the Investors shall be required for such joinder to this Agreement by such additional Investor, so long as such additional Investor has agreed in writing to be
bound by all of the obligations as an “Investor” hereunder. 
 4.13 Signatory Capacity. With respect to its signatory
capacity and liability, as the trustee of the Wellcome Trust, The Wellcome Trust Limited (the “Trustee”) enters into and delivers this Agreement in its capacity as the trustee for the time being of the Wellcome Trust but not
otherwise and it is hereby agreed and declared that notwithstanding anything to the contrary contained or implied in this Agreement or any related agreement: 

(a) the obligations incurred by the Trustee under or in consequence of this Agreement or any related agreement shall be enforceable against it
or the other trustees of the Wellcome Trust from time to time; and 
 (b) the liabilities of the Trustee (or such other trustees as are
referred to in subsection (a) above) in respect of such obligations shall be limited to such liabilities as can, and may lawfully and properly be met out of the assets of the Wellcome Trust that are for the time being in the hands or under the
control of the Trustee or such other trustees. 
 [Remainder of page intentionally left blank] 

  
 21 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	COMPANY:
	
	DOORDASH, INC.
		
	By:	 	/s/ Tony Xu
		 	Tony Xu
		 	President & CEO

  

					
		 	Address:	  	303 2nd Street, South Tower, 8th Floor
		 		  	San Francisco, CA 94107

 SIGNATURE PAGE TO DOORDASH , INC.

 SEVENTH AMENDED AND RESTATED INVESTORS’
RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 DURABLE CAPITAL MASTER FUND LP 

		
	By:	 	 Durable Capital Associates LLC, its general partner 

		
	By:	 	/s/ Michael Blandino

 
			
	Name:	 	Michael Blandino
	Title:	 	Authorized Person

  

					
		 	Address:	  	 c/o Durable Capital

		 		  	 5425 Wisconsin Avenue, Suite 802

		 		  	Chevy Chase, MD 20815
		 		  	Attn: Julie Jack, General Counsel

 SIGNATURE PAGE TO DOORDASH , INC.

 SEVENTH AMENDED AND RESTATED INVESTORS’
RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 DARSANA MASTER FUND LP

		
	By:	 	 Darsana Capital GP LLC

	By:	 	Its: General Partner
		
	By:	 	/s/ Chris Ferrante

 
			
	Name:	 	Chris Ferrante
	Title:	 	Authorized Signatory

  

					
		 	Address:	  	
		 		  	 Darsana Master Fund LP

		 		  	c/o Darsana Capital Partners LP
		 		  	Attn: Legal and Compliance
		 		  	40 West 57th Street, 15thFloor
		 		  	New York, NY 10019, U.S.A.
		 		  	Email:

 SIGNATURE PAGE TO DOORDASH , INC.

 SEVENTH AMENDED AND RESTATED INVESTORS’
RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 DOORSTEP DF HOLDINGS, LP

		
	By:	 	 /s/ Pat Robertson

			
	Name:	 	Pat Robertson
	Title:	 	Authorized Signatory

  

					
		 	Address:	  	
		 		  	 c/o Dragoneer Investment Group, LLC

		 		  	 1 Letterman Dr.

		 		  	Building D, Ste M500
		 		  	San Francisco, CA 94129

 SIGNATURE PAGE TO DOORDASH , INC.

 SEVENTH AMENDED AND RESTATED INVESTORS’
RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 KPCB HOLDINGS, INC., AS NOMINEE

		
	By:	 	 /s/ Sue Biglieri

			
	Name:	 	 Sue Biglieri

	Title:	 	Authorized Signatory
		 	
	Address:
	2750 Sand Hill Road
	Menlo Park, CA 94025

SIGNATURE PAGE TO DOORDASH , INC. 

SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 SANDS CAPITAL GLOBAL INNOVATION FUND, LLC

		
	By:	 	 /s/ Jonathan Goodman

		 	Name: Jonathan Goodman
		 	Title: General Counsel
	
	AU UNI UNISUP USSDGE
	By:	 	Sands Capital Management, LLC as Manager
		
	By:	 	/s/ Jonathan Goodman
		 	Name: Jonathan Goodman
		 	Title: General Counsel

 SIGNATURE
PAGE TO DOORDASH , INC. 
 SEVENTH AMENDED
AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 Sequoia Capital USV XIV Holdco, Ltd.

	
	 By: 

	 SEQUOIA CAPITAL U.S. VENTURE FUND

XIV, L.P.,
 SEQUOIA CAPITAL U.S. VENTURE

PARTNERS FUND XIV, L.P.,
 SEQUOIA CAPITAL U.S. VENTURE

PARTNERS FUND XIV (Q), L.P.,
 all Cayman Islands exempted
limited
 partnerships, its Members

	
	 By: SC U.S. VENTURE XIV MANAGEMENT, L.P.,

a Cayman Islands exempted limited partnership, General Partner of Each

	
	 By: SC US (TTGP), LTD.,
 a Cayman
Islands exempted company, its
 General Partner

 

			
	By:	 	/s/ Alfred Lin
	Name:	 	Alfred Lin
	Title:	 	Authorized Signatory

  

					
		 	Address:	  	 2800 Sand Hill Road, Suite 101

		 		  	 Menlo Park, CA 94025

 SIGNATURE PAGE TO DOORDASH , INC.

 SEVENTH AMENDED AND RESTATED INVESTORS’
RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 Sequoia Capital U.S. Growth Fund VI, L.P. 

	 Sequoia Capital U.S. Growth VI Principals Fund, L.P.

Each a Cayman Islands exempted limited partnership

		
	By:	 	 SC U.S. GROWTH VI MANAGEMENT, L.P.,
a Cayman Islands exempted limited partnership General Partner of Each

		
	By:	 	 SC US (TTGP), LTD.,
 a Cayman Islands
exempted company, its General
 Partner

		
	By:	 	/s/ Alfred Lin

 
			
	Name:	 	Alfred Lin
	Title:	 	Authorized Signatory
	
	Address: 2800 Sand Hill Road, Suite 101
		 	   Menlo Park, CA 94025

SIGNATURE PAGE TO DOORDASH, INC. 

SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 Sequoia Capital U.S. Growth Fund VII, L.P.

	 Sequoia Capital U.S. Growth VII Principals Fund, L.P.

Each a Cayman Islands exempted limited partnership

	
	 By: SC U.S. GROWTH VII MANAGEMENT, L.P.,

       a Cayman Islands exempted limited partnership

       General Partner of Each

	
	 By: SC US (TTGP), LTD.,

       a Cayman Islands exempted company, its General        Partner

		
	By:	 	/s/ Alfred Lin
	Name:	 	Alfred Lin
	Title:	 	Authorized Signatory
		 	
	
	 Sequoia Capital Global Growth Fund II, L.P.

	 Sequoia Capital Global Growth II Principals Fund, L.P.

Each a Cayman Islands exempted limited partnership

		
	By:	 	 SC GLOBAL GROWTH II MANAGEMENT, L.P.,
 a
Cayman Islands exempted limited partnership
 General Partner of Each

		
	By:	 	 SC US (TTGP), LTD.,
 a Cayman Islands
exempted company, its General Partner

		
	By:	 	/s/ Alfred Lin
	Name:	 	Alfred Lin
	Title:	 	Authorized Signatory
	
	Address: 2800 Sand Hill Road, Suite 101
		 	   Menlo Park, CA 94025

SIGNATURE PAGE TO DOORDASH, INC. 

SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 Sequoia Capital Global Growth Fund, LP

	 Sequoia Capital Global Growth Principals Fund, LP

	
	 By: SCGGF Management, LP 
 A Cayman
Islands exempted limited partnership
 General Partner of Each

	
	 By: SC US (TTGP), LTD.,
 A Cayman
Islands exempted company, its General Partner

		
	By:	 	/s/ Alfred Lin
	Name:	 	Alfred Lin
	Title:	 	Authorized Signatory

  

					
		 	Address:	  	 2800 Sand Hill Road, Suite 101

		 		  	 Menlo Park, CA 94025

 SIGNATURE PAGE TO DOORDASH, INC.

 SEVENTH AMENDED AND RESTATED INVESTORS’
RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 SCGE Fund, L.P.
 a Cayman
Islands limited partnership

	
	 By: SCGE (LTGP), L.P., a Cayman Islands limited partnership

Its: General Partner

		
	By:	 	/s/ Kimberly Summe

 
			
	Name:	 	Kimberly Summe
	Title:	 	Chief Operating Officer and General Counsel

  

					
		 	Address:	  	 2800 Sand Hill Road, Suite 101

		 		  	 Menlo Park, CA 94025

 SIGNATURE PAGE TO DOORDASH, INC.

 SEVENTH AMENDED AND RESTATED INVESTORS’
RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 SoftBank Vision Fund (AIV M2) L.P.

	
	 By: /s/ Ruwan
Weerasekera                                    

Name: Ruwan Weerasekera
 Title:   Director

	
	 SoftBank Vision Fund (AIV M2) L.P.

c/o SB Investment Advisers (UK) Limited
 69 Grosvenor Street

London, W1K 3JP
 Attention: Ayako Adachi

Email:

	
	and
	
	 SoftBank Vision Fund (AIV M2) L.P.

c/o SB Investment Advisers (US), Inc.
 1 Circle Star Way, 4F

San Carlos, CA 94070
 Attention: Brian Wheeler

Email:

SIGNATURE PAGE TO DOORDASH , INC. 

SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 FIDELITY CONTRAFUND: FIDELITY CONTRAFUND

		
	By:	 	 /s/ Chris Maher

	Name:	 	Chris Maher
	Title:	 	Authorized Signatory
	
	 Address:
 Mag & Co.

c/o Brown Brothers Harriman & Co.
 Attn: Corporate
Actions /Vault
 140 Broadway
 New York, NY 10005

 SIGNATURE PAGE TO
DOORDASH, INC. 
 SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	FIDELITY CONTRAFUND COMMINGLED POOL 
	By: Fidelity Management Trust Company, as Trustee
		
	By:	 	/s/ Chris Maher
	Name:	 	Chris Maher
	Title:	 	Authorized Signatory

  

	
	Address:
	Mag & Co.
	c/o Brown Brothers Harriman & Co.
	Attn: Corporate Actions /Vault
	140 Broadway
	New York, NY 10005

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	FIDELITY CONTRAFUND: FIDELITY CONTRAFUND K6
		
	By:	 	/s/ Chris Maher
	Name: Chris Maher
	Title: Authorized Signatory
	
	Address:
	 The Northern Trust Company
 Attn:
Fidelity Client Team – GFS Custody, C-1N
 333 South Wabash Ave, 32nd Floor

Chicago, Illinois 60604
 Fidelity Contrafund: Fidelity Contrafund
K6
 Reference Account #
 Email:

Fax number:

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	FIDELITY CONTRAFUND: FIDELITY ADVISOR NEW INSIGHTS FUND—SUB A
		
	By:	 	/s/ Chris Maher
	Name: Chris Maher
	Title: Authorized Signatory
	
	Address:
	 Mag & Co.
 c/o Brown
Brothers Harriman & Co.
 Attn: Corporate Actions /Vault

140 Broadway
 New York, NY 10005

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	FIDELITY INSIGHTS INVESTMENT TRUST
	By its manager Fidelity Investments Canada ULC
		
	By:	 	/s/ Chris Maher
	Name: Chris Maher
	Title: Authorized Signatory
	
	Address:
	 State Street Bank & Trust

PO Box 5756
 Boston, Massachusetts 02206

Attn: Thisbe & Co Fidelity Insights Investment Trust

Email:
 Fax number:

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	FIDELITY CONTRAFUND: FIDELITY FLEX OPPORTUNISTIC INSIGHTS FUND
		
	By:	 	/s/ Chris Maher
	Name:	 	Chris Maher
	Title:	 	Authorized Signatory
	
	Address:
	 The Northern Trust Company
 Attn:
Fidelity Client Team – GFS Custody, C-1N
 333 South Wabash Ave, 32nd Floor

Chicago, Illinois 60604
 Fidelity Contrafund: Fidelity Flex
Opportunistic Insights Fund
 Reference Account #

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	 FIDELITY CONTRAFUND: FIDELITY SERIES OPPORTUNISTIC INSIGHTS FUND

		
	By:	 	/s/ Chris Maher
	Name:	 	Chris Maher
	Title:	 	Authorized Signatory
	
	Address:
	 Mag & Co.
 c/o Brown
Brothers Harriman & Co.
 Attn: Corporate Actions /Vault

140 Broadway
 New York, NY 10005

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	 VARIABLE INSURANCE PRODUCTS FUND II: CONTRAFUND PORTFOLIO

		
	By:	 	/s/ Chris Maher
	Name:	 	Chris Maher
	Title:	 	Authorized Signatory
	
	Address:
	 Mag & Co.
 c/o Brown
Brothers Harriman & Co.
 Attn: Corporate Actions /Vault

140 Broadway
 New York, NY 10005

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

					
		 	INVESTOR:
		
		 	 T. Rowe Price Growth Stock Fund, Inc.

Seasons Series Trust—SA T. Rowe Price Growth Stock Portfolio

Voya Partners, Inc.—VY T. Rowe Price Growth Equity Portfolio

Brighthouse Funds Trust II—T. Rowe Price Large Cap Growth Portfolio

Lincoln Variable Insurance Products Trust—LVIP T. Rowe Price Growth Stock Fund

T. Rowe Price Growth Stock Trust
 Prudential Retirement
Insurance and Annuity Company Aon Savings Plan Trust
 Caleres, Inc. Retirement Plan

Colgate Palmolive Employees Savings and Investment
 Plan
Trust
 Brinker Capital Destinations Trust—Destinations Large Cap Equity Fund

Alight Solutions LLC 401K Plan Trust
 MassMutual Select
Funds—MassMutual Select T. Rowe Price Large Cap Blend Fund
 Legacy Health Employees’ Retirement Plan Legacy Health

		
		 	Each account, severally and not jointly
		
		 	By: T. Rowe Price Associates, Inc., Investment Adviser or Subadviser, as applicable
			
		 	By:	 	/s/ Andrew Baek
		 	Name:	 	Andrew Baek
		 	Title:	 	Vice President
			
	Address:	 		 	
		 	 T. Rowe Price Associates, Inc.
 100
East Pratt Street
 Baltimore, MD 21202
 Attn.: Andrew Baek,
Vice President
 Phone:
 Email:

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

					
		 	INVESTOR:
		
		 	 T. Rowe Price Communications & Technology Fund, Inc. TD Mutual Funds—TD Global Entertainment &
Communications Fund

		
		 	Each account, severally and not jointly
		
		 	By: T. Rowe Price Associates, Inc., Investment Adviser or Subadviser, as applicable
			
		 	By:	 	/s/ Andrew Baek
		 	Name:	 	Andrew Baek
		 	Title:	 	Vice President
			
	Address:	 		 	
		 	 T. Rowe Price Associates, Inc.
 100
East Pratt Street
 Baltimore, MD 21202
 Attn.: Andrew Baek,
Vice President
 Phone:
 Email:

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

					
		 	INVESTOR:
		
		 	 T. Rowe Price Global Stock Fund

Arkansas Teacher Retirement System
 T. Rowe Price Global
Focused Growth Equity Pool
 Union Pacific Corporation Master Retirement Trust

Hostplus Pooled Superannuation Trust
 UniSuper

Superannuation Funds Management Corporation of South Australia

Superannuation Funds Management Corporation of South Australia

Government Superannuation Fund
 The Board of Trustees of
the National Provident Fund in its capacity as trustee of the O Fund of the Global Asset Trust

		
		 	Each account, severally and not jointly
		
		 	 By: T. Rowe Price Associates, Inc., Investment Adviser or Subadviser, as applicable 

			
		 	By:	 	/s/ Andrew Baek
		 	Name:	 	Andrew Baek
		 	Title:	 	Vice President
			
	Address:	 		 	
		 	 T. Rowe Price Associates, Inc.
 100
East Pratt Street
 Baltimore, MD 21202
 Attn.: Andrew Baek,
Vice President
 Phone:
 Email:

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
 INVESTOR 

 

			
	 T. Rowe Price Large-Cap Growth Fund

Principal Funds, Inc.—LargeCap Growth Fund I

Principal Variable Contracts Funds, Inc.
 LargeCap
Growth Account I
 Trustees of the Ohio Operating Engineers Pension Fund

Consolidated Fund of the R.W. Grand Lodge of F. and AM. Of Pennsylvania

NextEra Energy Inc. Employee Pension Plan
 NextEra
Energy, Inc. Employee Retirement Savings Plan
 USG Corporation Retirement Plan Trust

T. Rowe Price U.S. Equities Trust
 Marriott
International, Inc. Pooled Investment Trust for Participant Directed Accounts
 Tucson Supplemental Retirement System

Delta Air Lines, Inc. Defined Contribution Plans Master Trust

Master Trust for Certain Tax Qualified Bechtel Retirement Plans

The KP Funds—KP Large Cap Equity Fund
 City of
Warwick Pension Plans
 The Master Trust adopted by the Home Depot

FutureBuilder and The Home Depot
 FutureBuilder for
Puerto Rico Plans
	  	 City of Tallahassee Pension Fund

Lettie Pate Evans Foundation, Inc.
 Joseph B. Whitehead
Foundation
 Robert W. Woodruff Foundation, Inc.

Robert W. Woodruff Health Sciences Center Fund, Inc.

Ohio Public Employees Deferred Compensation Program

Prudential Retirement Insurance and Annuity Company

Toyota Motor North America, Inc. Retirement Savings Plan

Union Bank & Trust Company
 Lettie Pate
Whitehead Foundation, Inc.
 The Community Foundation for Greater Atlanta, Inc.

Leonardo DRS, Inc. 401(k) Plan
 American Airlines, Inc.
401(k) Plan and the American Airlines, Inc. 401(k) Plan for Pilots
 Fresno County Employees Retirement Association

T. Rowe Price Large-Cap Growth Trust

RR Donnelley Savings Plan Trust
 Bank of the West 401(k)
Plan
 T. Rowe Price Large-Cap Growth Trust I

  

					
		 	Each account, severally and not jointly
		
		 	 By: T. Rowe Price Associates, Inc., Investment Adviser or Subadviser, as applicable

			
		 	By:	 	/s/ Andrew Baek
		 	Name:	 	Andrew Baek
		 	Title:	 	Vice President
			
	Address:	 		 	
		 	 T. Rowe Price Associates, Inc.
 100
East Pratt Street
 Baltimore, MD 21202
 Attn.: Andrew Baek,
Vice President
 Phone:
 Email:

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

					
		 	INVESTOR:
		
		 	 T. Rowe Price Global Consumer Fund

		
		 	 By: T. Rowe Price Associates, Inc., Investment Adviser or Subadviser, as applicable

			
		 	By:	 	/s/ Andrew Baek
		 	Name:	 	Andrew Baek
		 	Title:	 	Vice President
			
	Address:	 		 	
		 	 T. Rowe Price Associates, Inc.
 100
East Pratt Street
 Baltimore, MD 21202
 Attn.: Andrew Baek,
Vice President
 Phone:
 Email:

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

					
		 	INVESTOR:
		
		 	 T. Rowe Price Mid-Cap Growth Fund, Inc.

T. Rowe Price Institutional Mid-Cap Equity Growth Fund

T. Rowe Price Mid-Cap Growth Portfolio

T. Rowe Price U.S. Equities Trust
 Great-West Funds,
Inc.—Great-West T. Rowe Price Mid Cap Growth Fund
 TD Mutual Funds —TD U.S. Mid-Cap Growth
Fund
 MassMutual Select Funds—MassMutual Select Mid Cap Growth Fund

MML Series Investment Fund—MML Mid Cap Growth Fund

Brighthouse Funds Trust I—T. Rowe Price Mid Cap Growth Portfolio

Marriott International, Inc. Pooled Investment Trust for Participant Directed Accounts

T. Rowe Price U.S. Mid-Cap Growth Equity Trust

L’Oreal USA, Inc. Employee Retirement Savings Plan

Costco 401(k) Retirement Plan
 MassMutual Select
Funds—MassMutual Select T. Rowe Price Small and Mid Cap Blend Fund

		
		 	Each account, severally and not jointly
		
		 	 By: T. Rowe Price Associates, Inc., Investment Adviser or Subadviser, as applicable

			
		 	By:	 	/s/ Andrew Baek
		 	Name:	 	Andrew Baek
		 	Title:	 	Vice President
			
	Address:	 		 	
		 	 T. Rowe Price Associates, Inc.
 100
East Pratt Street
 Baltimore, MD 21202
 Attn.: Andrew Baek,
Vice President
 Phone:
 Email:

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	PEAR VENTURES I, L.P.
		
	By:	 	 /s/ Mar Hershenson

	Name:	 	Mar Hershenson
	Title:	 	Managing Partner
	
	Address:
	320 High Street
	Palo Alto, CA 94301

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Seventh Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	SVF FAST (CAYMAN) LIMITED 
		
	By:	 	 /s/ Karen Ellerbe

	Name: Karen Ellerbe
	Title: Director
	
	Address:
	27 Hospital Road
	Cayman Corporate Centre
	 George Town Grand Cayman

	 Cayman Islands KY1-9008

 SIGNATURE PAGE TO DOORDASH,
INC. 
 SEVENTH AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 

 SCHEDULE A 

INVESTORS 
 Sequoia Capital
USV XIV Holdco, Ltd. 
 Sequoia Capital U.S. Growth Fund VI, L.P. 

Sequoia Capital U.S. Growth VI Principals Fund, L.P. 

Sequoia Capital U.S. Growth Fund VII, L.P. 

Sequoia Capital U.S. Growth VII Principals Fund, L.P. 

Sequoia Capital Global Growth Fund, L.P. 

Sequoia Capital Global Growth Principals Fund, L.P. 

Sequoia Capital Global Growth Fund II, L.P. 

Sequoia Capital Global Growth II Principals Fund, L.P. 

SCGE Fund, L.P. 
 a16z Seed-III, LLC 
 Maverick YC, Ltd. 

Start Fund 2 LLC 
 Paul Buchheit

 SV Angel IV LP 
 Charles River
Partnership XV, LP 
 Russell and Elizabeth Siegelman Living Trust 

Moonshot Angels LLC 
 HKB Capital,
LLC 
 Pear Ventures I, L.P. 

Rachleff Family Trust 
 Streamlined
Ventures I, L.P. 
 Khosla Ventures IV, LP 

Khosla Ventures IV (CF), LP 
 Khosla
Ventures Seed B, LP 
 Khosla Ventures Seed B (CF), LP 

Brent Goldman 
 Ooga Labs LLC 

EEZ, LLC 
 KPCB Holdings, Inc., as
nominee 
 The Wellcome Trust Limited as trustee of the Wellcome Trust 

Y Combinator Continuity Holdings I, LLC 

Greenview Investment Pte Ltd 

Vanderbilt University 
 SVF Fast
(Cayman) Limited 
 Coatue US 11 LLC 

Coatue Kona III LP 
 DST Global VI,
L.P. 
 DSTG VI Investments, L.P. 

DSTG VI Investments-A, L.P. 

DST Investments XXII, L.P. 
 DST
Investments XXIII, L.P. 
 DSTG VI Investments-A, L.P. 

Rahul Ravindra Raj Mehta and Parul Mehta, JTWROS 

Doorstep DF Holdings, LP 
 Dahlia
Investments Pte Ltd. 
 Darsana Master Fund LP 

  
 S-1 

 Sands Capital Global Innovation Fund, LLC 

T. Rowe Price Growth Stock Fund, Inc. 

Seasons Series Trust—SA T. Rowe Price Growth Stock Portfolio 

Voya Partners, Inc.—VY T. Rowe Price Growth Equity Portfolio 

Brighthouse Funds Trust II—T. Rowe Price Large Cap Growth Portfolio 

Lincoln Variable Insurance Products Trust—LVIP T. Rowe Price Growth Stock Fund 

Penn Series Funds, Inc.—Large Growth Stock Fund 

T. Rowe Price Growth Stock Trust 

Sony Master Trust 
 Prudential
Retirement Insurance and Annuity Company 
 Aon Savings Plan Trust 

Caleres, Inc. Retirement Plan 

Colgate Palmolive Employees Savings and Investment Plan Trust 

Brinker Capital Destinations Trust—Destinations Large Cap Equity Fund 

Alight Solutions LLC 401K Plan Trust 

MassMutual Select Funds—MassMutual Select T. Rowe Price Large Cap Blend Fund 

Legacy Health Employees’ Retirement Plan 

Legacy Health 
 T. Rowe Price Global
Technology Fund, Inc. 
 TD Mutual Funds—TD Science & Technology Fund 

T. Rowe Price Communications & Technology Fund, Inc. 

TD Mutual Funds—TD Global Entertainment & Communications Fund 

T. Rowe Price Global Stock Fund 

Arkansas Teacher Retirement System 

T. Rowe Price Global Focused Growth Equity Pool 

Union Pacific Corporation Master Retirement Trust 

Hostplus Pooled Superannuation Trust 

Square, Inc. 
 Durable Capital
Master Fund LP 
 Fidelity Contrafund: Fidelity Contrafund 

Fidelity Contrafund Commingled Pool 

Fidelity Contrafund: Fidelity Contrafund K6 

Fidelity Contrafund: Fidelity Advisor New Insights Fund—Sub A 

Fidelity Insights Investment Trust 

Fidelity Contrafund: Fidelity Flex Opportunistic Insights Fund 

Fidelity Contrafund: Fidelity Series Opportunistic Insights Fund 

Variable Insurance Products Fund II: Contrafund Portfolio 

UniSuper 
 Superannuation Funds
Management Corporation of South Australia 
 Superannuation Funds Management Corporation of South Australia 

Government Superannuation Fund 
 The
Board of Trustees of the National Provident Fund in its capacity as trustee of the O Fund of the Global 
 Asset Trust 

T. Rowe Price Large-Cap Growth Fund 

Principal Funds, Inc.— LargeCap Growth Fund I 

Principal Variable Contracts Funds, Inc.— LargeCap Growth Account I 

Trustees of the Ohio Operating Engineers Pension Fund 

Consolidated Fund of the R.W. Grand Lodge of F. and AM. Of Pennsylvania 

NextEra Energy Inc. Employee Pension Plan 

NextEra Energy, Inc. Employee Retirement Savings Plan 

USG Corporation Retirement Plan Trust 

  
 S-2 

 T. Rowe Price U.S. Equities Trust 

Marriott International, Inc. Pooled Investment Trust for Participant Directed Accounts 

Tucson Supplemental Retirement System 

Delta Air Lines, Inc. Defined Contribution Plans Master Trust 

Master Trust for Certain Tax Qualified Bechtel Retirement Plans 

The KP Funds—KP Large Cap Equity Fund 

City of Warwick Pension Plans 
 The
Master Trust adopted by the Home Depot FutureBuilder and The Home Depot FutureBuilder for Puerto 
 Rico Plans 

City of Tallahassee Pension Fund 

Lettie Pate Evans Foundation, Inc. 

Joseph B. Whitehead Foundation 

Robert W. Woodruff Foundation, Inc. 

Robert W. Woodruff Health Sciences Center Fund, Inc. 

Ohio Public Employees Deferred Compensation Program 

Prudential Retirement Insurance and Annuity Company 

Toyota Motor North America, Inc. Retirement Savings Plan 

Union Bank & Trust Company 

Lettie Pate Whitehead Foundation, Inc. 

The Community Foundation for Greater Atlanta, Inc. 

Leonardo DRS, Inc. 401(k) Plan 

American Airlines, Inc. 401(k) Plan and the American Airlines, Inc. 401(k) Plan for Pilots 

Fresno County Employees Retirement Association 

T. Rowe Price Large-Cap Growth Trust 

RR Donnelley Savings Plan Trust 

Bank of the West 401(k) Plan 
 T.
Rowe Price Large-Cap Growth Trust I 
 T. Rowe Price Global Consumer Fund 

T. Rowe Price Mid-Cap Growth Fund, Inc. 

T. Rowe Price Institutional Mid-Cap Equity Growth Fund 

T. Rowe Price Mid-Cap Growth Portfolio 

T. Rowe Price U.S. Equities Trust 

Great-West Funds, Inc.—Great-West T. Rowe Price Mid Cap Growth Fund 

TD Mutual Funds - TD U.S. Mid-Cap Growth Fund 

MassMutual Select Funds—MassMutual Select Mid Cap Growth Fund 

MML Series Investment Fund—MML Mid Cap Growth Fund 

Brighthouse Funds Trust I—T. Rowe Price Mid Cap Growth Portfolio 

Marriott International, Inc. Pooled Investment Trust for Participant Directed Accounts 

T. Rowe Price U.S. Mid-Cap Growth Equity Trust 

L’Oreal USA, Inc. Employee Retirement Savings Plan 

Costco 401(k) Retirement Plan 

MassMutual Select Funds—MassMutual Select T. Rowe Price Small and Mid Cap Blend Fund 

AU UNI UNISUP USSDGE 

  
 S-3EX-10.4

 Exhibit 10.4 

DOORDASH, INC. 
 2014
STOCK PLAN 
 ADOPTED ON MARCH 28, 2014 

AMENDED AND RESTATED AS OF JUNE 19, 2018 

AMENDED AND RESTATED AS OF SEPTEMBER 15, 2020 
  

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	 SECTION 1. ESTABLISHMENT AND PURPOSE
	  	 	1	 
		
	 SECTION 2. ADMINISTRATION
	  	 	1	 
			
	 (a)
	  	 Committees of the Board of Directors
	  	 	1	 
	 (b)
	  	 Authority of the Board of Directors
	  	 	1	 
		
	 SECTION 3. ELIGIBILITY
	  	 	1	 
			
	 (a)
	  	 General Rule
	  	 	1	 
	 (b)
	  	 Ten-Percent Stockholders
	  	 	1	 
		
	 SECTION 4. STOCK SUBJECT TO PLAN 
	  	 	2	 
			
	 (a)
	  	 Basic Limitation
	  	 	2	 
	 (b)
	  	 Additional Shares
	  	 	2	 
		
	 SECTION 5. TERMS AND CONDITIONS OF AWARDS OR SALES 
	  	 	2	 
			
	 (a)
	  	 Stock Grant or Purchase Agreement
	  	 	2	 
	 (b)
	  	 Duration of Offers and Nontransferability of Rights
	  	 	2	 
	 (c)
	  	 Purchase Price
	  	 	2	 
		
	 SECTION 6. TERMS AND CONDITIONS OF OPTIONS 
	  	 	2	 
			
	 (a)
	  	 Stock Option Agreement
	  	 	2	 
	 (b)
	  	 Number of Shares
	  	 	3	 
	 (c)
	  	 Exercise Price
	  	 	3	 
	 (d)
	  	 Exercisability
	  	 	3	 
	 (e)
	  	 Basic Term
	  	 	3	 
	 (f)
	  	 Termination of Service (Except by Death)
	  	 	3	 
	 (g)
	  	 Leaves of Absence
	  	 	4	 
	 (h)
	  	 Death of Optionee
	  	 	4	 
	 (i)
	  	 Restrictions on Transfer of Options
	  	 	4	 
	 (j)
	  	 No Rights as a Stockholder
	  	 	4	 
	 (k)
	  	 Modification, Extension and Assumption of Options
	  	 	4	 
	 (l)
	  	 Company’s Right to Cancel Certain Options
	  	 	4	 
		
	 SECTION 7. PAYMENT FOR SHARES
	  	 	5	 
			
	 (a)
	  	 General Rule
	  	 	5	 
	 (b)
	  	 Services Rendered
	  	 	5	 
	 (c)
	  	 Promissory Note
	  	 	5	 
	 (d)
	  	 Surrender of Stock
	  	 	5	 
	 (e)
	  	 Exercise/Sale
	  	 	5	 
	 (f)
	  	 Net Exercise
	  	 	5	 
	 (g)
	  	 Other Forms of Payment
	  	 	5	 

							
	 SECTION 8. TERMS AND CONDITIONS OF RESTRICTED STOCK UNITS 
	  	 	6	 
			
	 (a)
	    	 Restricted Stock Unit Agreement
	  	 	6	 
	 (b)
	    	 Payment for Restricted Stock Units
	  	 	6	 
	 (c)
	    	 Vesting Conditions
	  	 	6	 
	 (d)
	    	 Forfeiture
	  	 	6	 
	 (e)
	    	 Voting and Dividend Rights
	  	 	6	 
	 (f)
	    	 Form and Time of Settlement of Restricted Stock Units
	  	 	6	 
	 (g)
	    	 Death of Recipient
	  	 	6	 
	 (h)
	    	 Creditors’ Rights
	  	 	6	 
	 (i)
	    	 Modification, Extension and Assumption of Restricted Stock Units
	  	 	6	 
	 (j)
	    	 Restrictions on Transfer of Restricted Stock Units
	  	 	7	 
		
	 SECTION 9. ADJUSTMENT OF SHARES
	  	 	7	 
			
	 (a)
	    	 General
	  	 	7	 
	 (b)
	    	 Corporate Transactions
	  	 	7	 
	 (c)
	    	 Reservation of Rights
	  	 	9	 
		
	 SECTION 10. MISCELLANEOUS PROVISIONS
	  	 	9	 
			
	 (a)
	    	 Securities Law Requirements
	  	 	9	 
	 (b)
	    	 No Retention Rights
	  	 	10	 
	 (c)
	    	 Treatment as Compensation
	  	 	10	 
	 (d)
	    	 Governing Law
	  	 	10	 
	 (e)
	    	 Conditions and Restrictions on Shares
	  	 	10	 
	 (f)
	    	 Tax Matters
	  	 	10	 
		
	 SECTION 11. DURATION AND AMENDMENTS; STOCKHOLDER APPROVAL
	  	 	11	 
			
	 (a)
	    	 Term of the Plan
	  	 	11	 
	 (b)
	    	 Right to Amend or Terminate the Plan
	  	 	11	 
	 (c)
	    	 Effect of Amendment or Termination
	  	 	11	 
	 (d)
	    	 Stockholder Approval
	  	 	11	 
		
	 SECTION 12. DEFINITIONS
	  	 	11	 
			
	 (a)
	    	 “Award”
	  	 	11	 
	 (b)
	    	 “Award Agreement”
	  	 	11	 
	 (c)
	    	 “Board of Directors”
	  	 	11	 
	 (d)
	    	 “Code”
	  	 	11	 
	 (e)
	    	 “Committee”
	  	 	12	 
	 (f)
	    	 “Company”
	  	 	12	 
	 (g)
	    	 “Consultant”
	  	 	12	 
	 (h)
	    	 “Date of Grant”
	  	 	12	 
	 (i)
	    	 “Disability”
	  	 	12	 
	 (j)
	    	 “Employee”
	  	 	12	 
	 (k)
	    	 “Exchange Act”
	  	 	12	 
	 (l)
	    	 “Exercise Price”
	  	 	12	 
	 (m)
	    	 “Fair Market Value”
	  	 	12	 
	 (n)
	    	 “Grantee”
	  	 	12	 
	 (o)
	    	 “ISO”
	  	 	12	 
	 (p)
	    	 “Nonstatutory Option”
	  	 	12	 
	 (q)
	    	 “Option”
	  	 	12	 
	 (r)
	    	 “Optionee”
	  	 	12	 

  
 ii 

					
	 (s)
	    	 “Outside Director”
	  	12
	 (t)
	    	 “Parent”
	  	12
	 (u)
	    	 “Participant”
	  	13
	 (v)
	    	 “Plan”
	  	13
	 (w)
	    	 “Purchase Price”
	  	13
	 (x)
	    	 “Purchaser”
	  	13
	 (y)
	    	 “Restricted Stock Unit”
	  	13
	 (z)
	    	 “Restricted Stock Unit Agreement”
	  	13
	 (aa)
	    	 “Securities Act”
	  	13
	 (bb)
	    	 “Service”
	  	13
	 (cc)
	    	 “Share”
	  	13
	 (dd)
	    	 “Stock”
	  	13
	 (ee)
	    	 “Stock Grant Agreement”
	  	13
	 (ff)
	    	 “Stock Option Agreement”
	  	13
	 (gg)
	    	 “Stock Purchase Agreement”
	  	13
	 (hh)
	    	 “Subsidiary”
	  	13

  
 iii 

 DOOR DASH, INC. 

2014 STOCK PLAN 
 SECTION 1.
ESTABLISHMENT AND PURPOSE. 
 The purpose of this Plan is to attract, incentivize and retain Employees, Outside Directors and Consultants
through the grant of Awards. The Plan provides for the direct award or sale of Shares, the grant of Options to purchase Shares and the grant of Restricted Stock Units to acquire shares. Options granted under the Plan may be ISOs intended to qualify
under Code Section 422 or Nonstatutory Options which are not intended to so qualify. 
 Capitalized terms are defined in
Section 12. 
 SECTION 2. ADMINISTRATION. 

(a)    Committees of the Board of Directors. The Plan may be administered by one or more Committees. Each
Committee shall consist, as required by applicable law, of one or more members of the Board of Directors who have been appointed by the Board of Directors. Each Committee shall have such authority and be responsible for such functions as the Board
of Directors has assigned to it. If no Committee has been appointed, the entire Board of Directors shall administer the Plan. Any reference to the Board of Directors in the Plan or an Award Agreement shall be construed as a reference to the
Committee (if any) to whom the Board of Directors has assigned a particular function. 
 (b)    Authority of
the Board of Directors. Subject to the provisions of the Plan, the Board of Directors shall have full authority and discretion to take any actions it deems necessary or advisable for the administration of the Plan. Notwithstanding
anything to the contrary in the Plan, with respect to the terms and conditions of awards granted to Participants outside the United States, the Board of Directors may vary from the provisions of the Plan to the extent it determines it necessary and
appropriate to do so; provided that it may not vary from those Plan terms requiring stockholder approval pursuant to Section 11(d) below. All decisions, interpretations and other actions of the Board of Directors shall be final and binding on
all Participants and all persons deriving their rights from a Participant.  
 SECTION 3. ELIGIBILITY. 

(a)    General Rule. Only Employees, Outside Directors and Consultants shall be eligible for the grant of
Nonstatutory Options, Restricted Stock Units or the direct award or sale of Shares. Only Employees shall be eligible for the grant of ISOs. 

(b)    Ten-Percent Stockholders. A person who owns more than 10% of
the total combined voting power of all classes of outstanding stock of the Company, its Parent or any of its Subsidiaries shall not be eligible for the grant of an ISO unless (i) the Exercise Price is at least 110% of the Fair Market Value of a
Share on the Date of Grant and (ii) such ISO by its terms is not exercisable after the expiration of five years from the Date of Grant. For purposes of this Subsection (b), in determining stock ownership, the attribution rules of Code
Section 424(d) shall be applied. 

 SECTION 4. STOCK SUBJECT TO PLAN. 

(a)    Basic Limitation. Not more than 638,298 Shares may be issued under the Plan, subject to Subsection
(b) below and Section 9(a). All of these Shares may be issued upon the exercise of ISOs. The number of Shares that are subject to Awards outstanding at any time under the Plan may not exceed the number of Shares that then remain available
for issuance under the Plan. The Company, during the term of the Plan, shall at all times reserve and keep available sufficient Shares to satisfy the requirements of the Plan. Shares offered under the Plan may be authorized but unissued Shares or
treasury Shares. 
 (b)    Additional Shares. In the event that Shares previously issued under the Plan
are reacquired by the Company, such Shares shall be added to the number of Shares then available for issuance under the Plan. In the event that Shares that otherwise would have been issuable under the Plan are withheld by the Company in payment of
the Purchase Price, Exercise Price or withholding taxes, such Shares shall remain available for issuance under the Plan. In the event that an outstanding Option, Restricted Stock Unit or other right for any reason expires or is canceled, the Shares
allocable to the unexercised or unsettled portion of such Option, Restricted Stock Unit or other right shall be added to the number of Shares then available for issuance under the Plan. Notwithstanding the foregoing, in the case of ISOs, this
Subsection (b) shall be subject to any limitations imposed under Section 422 of the Code and the treasury regulations thereunder. 
 SECTION 5.
TERMS AND CONDITIONS OF AWARDS OR SALES. 
 (a)    Stock Grant or Purchase Agreement. Each award of
Shares under the Plan shall be evidenced by a Stock Grant Agreement between the Grantee and the Company. Each sale of Shares under the Plan (other than pursuant to an Option or Restricted Stock Unit) shall be evidenced by a Stock Purchase Agreement
between the Purchaser and the Company. Such award or sale shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions which are not inconsistent with the Plan and which the Board of
Directors deems appropriate for inclusion in a Stock Grant Agreement or Stock Purchase Agreement. The provisions of the various Stock Grant Agreements and Stock Purchase Agreements entered into under the Plan need not be identical. 

(b)    Duration of Offers and Nontransferability of Rights. Any right to purchase Shares under the Plan
(other than an Option) shall automatically expire if not exercised by the Purchaser within 30 days (or such other period as may be specified in the Award Agreement) after the grant of such right was communicated to the Purchaser by the Company. Such
right is not transferable and may be exercised only by the Purchaser to whom such right was granted. 

(c)    Purchase Price. The Board of Directors shall determine the Purchase Price of Shares to be offered
under the Plan at its sole discretion. The Purchase Price shall be payable in a form described in Section 7. 
 SECTION 6. TERMS AND CONDITIONS OF
OPTIONS. 
 (a)    Stock Option Agreement. Each grant of an Option under the Plan shall be evidenced by
a Stock Option Agreement between the Optionee and the Company. The Option shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions that are not inconsistent with the Plan and that the
Board of Directors deems appropriate for inclusion in a Stock Option Agreement. The provisions of the various Stock Option Agreements entered into under the Plan need not be identical. 

  
 2 

 (b)    Number of Shares. Each Stock Option Agreement shall
specify the number of Shares that are subject to the Option and shall provide for the adjustment of such number in accordance with Section 9. The Stock Option Agreement shall also specify whether the Option is an ISO or a Nonstatutory Option.

 (c)    Exercise Price. Each Stock Option Agreement shall specify the Exercise Price. The Exercise Price
of an Option shall not be less than 100% of the Fair Market Value of a Share on the Date of Grant, and in the case of an ISO a higher percentage may be required by Section 3(b). Subject to the preceding sentence, the Exercise Price shall be
determined by the Board of Directors at its sole discretion. The Exercise Price shall be payable in a form described in Section 7. This Subsection (c) shall not apply to an Option granted pursuant to an assumption of, or substitution for,
another option in a manner that complies with Code Section 424(a) (whether or not the Option is an ISO). 

(d)    Exercisability. Each Stock Option Agreement shall specify the date when all or any installment of the
Option is to become exercisable. No Option shall be exercisable unless the Optionee (i) has delivered an executed copy of the Stock Option Agreement to the Company or (ii) otherwise agrees to be bound by the terms of the Stock Option
Agreement. The Board of Directors shall determine the exercisability provisions of the Stock Option Agreement at its sole discretion. 

(e)    Basic Term. The Stock Option Agreement shall specify the term of the Option. The term shall not
exceed 10 years from the Date of Grant, and in the case of an ISO, a shorter term may be required by Section 3(b). Subject to the preceding sentence, the Board of Directors at its sole discretion shall determine when an Option is to expire.

 (f)    Termination of Service (Except by Death). If an Optionee’s Service terminates for any
reason other than the Optionee’s death, then the Optionee’s Options shall expire on the earliest of the following dates: 

(i)    The expiration date determined pursuant to Subsection (e) above; 

(ii)    The date three months after the termination of the Optionee’s Service for any reason other than Disability,
or such earlier or later date as the Board of Directors may determine (but in no event earlier than 30 days after the termination of the Optionee’s Service); or 

(iii)    The date six months after the termination of the Optionee’s Service by reason of Disability, or such later
date as the Board of Directors may determine. 
 The Optionee may exercise all or part of the Optionee’s Options at any time before the
expiration of such Options under the preceding sentence, but only to the extent that such Options had become exercisable before the Optionee’s Service terminated (or became exercisable as a result of the termination) and the underlying Shares
had vested before the Optionee’s Service terminated (or vested as a result of the termination). The balance of such Options shall lapse when the Optionee’s Service terminates. In the event that the Optionee dies after the termination of
the Optionee’s Service but before the expiration of the Optionee’s Options, all or part of such Options may be exercised (prior to expiration) by the executors or administrators of the Optionee’s estate or by any person who has
acquired such Options directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that such Options had become exercisable before the Optionee’s Service terminated (or became exercisable as a result of
the termination) and the underlying Shares had vested before the Optionee’s Service terminated (or vested as a result of the termination). 

  
 3 

 (g)    Leaves of Absence. For purposes of Subsection
(f) above, Service shall be deemed to continue while the Optionee is on a bona fide leave of absence, if such leave was approved by the Company in writing and if continued crediting of Service for this purpose is expressly required by the terms
of such leave or by applicable law (as determined by the Company). 
 (h)    Death of Optionee. If an
Optionee dies while the Optionee is in Service, then the Optionee’s Options shall expire on the earlier of the following dates: 

(i)    The expiration date determined pursuant to Subsection (e) above; or 

(ii)    The date 12 months after the Optionee’s death, or such earlier or later date as the Board of Directors may
determine (but in no event earlier than six months after the Optionee’s death). 
 All or part of the Optionee’s Options may be
exercised at any time before the expiration of such Options under the preceding sentence by the executors or administrators of the Optionee’s estate or by any person who has acquired such Options directly from the Optionee by beneficiary
designation, bequest or inheritance, but only to the extent that such Options had become exercisable before the Optionee’s death (or became exercisable as a result of the death) and the underlying Shares had vested before the Optionee’s
death (or vested as a result of the Optionee’s death). The balance of such Options shall lapse when the Optionee dies. 

(i)    Restrictions on Transfer of Options. An Option shall be transferable by the Optionee only by
(i) a beneficiary designation, (ii) a will or (iii) the laws of descent and distribution, except as provided in the next sentence. If the Board of Directors so provides, in a Stock Option Agreement or otherwise, a Nonstatutory Option
may be transferable to the extent permitted by Rule 701 under the Securities Act. An ISO may be exercised during the lifetime of the Optionee only by the Optionee or by the Optionee’s guardian or legal representative. 

(j)    No Rights as a Stockholder. An Optionee, or a transferee of an Optionee, shall have no rights as a
stockholder with respect to any Shares covered by the Optionee’s Option until such person becomes entitled to receive such Shares by filing a notice of exercise and paying the Exercise Price pursuant to the terms of such Option. 

(k)    Modification, Extension and Assumption of Options. Within the limitations of the Plan, and without
stockholder approval, the Board of Directors may modify, extend or assume outstanding Options (including increasing or reducing the Exercise Price in its sole discretion), or may accept the cancellation of outstanding Options (whether granted by the
Company or another issuer) in return for (i) the grant of new Options, (ii) a different type of award for the same or a different number of Shares and at the same or a different Exercise Price (if applicable), and/or (iii) cash, or
may permit Participants to transfer any outstanding Options granted under the 2014 Plan to a financial institution or other person or entity selected by the Board of Directors. The foregoing notwithstanding, no modification of an Option shall,
without the consent of the Optionee, impair the Optionee’s rights or increase the Optionee’s obligations under such Option. 

(l)    Company’s Right to Cancel Certain Options. Any other provision of the Plan or a
Stock Option Agreement notwithstanding, the Company shall have the right at any time to cancel an Option that was not granted in compliance with Rule 701 under the Securities Act. Prior to canceling such Option, the Company shall give the Optionee
not less than 30 days’ notice in writing. If the Company elects to cancel such Option, it shall deliver to the Optionee consideration with an aggregate Fair Market Value equal to the excess of (i) the Fair Market Value of the Shares
subject to such Option as of the time of the cancellation over (ii) the 

  
 4 

 
Exercise Price of such Option. The consideration may be delivered in the form of cash or cash equivalents, in the form of Shares, or a combination of both. If the consideration would be a
negative amount, such Option may be cancelled without the delivery of any consideration. 
 SECTION 7. PAYMENT FOR SHARES. 

(a)    General Rule. The entire Purchase Price or Exercise Price of Shares issued under the Plan shall be
payable in cash or cash equivalents at the time when such Shares are purchased, except as otherwise provided in this Section 7. In addition, the Board of Directors in its sole discretion may also permit payment through any of the methods
described in (b) through below: 
 (b)    Services Rendered. Shares may be awarded under the Plan in
consideration of services rendered to the Company, a Parent or a Subsidiary prior to the award. 

(c)    Promissory Note. All or a portion of the Purchase Price or Exercise Price (as the case may be) of
Shares issued under the Plan may be paid with a full-recourse promissory note. The Shares shall be pledged as security for payment of the principal amount of the promissory note and interest thereon. The interest rate payable under the terms of the
promissory note shall not be less than the minimum rate (if any) required to avoid the imputation of additional interest under the Code. Subject to the foregoing, the Board of Directors (at its sole discretion) shall specify the term, interest rate,
amortization requirements (if any) and other provisions of such note. 
 (d)    Surrender of Stock. All or
any part of the Exercise Price may be paid by surrendering, or attesting to the ownership of, Shares that are already owned by the Optionee. Such Shares shall be surrendered to the Company in good form for transfer and shall be valued at their Fair
Market Value as of the date when the Option is exercised. 
 (e)    Exercise/Sale. If the Stock is
publicly traded, all or part of the Exercise Price and any withholding taxes may be paid by the delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker approved by the Company to sell Shares and to deliver
all or part of the sales proceeds to the Company. 
 (f)    Net Exercise. An Option may permit exercise
through a “net exercise” arrangement pursuant to which the Company will reduce the number of Shares issued upon exercise by the largest whole number of Shares having an aggregate Fair Market Value (determined by the Board of Directors as
of the exercise date) that does not exceed the aggregate Exercise Price or the sum of the aggregate Exercise Price plus all or a portion of the minimum amount required to be withheld under applicable tax law (with the Company accepting from the
Optionee payment of cash or cash equivalents to satisfy any remaining balance of the aggregate Exercise Price and, if applicable, any additional withholding obligation not satisfied through such reduction in Shares); provided that to the
extent Shares subject to an Option are withheld in this manner, the number of Shares subject to the Option following the net exercise will be reduced by the sum of the number of Shares withheld and the number of Shares delivered to the Optionee as a
result of the exercise. 
 (g)    Other Forms of Payment. To the extent that an Award Agreement so
provides, the Purchase Price or Exercise Price of Shares issued under the Plan may be paid in any other form permitted by the Delaware General Corporation Law, as amended. 

  
 5 

 SECTION 8. TERMS AND CONDITIONS OF RESTRICTED STOCK UNITS. 

(a)    Restricted Stock Unit Agreement. Each grant of Restricted Stock Units under the Plan shall be
evidenced by a Restricted Stock Unit Agreement between the recipient and the Company. Such Restricted Stock Units shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions that are not
inconsistent with the Plan and which the Board of Directors deems appropriate for inclusion in a Restricted Stock Unit Agreement. The provisions of the various Restricted Stock Unit Agreements entered into under the Plan need not be identical. 

(b)    Payment for Restricted Stock Units. No cash consideration shall be required of the recipient in
connection with the grant of Restricted Stock Units. 
 (c)    Vesting Conditions. Each Restricted Stock
Unit Agreement shall specify the vesting requirements applicable to the Restricted Stock Units subject thereto, which the Board of Directors shall determine in its sole discretion. 

(d)    Forfeiture. Unless a Restricted Stock Unit Agreement provides otherwise, upon termination of the
recipient’s Service and upon such other times specified in the Restricted Stock Unit Agreement, any unvested Restricted Stock Units shall be forfeited to the Company. 

(e)    Voting and Dividend Rights. The holders of Restricted Stock Units shall have no voting rights. Prior
to settlement or forfeiture, any Restricted Stock Unit granted under the Plan may, at the discretion of the Board of Directors, carry with it a right to dividend equivalents. Such right entitles the holder to be credited with an amount equal to all
cash dividends paid on one Share while the Restricted Stock Unit is outstanding. Dividend equivalents may be converted into additional Restricted Stock Units. Settlement of dividend equivalents may be made in the form of cash, in the form of Shares,
or in a combination of both. Prior to distribution, any dividend equivalents that are not paid shall be subject to the same conditions and restrictions as the Restricted Stock Units to which they attach. 

(f)    Form and Time of Settlement of Restricted Stock Units. Settlement of vested Restricted Stock Units
may be made in the form of (i) cash, (ii) Shares or (iii) any combination of both, as determined by the Board of Directors. The actual number of Restricted Stock Units eligible for settlement may be larger or smaller than the number
included in the original award, based on predetermined performance factors. Vested Restricted Stock Units shall be settled in such manner and at such time(s) as specified in the Restricted Stock Unit Agreement. Until Restricted Stock Units are
settled, the number of Shares represented by such Restricted Stock Units shall be subject to adjustment pursuant to Section 9. 

(g)    Death of Recipient. Any Restricted Stock Units that become distributable after the Participant’s
death shall be distributed to the Participant’s estate or to any person who has acquired such Restricted Stock Units directly from the recipient by beneficiary designation, bequest or inheritance. 

(h)    Creditors’ Rights. A holder of Restricted Stock Units shall have no rights other
than those of a general creditor of the Company. Restricted Stock Units represent an unfunded and unsecured obligation of the Company, subject to the terms and conditions of the applicable Restricted Stock Unit Agreement. 

(i)    Modification, Extension and Assumption of Restricted Stock Units. Within the limitations of the Plan,
and without stockholder approval, the Board of Directors may modify, extend or assume 

  
 6 

 
outstanding restricted stock units (whether granted by the Company or a different issuer), or may accept the cancellation of outstanding restricted stock units (whether granted by the Company or
another issuer) in return for (i) a different type of award for the same or a different number of Shares, and/or (ii) cash, or may permit Participants to transfer any outstanding restricted stock units granted under the 2014 Plan to a
financial institution or other person or entity selected by the Board of Directors. The foregoing notwithstanding, no modification of a Restricted Stock Unit shall, without the consent of the Participant, impair the Participant’s rights or
increase the Participant’s obligations under such Restricted Stock Unit. 
 (j)    Restrictions on Transfer of
Restricted Stock Units . A Restricted Stock Unit shall be transferable by the Participant only by (i) a beneficiary designation, (ii) a will or (iii) the laws of descent and distribution, except as provided in the next
sentence. In addition, if the Board of Directors so provides, in a Restricted Stock Unit Agreement or otherwise, a Restricted Stock Unit shall also be transferable to the extent permitted by Rule 701 under the Securities Act. 

SECTION 9. ADJUSTMENT OF SHARES. 

(a)    General. In the event of a subdivision of the outstanding Stock, a declaration of a dividend payable
in Shares, a combination or consolidation of the outstanding Stock into a lesser number of Shares, a reclassification, or any other increase or decrease in the number of issued shares of Stock effected without receipt of consideration by the
Company, proportionate adjustments shall automatically be made in each of (i) the number and kind of Shares available for future grants under Section 4, (ii) the number and kind of Shares covered by each outstanding Option, Award of
Restricted Stock Units and any outstanding and unexercised right to purchase Shares that has not yet expired pursuant to Section 5(b), (iii) the Exercise Price under each outstanding Option and the Purchase Price applicable to any unexercised
stock purchase right described in clause (ii) above, and (iv) any repurchase price that applies to Shares granted under the Plan pursuant to the terms of a Company repurchase right under the applicable Award Agreement. In the event of a
declaration of an extraordinary dividend payable in a form other than Shares in an amount that has a material effect on the Fair Market Value of the Stock, a recapitalization, a spin-off, or a similar
occurrence, the Board of Directors at its sole discretion may make appropriate adjustments in one or more of the items listed in clauses (i) through (iv) above; provided, however, that the Board of Directors shall in any event make such
adjustments as may be required by Section 25102(o) of the California Corporations Code. No fractional Shares shall be issued under the Plan as a result of an adjustment under this Section 9(a), although the Board of Directors in its sole
discretion may make a cash payment in lieu of fractional Shares. 
 (b)    Corporate Transactions. In the
event that the Company is a party to a merger or consolidation, or in the event of a sale of all or substantially all of the Company’s stock or assets, all Shares acquired under the Plan and all Awards outstanding on the effective date of the
transaction shall be treated in the manner described in the definitive transaction agreement (or, in the event the transaction does not entail a definitive agreement to which the Company is party, in the manner determined by the Board of Directors
in its capacity as administrator of the Plan, with such determination having final and binding effect on all parties), which agreement or determination need not treat all Awards (or all portions of Award) in an identical manner. The treatment
specified in the transaction agreement may include (without limitation) one or more of the following with respect to each outstanding Award: 

(i)    Continuation of the Award by the Company (if the Company is the surviving corporation). 

  
 7 

 (ii)    Assumption of the Award by the surviving corporation or its
parent, provided that the assumption of an Option shall be in a manner that complies with Code Section 424(a) (whether or not the Option is an ISO). 

(iii)    Substitution by the surviving corporation or its parent of a comparable award for the Award (including, but not
limited to, an award to acquire the same consideration paid to the holders of Shares in the transaction). For avoidance of doubt, a comparable award need not be the same type of award as the Award for which it is substituted, and, in the case of an
Option, need not have the same tax-status (e.g., a Nonstatutory Option may be substituted for an ISO). 

(iv)    Cancellation of the Award and a payment to the Participant with respect to each Share subject to the portion of
the Award that is vested as of the transaction date equal to the excess of (A) the value, as determined by the Board of Directors in its absolute discretion, of the property (including cash) received by the holder of a share of Stock as a
result of the transaction, over (if applicable) (B) the per-Share Exercise Price of the Award (such excess, the “Spread”). Such payment shall be made in the form of cash, cash equivalents, or
securities of the surviving corporation or its parent having a value equal to the Spread. In addition, any escrow, indemnification, holdback, earn-out or similar provisions in the transaction agreement may
apply to such payment to the same extent and in the same manner as such provisions apply to the holders of Stock. If the Spread applicable to an Award is zero or a negative number, then the Award may be cancelled without making a payment to the
Participant. 
 (v)    Even if the Spread applicable to an Option is a positive number, cancellation of the Option
without the payment of any consideration; provided that the Optionee shall be notified of such treatment and given an opportunity to exercise the Option (to the extent the Option is vested or becomes vested as of the effective date of the
transaction) during a period of not less than five (5) business days preceding the effective date of the transaction, unless (A) a shorter period is required to permit a timely closing of the transaction and (B) such shorter period
still offers the Optionee a reasonable opportunity to exercise the Option. Any exercise of the Option during such period may be contingent upon the closing of the transaction. 

(vi)    In the case of an Option: (A) suspension of the Optionee’s right to exercise the Option during a
limited period of time preceding the closing of the transaction if such suspension is administratively necessary to permit the closing of the transaction and/or (B) termination of any right the Optionee has to exercise the Option prior to
vesting in the Shares subject to the Option (i.e., “early exercise”), such that following the closing of the transaction the Option may only be exercised to the extent it is vested. 

For the avoidance of doubt, the Board of Directors has discretion to accelerate, in whole or part, the vesting and exercisability of an Award
in connection with a corporate transaction covered by this Section 9(b). 
 Notwithstanding anything to the contrary in this
Section 9(b), in the event that the Company is a party to a merger or consolidation, or in the event of a sale of all or substantially all of the Company’s stock or assets, a successor corporation does not assume or substitute for an Award
(or portion thereof), the Participant holding such Award will fully vest in and have the right to exercise the Participant’s outstanding Option (or portion thereof) that is not assumed or substituted for, including Shares as to which such Award
would not otherwise be vested or exercisable, all restrictions on any award of Shares and Restricted Stock Units (or portions thereof) not assumed or substituted for will lapse, and, with respect to such Awards with performance-based vesting (or
portions thereof) not assumed or substituted for, all performance goals or other vesting criteria will be deemed achieved at one hundred percent (100%) of target levels and all other terms and conditions met,

  
 8 

 
in each case, unless specifically provided otherwise under the applicable Award Agreement or other written agreement between the Participant and the Company or any of its subsidiaries or parents,
as applicable. In addition, if an Option (or portion thereof) is not assumed or substituted for in the event that, in connection with a merger or consolidation in which the Company is a party, or in the event of a sale of all or substantially all of
the Company’s stock or assets, the Board of Directors, or the Committee to whom the Board of Directors has assigned a particular function in accordance with the Plan will notify the Participant in writing or electronically that such Option (or
its applicable portion) will be exercisable for a period of time determined by the Board of Directors in its sole discretion, and the option (or its applicable portion) will terminate upon the expiration of such period. 

For the purposes of the foregoing paragraph, an Award will be considered assumed if, following the merger or consolidation, or in the event of
a sale of all or substantially all of the Company’s stock or assets, the Award confers the right to purchase or receive, for each Share subject to the Award immediately prior to such transaction, the consideration (whether stock, cash, or other
securities or property) received in the transaction by holders of Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a
majority of the outstanding Shares); provided, however, that if such consideration received in the transaction is not solely common stock of the successor corporation or its Parent, the Board of Directors may, with the consent of the successor
corporation, provide for the consideration to be received upon the exercise of an Option or upon the payout of a Restricted Stock Unit, for each Share subject to such Award, to be solely common stock of the successor corporation or its Parent equal
in fair market value to the per share consideration received by holders of Stock in the transaction. 
 Notwithstanding anything in this
subsection to the contrary, and unless otherwise provided in an Award Agreement or other written agreement between the Participant and the Company or any of its Subsidiaries or Parents, as applicable, an Award that vests, is earned or paid-out upon the satisfaction of one or more performance goals will not be considered assumed if the Company or its successor modifies any of such performance goals without the Participant’s consent; provided,
however, a modification to such performance goals only to reflect the successor corporation’s post-transaction corporate structure will not be deemed to invalidate an otherwise valid Award assumption. 

(c)    Reservation of Rights. Except as provided in this Section 9, a Participant shall have no rights
by reason of (i) any subdivision or consolidation of shares of stock of any class, (ii) the payment of any dividend or (iii) any other increase or decrease in the number of shares of stock of any class. Any issuance by the Company of
shares of stock of any class, or securities convertible into shares of stock of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number or Exercise Price of Shares subject to an Award. The grant of
an Award pursuant to the Plan shall not affect in any way the right or power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structure, to merge or consolidate or to dissolve, liquidate,
sell or transfer all or any part of its business or assets. 
 SECTION 10. MISCELLANEOUS PROVISIONS. 

(a)    Securities Law Requirements. Shares shall not be issued under the Plan unless, in the opinion of
counsel acceptable to the Board of Directors, the issuance and delivery of such Shares comply with (or are exempt from) all applicable requirements of law, including (without limitation) the Securities Act, the rules and regulations promulgated
thereunder, state securities laws and regulations, and the regulations of any stock exchange or other securities market on which the Company’s securities may then be traded. The Company shall not be liable for a failure to issue Shares as a
result of such requirements. 

  
 9 

 (b)    No Retention Rights. Nothing in the Plan or in any right
or Award granted under the Plan shall confer upon the Participant any right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary
employing or retaining the Participant) or of the Participant, which rights are hereby expressly reserved by each, to terminate his or her Service at any time and for any reason, with or without cause. 

(c)    Treatment as Compensation. Any compensation that an individual earns or is deemed to earn under this
Plan shall not be considered a part of his or her compensation for purposes of calculating contributions, accruals or benefits under any other plan or program that is maintained or funded by the Company, a Parent or a Subsidiary. 

(d)    Governing Law. The Plan and all awards, sales and grants under the Plan shall be governed by, and
construed in accordance with, the laws of the State of Delaware, as such laws are applied to contracts entered into and performed in such State. 

(e)    Conditions and Restrictions on Shares. Shares issued under the Plan shall be subject to such
forfeiture conditions, rights of repurchase, rights of first refusal, other transfer restrictions and such other terms and conditions as the Board of Directors may determine. Such conditions and restrictions shall be set forth in the applicable
Award Agreement and shall apply in addition to any restrictions that may apply to holders of Shares generally. In addition, Shares issued under the Plan shall be subject to conditions and restrictions imposed either by applicable law or by Company
policy, as adopted from time to time, designed to ensure compliance with applicable law or laws with which the Company determines in its sole discretion to comply including in order to maintain any statutory, regulatory or tax advantage. 

(f)    Tax Matters. 

(i)    As a condition to the award, grant, issuance, vesting, purchase, exercise, settlement or transfer of any Award, or
Shares issued pursuant to any Award, granted under this Plan, the Participant shall make such arrangements as the Board of Directors may require or permit for the satisfaction of any federal, state, local or foreign withholding tax obligations that
may arise in connection with such event. 
 (ii)    Unless otherwise expressly set forth in an Award Agreement, it is
intended that Awards shall be exempt from Code Section 409A, and any ambiguity in the terms of an Award Agreement and the Plan shall be interpreted consistently with this intent. To the extent an Award is not exempt from Code Section 409A
(any such award, a “409A Award”), any ambiguity in the terms of such Award and the Plan shall be interpreted in a manner that to the maximum extent permissible supports the award’s compliance with the requirements of that
statute. Notwithstanding anything to the contrary permitted under the Plan, in no event shall a modification of an Award not already subject to Code Section 409A be given effect if such modification would cause the Award to become subject to
Code Section 409A unless the parties explicitly acknowledge and consent to the modification as one having that effect. A 409A Award shall be subject to such additional rules and requirements as specified by the Board of Directors from time to
time in order for it to comply with the requirements of Code Section 409A. In this regard, if any amount under a 409A Award is payable upon a “separation from service” to an individual who is considered a “specified
employee” (as each term is defined under Code Section 409A), then no such payment shall be made prior to the date that is the earlier of (i) six months and one day after the Participant’s separation from service or (ii) the
Participant’s death, but only to the 

  
 10 

 
extent such delay is necessary to prevent such payment from being subject to Section 409A(a)(1). In addition, if a transaction subject to Section 9(b) constitutes a payment event with
respect to any 409A Award, then the transaction with respect to such award must also constitute a “change in control event” as defined in Treasury Regulation Section 1.409A- 3(i)(5) to the extent required by Code Section 409A.

 (iii)    Neither the Company nor any member of the Board of Directors shall have any liability to a Participant in
the event an award held by the Participant fails to achieve its intended characterization under applicable tax law. 
 SECTION 11. DURATION AND
AMENDMENTS; STOCKHOLDER APPROVAL. 
 (a)    Term of the Plan. The Plan, as set forth herein, shall become
effective on the date of its adoption by the Board of Directors, subject to approval of the Company’s stockholders under Subsection (d) below. The Plan shall terminate automatically 10 years after the later of (i) the date when the
Board of Directors adopted the Plan or (ii) the date when the Board of Directors approved the most recent increase in the number of Shares reserved under Section 4 that was also approved by the Company’s stockholders. The Plan may be
terminated on any earlier date pursuant to Subsection (b) below. 
 (b)    Right to Amend or Terminate
the Plan. Subject to Subsection (d) below, the Board of Directors may amend, suspend or terminate the Plan at any time and for any reason. 

(c)    Effect of Amendment or Termination. No Shares shall be issued or sold and no Award granted under the
Plan after the termination thereof, except upon exercise or settlement of an Award granted under the Plan prior to such termination. The termination of the Plan, or any amendment thereof, shall not affect any Share previously issued or any Award
previously granted under the Plan. 
 (d)    Stockholder Approval. To the extent required by applicable
law, the Plan will be subject to approval of the Company’s stockholders within 12 months of its adoption date. To the extent required by applicable law, any amendment of the Plan will be subject to the approval of the Company’s
stockholders within 12 months of the amendment date if it (i) increases the number of Shares available for issuance under the Plan (except as provided in Section 9), or (ii) materially changes the class of persons who are eligible for
the grant of ISOs. In addition, an amendment effecting any other material change to the Plan terms will be subject to approval of the Company’s stockholder only if required by applicable law. Unless otherwise required by applicable law,
stockholder approval shall not be required for any other amendment of the Plan. 
 SECTION 12. DEFINITIONS. 

(a)    “Award” means any award granted under the Plan, including an Option, an award
of Restricted Stock Units or the grant or sale of Shares pursuant to Section 5 of the Plan. 

(b)    “Award Agreement” means a Restricted Stock Unit Agreement, Stock Grant
Agreement, Stock Option Agreement or Stock Purchase Agreement or such other agreement evidencing an Award under the Plan. 

(c)    “Board of Directors” means the Board of Directors of the Company, as
constituted from time to time. 
 (d)    “Code” means the Internal Revenue Code of
1986, as amended. 

  
 11 

 (e)    “Committee” means a
committee of the Board of Directors, as described in Section 2(a). 

(f)    “Company” means DoorDash, Inc., a Delaware corporation. 

(g)    “Consultant” means a person, excluding Employees and Outside Directors, who
performs bona fide services for the Company, a Parent or a Subsidiary as a consultant or advisor and who qualifies as a consultant or advisor under Rule 701(c)(1) of the Securities Act or under Instruction A.1.(a)(1) of Form S-8 under the Securities Act. 
 (h)    “Date of
Grant” means the date of grant specified in the applicable Award Agreement, which date shall be the later of (i) the date on which the Board of Directors resolved to grant the Award or (ii) the first day of the
Participant’s Service. 
 (i)    “Disability” means that the Optionee is
unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment. 

(j)    “Employee” means any individual who is a
common-law employee of the Company, a Parent or a Subsidiary. 

(k)    “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

(l)    “Exercise Price” means the amount for which one Share may be purchased upon
exercise of an Option, as specified by the Board of Directors in the applicable Stock Option Agreement. 

(m)    “Fair Market Value” means the fair market value of a Share, as determined by
the Board of Directors in good faith. Such determination shall be conclusive and binding on all persons. 

(n)    “Grantee” means a person to whom the Board of Directors has awarded Shares
under the Plan. 
 (o)    “ISO” means an Option that qualifies as an incentive
stock option as described in Code Section 422(b). Notwithstanding its designation as an ISO, an Option that does not qualify as an ISO under applicable law shall be treated for all purposes as a Nonstatutory Option. 

(p)    “Nonstatutory Option” means an Option that does not qualify as an incentive
stock option as described in Code Section 422(b) or 423(b). 

(q)    “Option” means an ISO or Nonstatutory Option granted under the Plan and
entitling the holder to purchase Shares. 
 (r)    “Optionee” means a person who
holds an Option. 
 (s)    “Outside Director” means a member of the Board of
Directors who is not an Employee. 
 (t)    “Parent” means any corporation (other
than the Company) in an unbroken chain of corporations ending with the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other
corporations in such chain. A corporation that attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent commencing as of such date. 

  
 12 

 (u)    “Participant” means the
holder of an outstanding Award. 
 (v)    “Plan” means this DoorDash, Inc. 2014
Stock Plan. 
 (w)    “Purchase Price” means the consideration for which one Share
may be acquired under the Plan (other than upon exercise of an Option), as specified by the Board of Directors. 

(x)    “Purchaser” means a person to whom the Board of Directors has offered the
right to purchase Shares under the Plan (other than upon exercise of an Option). 

(y)    “Restricted Stock Unit” means a bookkeeping entry representing the equivalent
of one Share, as awarded under the Plan. 
 (z)    “Restricted Stock Unit
Agreement” means the agreement between the Company and the recipient of a Restricted Stock Unit that contains the terms, conditions and restrictions pertaining to such Restricted Stock Unit. 

(aa)    “Securities Act” means the Securities Act of 1933, as amended. 

(bb)    “Service” means service as an Employee, Outside Director or Consultant. In
case of any dispute as to whether and when Service has terminated, the Board of Directors shall have sole discretion to determine whether such termination has occurred and the effective date of such termination. 

(cc)    “Share” means one share of Stock, as adjusted in accordance with
Section 9 (if applicable). 
 (dd)    “Stock” means the Common Stock of the
Company. 
 (ee)    “Stock Grant Agreement” means the agreement between the
Company and a Grantee who is awarded Shares under the Plan that contains the terms, conditions and restrictions pertaining to the award of such Shares. 

(ff)    “Stock Option Agreement” means the agreement between the Company and an
Optionee that contains the terms, conditions and restrictions pertaining to the Optionee’s Option. 

(gg)    “Stock Purchase Agreement” means the agreement between the Company and a
Purchaser who purchases Shares under the Plan that contains the terms, conditions and restrictions pertaining to the purchase of such Shares. 

(hh)    “Subsidiary” means any corporation (other than the Company) in an unbroken
chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other
corporations in such chain. A corporation that attains the status of a Subsidiary on a date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date. 

  
 13 

 DOORDASH, INC. 2014 STOCK
PLAN 
 NOTICE OF STOCK OPTION GRANT
(INSTALLMENT EXERCISE) 
 The Optionee has been granted the following option to purchase shares of the Common Stock of
DoorDash, Inc.: 
  

			
	Name of Optionee:	  	«Name»
		
	Total Number of Shares:	  	«TotalShares»
		
	Type of Option:	  	«ISO» Incentive Stock Option (ISO)
		
		  	«NSO» Nonstatutory Stock Option (NSO)
		
	Exercise Price per Share:	  	$«PricePerShare»
		
	Date of Grant:	  	«DateGrant»
		
	Date Exercisable:	  	This option may be exercised with respect to the first «Percent»% of the Shares subject to this option when the Optionee completes «CliffPeriod» months of continuous Service beginning with the Vesting
Commencement Date set forth below. This option may be exercised with respect to an additional «Fraction»% of the Shares subject to this option when the Optionee completes each month of continuous Service thereafter.
		
	Vesting Commencement Date:	  	«VestComDate»
		
	Expiration Date:	  	«ExpDate». This option expires earlier if the Optionee’s Service terminates earlier, as provided in Section 6 of the Stock Option Agreement, or if the Company engages in certain corporate transactions, as
provided in Section 8(b) of the Plan.

 By signing below, the Optionee and the Company agree that this option is granted under, and governed by the terms and
conditions of, the 2014 Stock Plan and the Stock Option Agreement. Both of these documents are attached to, and made a part of, this Notice of Stock Option Grant. Section 13 of the Stock Option Agreement includes important
acknowledgements of the Optionee . 
  

			
	OPTIONEE:	  	DOORDASH, INC.
		
		  	By:
		  	Title:

 THE OPTION GRANTED PURSUANT TO THIS AGREEMENT AND THE SHARES ISSUABLE UPON THE EXERCISE THEREOF HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT
SUCH REGISTRATION IS NOT REQUIRED. 
 DOORDASH, INC. 2014 STOCK
PLAN: 
 STOCK OPTION AGREEMENT (INSTALLMENT
EXERCISE) 
 SECTION 1.    GRANT OF OPTION. 

(a)    O ption . On the terms and conditions set forth in the Notice of Stock Option Grant and this
Agreement, the Company grants to the Optionee on the Date of Grant the option to purchase at the Exercise Price the number of Shares set forth in the Notice of Stock Option Grant. The Exercise Price is agreed to be at least 100% of the Fair Market
Value per Share on the Date of Grant (110% of Fair Market Value if this option is designated as an ISO in the Notice of Stock Option Grant and Section 3(b) of the Plan applies). This option is intended to be an ISO or an NSO, as provided in the
Notice of Stock Option Grant. 
 (b)    $100,000 Limitation . Even if this option is designated as an ISO
in the Notice of Stock Option Grant, it shall be deemed to be an NSO to the extent (and only to the extent) required by the $100,000 annual limitation under Section 422(d) of the Code. 

(c)    Stock Plan and Defined Terms . This option is granted pursuant to the Plan, a copy of which the
Optionee acknowledges having received. The provisions of the Plan are incorporated into this Agreement by this reference. Except as otherwise defined in this Agreement (including without limitation Section 14 hereof), capitalized terms shall
have the meaning ascribed to such terms in the Plan. 
 SECTION 2.    RIGHT TO EXERCISE.

 (a)    Exercisability . Subject to Subsection (b) below and the other conditions set forth in
this Agreement, all or part of this option may be exercised prior to its expiration at the time or times set forth in the Notice of Stock Option Grant. 

(b)    Stockholder Approval . Any other provision of this Agreement notwithstanding, no portion of this
option shall be exercisable at any time prior to the approval of the Plan by the Company’s stockholders. 
 SECTION
3.    NO TRANSFER OR ASSIGNMENT OF OPTION. 

Except as otherwise provided in this Agreement, this option and the rights and privileges conferred hereby shall not be sold, pledged or
otherwise transferred (whether by operation of law or otherwise) and shall not be subject to sale under execution, attachment, levy or similar process. 

 SECTION 4.    EXERCISE PROCEDURES. 

(a)    Notice of Exercise . The Optionee or the Optionee’s representative may exercise this option by:
(i) signing and delivering written notice to the Company pursuant to Section 12(c) specifying the election to exercise this option, the number of Shares for which it is being exercised and the form of payment and (ii) delivering
payment, in a form permissible under Section 5, for the full amount of the Purchase Price (together with any applicable withholding taxes under Subsection (b)). In the event that this option is being exercised by the representative of the
Optionee, the notice shall be accompanied by proof (satisfactory to the Company) of the representative’s right to exercise this option. 

(b)    Withholding Taxes . In the event that the Company determines that it is required to withhold any tax
(including without limitation any income tax, social insurance contributions, payroll tax, payment on account or other tax-related items arising in connection with the Optionee’s participation in the Plan and legally applicable to the Optionee
(the “ Tax-Related Items ”)) as a result of the grant, vesting or exercise of this option, or as a result of the transfer of shares acquired upon exercise of this option, the Optionee, as a condition of this option,
shall make arrangements satisfactory to the Company to enable it to satisfy all Tax-Related Items. The Optionee acknowledges that the responsibility for all Tax-Related Items is the Optionee’s and may exceed the amount actually withheld by the
Company (or its affiliate or agent). 
 (c)    Issuance of Shares . After satisfying all requirements for
exercise of this option, the Company shall cause to be issued one or more certificates evidencing the Shares for which this option has been exercised. Such Shares shall be registered (i) in the name of the person exercising this option,
(ii) in the names of such person and his or her spouse as community property or as joint tenants with the right of survivorship or (iii) with the Company’s consent, in the name of a revocable trust. Until the issuance of the Shares
has been entered into the books and records of the Company or a duly authorized transfer agent of the Company, no right to vote, receive dividends or any other right as a stockholder will exist with respect to such Shares. The Company shall cause
such certificates to be delivered to or upon the order of the person exercising this option. 
 SECTION 5.    PAYMENT
FOR STOCK. 
 (a)    Cash . All or part of the Purchase Price may be paid
in cash or cash equivalents. 
 (b)    Surrender of Stock . At the discretion of the Board of Directors,
all or any part of the Purchase Price may be paid by surrendering, or attesting to the ownership of, Shares that are already owned by the Optionee. Such Shares shall be surrendered to the Company in good form for transfer and shall be valued at
their Fair Market Value as of the date when this option is exercised. 

 (c)    Exercise/Sale . All or part of the Purchase Price and any
withholding taxes may be paid by the delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker approved by the Company to sell Shares and to deliver all or part of the sales proceeds to the Company. However,
payment pursuant to this Subsection (c) shall be permitted only if (i) Stock then is publicly traded and (ii) such payment does not violate applicable law. 

SECTION 6.    TERM AND EXPIRATION. 

(a)    Basic Term . This option shall in any event expire on the expiration date set forth in the Notice of Stock
Option Grant, which date is 10 years after the Date of Grant (five years after the Date of Grant if this option is designated as an ISO in the Notice of Stock Option Grant and Section 3(b) of the Plan applies). 

(b)    Termination of Service (Except by Death) . If the Optionee’s Service terminates for any reason other
than death, then this option shall expire on the earliest of the following occasions: 
 (i)    The
expiration date determined pursuant to Subsection (a) above; 
 (ii)    The date three months after
the termination of the Optionee’s Service for any reason other than Disability; or 
 (iii)    The
date six months after the termination of the Optionee’s Service by reason of Disability. 
 The Optionee may exercise all or part of this option at any
time before its expiration under the preceding sentence, but only to the extent that this option had become exercisable before the Optionee’s Service terminated. When the Optionee’s Service terminates, this option shall expire immediately
with respect to the number of Shares for which this option is not yet exercisable. In the event that the Optionee dies after termination of Service but before the expiration of this option, all or part of this option may be exercised (prior to
expiration) by the executors or administrators of the Optionee’s estate or by any person who has acquired this option directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that this option had
become exercisable before the Optionee’s Service terminated. Once this option (or portion thereof) has terminated, the Optionee shall have no further rights with respect to the option (or portion thereof) or to the underlying Shares. 

 (c)    Death of the Optionee . If the Optionee dies while in
Service, then this option shall expire on the earlier of the following dates: 
 (i)    The expiration
date determined pursuant to Subsection (a) above; or 
 (ii)    The date 12 months after the
Optionee’s death. 
 All or part of this option may be exercised at any time before its expiration under the preceding sentence by the executors or
administrators of the Optionee’s estate or by any person who has acquired this option directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that this option had become exercisable before the
Optionee’s death. When the Optionee dies, this option shall expire immediately with respect to the number of Shares for which this option is not yet exercisable. Once this option (or portion thereof) has terminated, the Optionee shall have no
further rights with respect to the option (or portion thereof) or to the underlying Shares. 

 (d)    Extension of Post-Termination Exercise
Periods . Following the date on which the Company’s Stock is first listed for trading on an established securities market, if during any part of the exercise period described in Subsections (b)(ii) or (iii) or Subsection (c)(ii) above
the exercise of this option would be prohibited solely because the issuance of Shares upon such exercise would violate the registration requirements under the Securities Act or a similar provision of other applicable law, then instead of terminating
at the end of such prescribed period, the then-vested portion of this option will instead remain outstanding and not expire until the earlier of (i) the expiration date determined pursuant to Section 6(a) above or (ii) the date on
which the then-vested portion of this option has been exercisable without violation of applicable law for the aggregate period (which need not be consecutive) after termination of the Optionee’s Service specified in the applicable Subsection
above. 
 (e)    Part-Time Employment and Leaves of Absence . If the Optionee commences
working on a part-time basis, then the Company may adjust the vesting schedule set forth in the Notice of Stock Option Grant. If the Optionee goes on a leave of absence, then the Company may adjust the vesting schedule set forth in the Notice of
Stock Option Grant in accordance with the Company’s leave of absence policy or the terms of such leave. Except as provided in the preceding sentence, Service shall be deemed to continue for any purpose under this Agreement while the Optionee is
on a bona fide leave of absence, if (i) such leave was approved by the Company in writing and (ii) continued crediting of Service for such purpose is expressly required by the terms of such leave or by applicable law (as determined
by the Company). Service shall be deemed to terminate when such leave ends, unless the Optionee immediately returns to active work. 

(f)    Notice Concerning ISO Treatment . Even if this option is designated as an ISO in the Notice of Stock
Option Grant, it ceases to qualify for favorable tax treatment as an ISO to the extent that it is exercised: 

(i)    More than three months after the date when the Optionee ceases to be an Employee for any reason
other than death or permanent and total disability (as defined in Section 22(e)(3) of the Code); 

(ii)    More than 12 months after the date when the Optionee ceases to be an Employee by reason of
permanent and total disability (as defined in Section 22(e)(3) of the Code); or 
 (iii)    More
than three months after the date when the Optionee has been on a leave of absence for three months, unless the Optionee’s reemployment rights following such leave were guaranteed by statute or by contract. 

 SECTION 7.    RIGHT OF FIRST
REFUSAL. 
 (a)    Right of First Refusal . In the event that the Optionee proposes to
sell, pledge or otherwise transfer to a third party any Shares acquired under this Agreement, or any interest in such Shares, the Company shall have the Right of First Refusal with respect to all (and not less than all) of such Shares. If the
Optionee desires to transfer Shares acquired under this Agreement, the Optionee shall give a written Transfer Notice to the Company describing fully the proposed transfer, including the number of Shares proposed to be transferred, the proposed
transfer price, the name and address of the proposed Transferee and proof satisfactory to the Company that the proposed sale or transfer will not violate any applicable federal, State or foreign securities laws. The Transfer Notice shall be signed
both by the Optionee and by the proposed Transferee and must constitute a binding commitment of both parties to the transfer of the Shares. The Company shall have the right to purchase all, and not less than all, of the Shares on the terms of the
proposal described in the Transfer Notice (subject, however, to any change in such terms permitted under Subsection (b) below) by delivery of a notice of exercise of the Right of First Refusal within 30 days after the date when the Transfer
Notice was received by the Company. 
 (b)    Transfer of Shares . If the Company fails to exercise its
Right of First Refusal within 30 days after the date when it received the Transfer Notice, the Optionee may, not later than 90 days following receipt of the Transfer Notice by the Company, conclude a transfer of the Shares subject to the Transfer
Notice on the terms and conditions described in the Transfer Notice, provided that any such sale is made in compliance with applicable federal, State and foreign securities laws and not in violation of any other contractual restrictions to which the
Optionee is bound. Any proposed transfer on terms and conditions different from those described in the Transfer Notice, as well as any subsequent proposed transfer by the Optionee, shall again be subject to the Right of First Refusal and shall
require compliance with the procedure described in Subsection (a) above. If the Company exercises its Right of First Refusal, the parties shall consummate the sale of the Shares on the terms set forth in the Transfer Notice within 60 days after
the date when the Company received the Transfer Notice (or within such longer period as may have been specified in the Transfer Notice); provided, however, that in the event the Transfer Notice provided that payment for the Shares was to be made in
a form other than cash or cash equivalents paid at the time of transfer, the Company shall have the option of paying for the Shares with cash or cash equivalents equal to the present value of the consideration described in the Transfer Notice. 

(c)    Additional or Exchanged Securities and Property . In the event of a merger or consolidation of the
Company, a sale of all or substantially all of the Company’s stock or assets, any other corporate reorganization, a stock split, the declaration of a stock dividend, the declaration of an extraordinary dividend payable in a form other than
stock, a spin-off, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities, any securities or other property (including cash or cash equivalents) that are by reason of such
transaction exchanged for, or distributed with respect to, any Shares subject to this Section 7 shall immediately be subject to the Right of First Refusal. Appropriate adjustments to reflect the exchange or distribution of such securities or
property shall be made to the number and/or class of the Shares subject to this Section 7. 

 (d)    Termination of Right of First Refusal . Any other
provision of this Section 7 notwithstanding, in the event that the Stock is readily tradable on an established securities market when the Optionee desires to transfer Shares, the Company shall have no Right of First Refusal, and the Optionee
shall have no obligation to comply with the procedures prescribed by Subsections (a) and (b) above. 

(e)    Permitted Transfers . This Section 7 shall not apply to (i) a transfer by beneficiary
designation, will or intestate succession or (ii) a transfer to one or more members of the Optionee’s Immediate Family or to a trust established by the Optionee for the benefit of the Optionee and/or one or more members of the
Optionee’s Immediate Family, provided in either case that the Transferee agrees in writing on a form prescribed by the Company to be bound by all provisions of this Agreement. If the Optionee transfers any Shares acquired under this Agreement,
either under this Subsection (e) or after the Company has failed to exercise the Right of First Refusal, then this Agreement shall apply to the Transferee to the same extent as to the Optionee. 

(f)    Termination of Rights as Stockholder . If the Company makes available, at the time and place and in
the amount and form provided in this Agreement, the consideration for the Shares to be purchased in accordance with this Section 7, then after such time the person from whom such Shares are to be purchased shall no longer have any rights as a
holder of such Shares (other than the right to receive payment of such consideration in accordance with this Agreement). Such Shares shall be deemed to have been purchased in accordance with the applicable provisions hereof, whether or not the
certificate(s) therefor have been delivered as required by this Agreement. 
 (g)    Assignment of Right of
First Refusal . The Board of Directors may freely assign the Company’s Right of First Refusal, in whole or in part. Any person who accepts an assignment of the Right of First Refusal from the Company shall assume all of the Company’s
rights and obligations under this Section 7. 

 SECTION 8.    LEGALITY OF INITIAL
ISSUANCE. 
 No Shares shall be issued upon the exercise of this option unless and until the Company has determined that:

 (a)    It and the Optionee have taken any actions required to register the Shares under the Securities
Act or to perfect an exemption from the registration requirements thereof; 
 (b)    Any applicable
listing requirement of any stock exchange or other securities market on which Stock is listed has been satisfied; and 

(c)    Any other applicable provision of federal, State or foreign law has been satisfied. 

SECTION 9.    NO REGISTRATION RIGHTS. 

The Company may, but shall not be obligated to, register or qualify the sale of Shares under the Securities Act or any other applicable law.
The Company shall not be obligated to take any affirmative action in order to cause the sale of Shares under this Agreement to comply with any law. 

 SECTION 10.    RESTRICTIONS ON TRANSFER
OF SHARES. 
 (a)    Bylaws Restrictions . The Shares acquired under this
Agreement shall be subject to the transfer restrictions in Article IX of the Company’s Amended and Restated Bylaws, as may be amended from time to time, in addition to, and not in limitation of, the provisions of Section 8 of this
Agreement. 
 (b)    Securities Law Restrictions . Regardless of whether the offer and sale of Shares
under the Plan have been registered under the Securities Act or have been registered or qualified under the securities laws of any State or other relevant jurisdiction, the Company at its discretion may impose restrictions upon the sale, pledge or
other transfer of such Shares (including the placement of appropriate legends on the stock certificates (or electronic equivalent) or the imposition of stop-transfer instructions) and may refuse (or may be required to refuse) to transfer Shares
acquired hereunder (or Shares proposed to be transferred in a subsequent transfer) if, in the judgment of the Company, such restrictions, legends or refusal are necessary or appropriate to achieve compliance with the Securities Act or other relevant
securities or other laws, including without limitation under Regulation S of the Securities Act or pursuant to another available exemption from registration. 

(c)    Market Stand-Off. In connection with any underwritten public offering by the Company of
its equity securities pursuant to an effective registration statement filed under the Securities Act, including the Company’s initial public offering, the Optionee or a Transferee shall not directly or indirectly sell, make any short sale of,
loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions
with respect to, any Shares acquired under this Agreement without the prior written consent of the Company or its managing underwriter. Such restriction (the “ Market Stand-Off”) shall be in effect for such period of
time following the date of the final prospectus for the offering as may be requested by the Company or such underwriter. In no event, however, shall such period exceed 180 days plus such additional period as may reasonably be requested by the
Company or such underwriter to accommodate regulatory restrictions on (i) the publication or other distribution of research reports or (ii) analyst recommendations and opinions, including (without limitation) the restrictions set forth in
Rule 2711(f)(4) of the National Association of Securities Dealers and Rule 472(f)(4) of the New York Stock Exchange, as amended, or any similar successor rules. The Market Stand-Off shall in any event terminate two years after the date of the
Company’s initial public offering. In the event of the declaration of a stock dividend, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding
securities without receipt of consideration, any new, substituted or additional securities which are by reason of such transaction distributed with respect to any Shares subject to the Market Stand-Off, or into which such Shares thereby become
convertible, shall immediately be subject to the Market Stand-Off. In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the Shares acquired under this Agreement until the end of the applicable
stand-off period. The Company’s underwriters shall be beneficiaries of the agreement set forth in this Subsection (b). This Subsection (b) shall not apply to Shares registered in the public offering under the Securities Act. 

 (d)    Investment Intent at Grant . The Optionee
represents and agrees that the Shares to be acquired upon exercising this option will be acquired for investment, and not with a view to the sale or distribution thereof. 

(e)    Investment Intent at Exercise . In the event that the sale of Shares under the Plan is not registered
under the Securities Act but an exemption is available that requires an investment representation or other representation, the Optionee shall represent and agree at the time of exercise that the Shares being acquired upon exercising this option are
being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations as are deemed necessary or appropriate by the Company and its counsel, including (if applicable because the Company is
relying on Regulation S under the Securities Act) that as of the date of exercise the Optionee is (i) not a U.S. Person; (ii) not acquiring the Shares on behalf, or for the account or benefit, of a U.S. Person; and (iii) is not
exercising the option in the United States. 
 (f)    Legends . All certificates evidencing Shares
purchased under this Agreement shall bear the following legend: 
 “THE SHARES REPRESENTED HEREBY MAY NOT BE SOLD, ASSIGNED,
TRANSFERRED, ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE TERMS OF A WRITTEN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES). SUCH AGREEMENT GRANTS TO THE
COMPANY CERTAIN RIGHTS OF FIRST REFUSAL UPON AN ATTEMPTED TRANSFER OF THE SHARES. IN ADDITION, THE SHARES ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR A LIMITED PERIOD FOLLOWING THE EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE
COMPANY’S SECURITIES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. THE SECRETARY OF THE COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE
HOLDER HEREOF WITHOUT CHARGE.” 
 All certificates evidencing Shares purchased under this Agreement in an unregistered transaction shall bear the
following legend (and such other restrictive legends as are required or deemed advisable under the provisions of any applicable law): 

“THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY
SECURITIES LAWS OF ANY U.S. STATE, AND MAY NOT BE SOLD, REOFFERED, PLEDGED, ASSIGNED, ENCUMBERED OR OTHERWISE TRANSFERRED OR DISPOSED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND
ITS COUNSEL, 

 THAT SUCH REGISTRATION IS NOT REQUIRED. IN THE ABSENCE OF REGISTRATION OR THE AVAILABILITY
(CONFIRMED BY OPINION OF COUNSEL) OF AN ALTERNATIVE EXEMPTION FROM REGISTRATION UNDER THE ACT (INCLUDING WITHOUT LIMITATION IN ACCORDANCE WITH REGULATION S UNDER THE ACT), THESE SHARES MAY NOT BE SOLD, REOFFERED, PLEDGED, ASSIGNED, ENCUMBERED OR
OTHERWISE TRANSFERRED OR DISPOSED OF. HEDGING TRANSACTIONS INVOLVING THESE SHARES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT.” 

(g)    Removal of Legends . If, in the opinion of the Company and its counsel, any legend placed on a stock
certificate representing Shares sold under this Agreement is no longer required, the holder of such certificate shall be entitled to exchange such certificate for a certificate representing the same number of Shares but without such legend. 

(h)    Administration . Any determination by the Company and its counsel in connection with any of the
matters set forth in this Section 10 shall be conclusive and binding on the Optionee and all other persons. 
 SECTION
11.    ADJUSTMENT OF SHARES. 
 In the event of any transaction
described in Section 8(a) of the Plan, the terms of this option (including, without limitation, the number and kind of Shares subject to this option and the Exercise Price) shall be adjusted as set forth in Section 8(a) of the Plan. In the
event that the Company is a party to a merger or consolidation or in the event of a sale of all or substantially all of the Company’s stock or assets, this option shall be subject to the treatment provided by the Board of Directors in its sole
discretion, as provided in Section 8(b) of the Plan. 

 SECTION 12.    MISCELLANEOUS PROVISIONS. 

(a)    Rights as a Stockholder . Neither the Optionee nor the Optionee’s representative shall have any
rights as a stockholder with respect to any Shares subject to this option until the Optionee or the Optionee’s representative becomes entitled to receive such Shares by filing a notice of exercise and paying the Purchase Price pursuant to
Sections 4 and 5. 
 (b)    No Retention Rights . Nothing in this option or in the Plan shall confer upon
the Optionee any right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or retaining the Optionee) or of the Optionee,
which rights are hereby expressly reserved by each, to terminate his or her Service at any time and for any reason, with or without cause. 

(c)    Notice . Any notice required by the terms of this Agreement shall be given in writing. It shall be
deemed effective upon (i) personal delivery, (ii) deposit with the United States Postal Service, by registered or certified mail, with postage and fees prepaid, (iii) deposit with Federal Express Corporation, with shipping charges
prepaid or (iv) deposit with any internationally recognized express mail courier service. Notice shall be addressed to the Company at its principal executive office and to the Optionee at the address that he or she most recently provided to the
Company in accordance with this Subsection (c). 
 (d)    Modifications and Waivers . No provision of this
Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by the Optionee and by an authorized officer of the Company (other than the Optionee). No waiver by either party of any
breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 

(e)    Entire Agreement . The Notice of Stock Option Grant, this Agreement and the Plan constitute the
entire contract between the parties hereto with regard to the subject matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter
hereof. 
 (f)    Choice of Law . This Agreement shall be governed by, and construed in accordance with,
the laws of the State of Delaware, as such laws are applied to contracts entered into and performed in such State. 
 SECTION
13.    ACKNOWLEDGEMENTS OF THE OPTIONEE. 
 In addition
to the other terms, conditions and restrictions imposed on this option and the Shares issuable under this option pursuant to this Agreement and the Plan, the Optionee expressly acknowledges being subject to Sections 7 (Right of First Refusal), 8
(Legality of Initial 

 
Issuance) and 10 (Restrictions on Transfer of Shares, including without limitation the Market Stand-Off), as well as the following provisions: 

(a)    Tax Consequences (No Liability for Discounted Options) . The Optionee agrees that the Company does
not have a duty to design or administer the Plan or its other compensation programs in a manner that minimizes the Optionee’s tax liabilities. The Optionee shall not make any claim against the Company or its Board of Directors, officers or
employees related to tax liabilities arising from this option or the Optionee’s other compensation. In particular, any Optionee subject to U.S. taxation acknowledges that this option is exempt from Section 409A of the Code only if the
Exercise Price is at least equal to the Fair Market Value per Share on the Date of Grant. Since Shares are not traded on an established securities market, the determination of their Fair Market Value is made by the Board of Directors or by an
independent valuation firm retained by the Company. The Optionee acknowledges that there is no guarantee in either case that the Internal Revenue Service will agree with the valuation, and the Optionee shall not make any claim against the Company or
its Board of Directors, officers or employees in the event that the Internal Revenue Service asserts that the valuation was too low. 

(b)    Electronic Delivery of Documents . The Optionee agrees to accept by email all documents relating to
the Company, the Plan or this option and all other documents that the Company is required to deliver to its security holders (including, without limitation, disclosures that may be required by the Securities and Exchange Commission). The Optionee
also agrees that the Company may deliver these documents by posting them on a website maintained by the Company or by a third party under contract with the Company. If the Company posts these documents on a website, it shall notify the Optionee by
email of their availability. The Optionee acknowledges that he or she may incur costs in connection with electronic delivery, including the cost of accessing the internet and printing fees, and that an interruption of internet access may interfere
with his or her ability to access the documents. This consent shall remain in effect until this option expires or until the Optionee gives the Company written notice that it should deliver paper documents. 

(c)    No Notice of Expiration Date . The Optionee agrees that the Company and its officers, employees,
attorneys and agents do not have any obligation to notify him or her prior to the expiration of this option pursuant to Section 6, regardless of whether this option will expire at the end of its full term or on an earlier date related to the
termination of the Optionee’s Service. The Optionee further agrees that he or she has the sole responsibility for monitoring the expiration of this option and for exercising this option, if at all, before it expires. This Subsection
(c) shall supersede any contrary representation that may have been made, orally or in writing, by the Company or by an officer, employee, attorney or agent of the Company. 

 (d)    Waiver of Statutory Information Rights . The
Optionee acknowledges and agrees that, upon exercise of this option and until the first sale of the Company’s Stock to the general public pursuant to a registration statement filed under the Securities Act, he or she will be deemed to have
waived any rights the Optionee might otherwise have had under Section 220 of the Delaware General Corporation Law (or under similar rights under other applicable law) to inspect for any proper purpose and to make copies and extracts from the
Company’s stock ledger, a list of its stockholders and its other books and records or the books and records of any subsidiary. This waiver applies only in the Optionee’s capacity as a stockholder and does not affect any other inspection
rights the Optionee may have under other law or pursuant to a written agreement with the Company. 

(e)    Plan Discretionary . The Optionee understands and acknowledges that (i) the Plan is entirely
discretionary, (ii) the Company and the Optionee’s employer have reserved the right to amend, suspend or terminate the Plan at any time, (iii) the grant of an option does not in any way create any contractual or other right to receive
additional grants of options (or benefits in lieu of options) at any time or in any amount and (iv) all determinations with respect to any additional grants, including (without limitation) the times when options will be granted, the number of
Shares offered, the Exercise Price and the vesting schedule, will be at the sole discretion of the Company. 

(f)    Termination of Service . The Optionee understands and acknowledges that participation in the Plan
ceases upon termination of his or her Service for any reason, except as may explicitly be provided otherwise in the Plan or this Agreement. 

(g)    Extraordinary Compensation . The value of this option shall be an extraordinary item of compensation
outside the scope of the Optionee’s employment contract, if any, and shall not be considered a part of his or her normal or expected compensation for purposes of calculating severance, resignation, redundancy or endof-service payments, bonuses,
long-service awards, pension or retirement benefits or similar payments. 
 (h)    Authorization to Disclose
. The Optionee hereby authorizes and directs the Optionee’s employer to disclose to the Company or any Subsidiary any information regarding the Optionee’s employment, the nature and amount of the Optionee’s compensation and the
fact and conditions of the Optionee’s participation in the Plan, as the Optionee’s employer deems necessary or appropriate to facilitate the administration of the Plan. 

 (i)    Personal Data Authorization . The Optionee consents to the
collection, use and transfer of personal data as described in this Subsection (i). The Optionee understands and acknowledges that the Company, the Optionee’s employer and the Company’s other Subsidiaries hold certain personal information
regarding the Optionee for the purpose of managing and administering the Plan, including (without limitation) the Optionee’s name, home address, telephone number, date of birth, social insurance number, salary, nationality, job title, any
Shares or directorships held in the Company and details of all options or any other entitlements to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Optionee’s favor (the “ Data ”). The Optionee
further understands and acknowledges that the Company and/or its Subsidiaries will transfer Data among themselves as necessary for the purpose of implementation, administration and management of the Optionee’s participation in the Plan and that
the Company and/or any Subsidiary may each further transfer Data to any third party assisting the Company in the implementation, administration and management of the Plan. The Optionee understands and acknowledges that the recipients of Data may be
located in the United States or elsewhere. The Optionee authorizes such recipients to receive, possess, use, retain and transfer Data, in electronic or other form, for the purpose of administering the Optionee’s participation in the Plan,
including a transfer to any broker or other third party with whom the Optionee elects to deposit Shares acquired under the Plan of such Data as may be required for the administration of the Plan and/or the subsequent holding of Shares on the
Optionee’s behalf. The Optionee may, at any time, view the Data, require any necessary modifications of Data or withdraw the consents set forth in this Subsection (i) by contacting the Company in writing. 

SECTION 14.    DEFINITIONS. 

(a)    “ Agreement” shall mean this Stock Option Agreement. 

(b)    “ Board of Directors ” shall mean the Board of Directors of the Company, as constituted from time
to time or, if a Committee has been appointed, such Committee. 
 (c)    “ Company ” shall mean
DoorDash, Inc., a Delaware corporation. 
 (d)    “ Immediate Family ” shall mean any child, stepchild,
grandchild, parent, stepparent, grandparent, spouse, sibling, motherin-law, fatherin-law, sonin-law, daughter-in-law, brother-in-law or sister-in-law and shall include adoptive relationships. 

(e)    “ Optionee ” shall mean the person named in the Notice of Stock Option Grant. 

(f)    “ Plan ” shall mean the DoorDash, Inc. 2014 Stock Plan, as in effect on the Date of Grant. 

(g)    “ Purchase Price ” shall mean the Exercise Price multiplied by the number of Shares with respect
to which this option is being exercised. 

 (h)    “ Right of First Refusal” shall mean the
Company’s right of first refusal described in Section 7. 
 (i)    “ Service ” means service
as an Employee, Outside Director or Consultant. 
 (j)    “ Transferee ” shall mean any person to whom
the Optionee has directly or indirectly transferred any Share acquired under this Agreement. 
 (k)    “
Transfer Notice ” shall mean the notice of a proposed transfer of Shares described in Section 7. 

(l)    “ U.S. Person ” shall mean a person described in Rule 902(k) of Regulation S of the Securities Act
(or any successor rule or provision), which generally defines a U.S. person as any natural person resident in the United States, any estate of which any executor or administrator is a U.S. Person, or any trust of which of any trustee is a U.S.
Person. 

 DOORDASH, INC. 2014 STOCK
PLAN 
 NOTICE OF STOCK OPTION GRANT
(EARLY EXERCISE) 
 The Optionee has been granted the following option to purchase shares of the Common Stock of DoorDash,
Inc.: 
  

			
	Name of Optionee:	  	«Name»
		
	Total Number of Shares:	  	«TotalShares»
		
	Type of Option:	  	«ISO» Incentive Stock Option (ISO)
		
		  	«NSO» Nonstatutory Stock Option (NSO)
		
	Exercise Price per Share:	  	$«PricePerShare»
		
	Date of Grant:	  	«DateGrant»
		
	Date Exercisable:	  	This option may be exercised at any time after the Date of Grant for all or any part of the Shares subject to this option.
		
	Vesting Commencement Date:	  	«VestComDate»
		
	Vesting Schedule:	  	The Right of Repurchase shall lapse with respect to the first «Percent»% of the Shares subject to this option when the Optionee completes «CliffPeriod» months of continuous Service beginning with the Vesting
Commencement Date set forth above. The Right of Repurchase shall lapse with respect to an additional «Fraction»% of the Shares subject to this option when the Optionee completes each month of continuous Service thereafter.
		
	Expiration Date:	  	«ExpDate». This option expires earlier if the Optionee’s Service terminates earlier, as provided in Section 6 of the Stock Option Agreement, or if the Company engages in certain corporate transactions, as
provided in Section 8(b) of the Plan.

 By signing below, the Optionee and the Company agree that this option is granted under, and governed by the terms and
conditions of, the 2014 Stock Plan and the Stock Option Agreement. Both of these documents are attached to, and made a part of, this Notice of Stock Option Grant. Section 14 of the Stock Option Agreement includes important
acknowledgements of the Optionee . 
  

			
	OPTIONEE:	  	DOORDASH, INC.
		
		  	 By:

		  	 Title:

 THE OPTION GRANTED PURSUANT TO THIS AGREEMENT AND THE SHARES ISSUABLE UPON THE EXERCISE THEREOF HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT
SUCH REGISTRATION IS NOT REQUIRED. 
 DOORDASH, INC. 2014 STOCK PLAN: 

STOCK OPTION AGREEMENT (EARLY EXERCISE) 

SECTION 1. GRANT OF OPTION. 
 (a)
Option. On the terms and conditions set forth in the Notice of Stock Option Grant and this Agreement, the Company grants to the Optionee on the Date of Grant the option to purchase at the Exercise Price the number of Shares set forth in the
Notice of Stock Option Grant. The Exercise Price is agreed to be at least 100% of the Fair Market Value per Share on the Date of Grant (110% of Fair Market Value if this option is designated as an ISO in the Notice of Stock Option Grant and
Section 3(b) of the Plan applies). This option is intended to be an ISO or an NSO, as provided in the Notice of Stock Option Grant. 

(b) $100,000 Limitation. Even if this option is designated as an ISO in the Notice of Stock Option Grant, it shall be deemed to be an
NSO to the extent (and only to the extent) required by the $100,000 annual limitation under Section 422(d) of the Code. 
 (c) Stock
Plan and Defined Terms. This option is granted pursuant to the Plan, a copy of which the Optionee acknowledges having received. The provisions of the Plan are incorporated into this Agreement by this reference. Except as otherwise defined in
this Agreement (including without limitation Section 15 hereof), capitalized terms shall have the meaning ascribed to such terms in the Plan. 

SECTION 2. RIGHT TO EXERCISE. 
 (a)
Exercisability. Subject to Subsection (b) below and the other conditions set forth in this Agreement, all or part of this option may be exercised prior to its expiration at the time or times set forth in the Notice of Stock Option Grant.
Shares purchased by exercising this option may be subject to the Right of Repurchase under Section 7. 
 (b) Stockholder
Approval. Any other provision of this Agreement notwithstanding, no portion of this option shall be exercisable at any time prior to the approval of the Plan by the Company’s stockholders. 

SECTION 3. NO TRANSFER OR ASSIGNMENT OF OPTION. 

Except as otherwise provided in this Agreement, this option and the rights and privileges conferred hereby shall not be sold, pledged or
otherwise transferred (whether by operation of law or otherwise) and shall not be subject to sale under execution, attachment, levy or similar process. 

  
 -2- 

 SECTION 4. EXERCISE PROCEDURES. 

(a) Notice of Exercise. The Optionee or the Optionee’s representative may exercise this option by: (i) signing and delivering
written notice to the Company pursuant to Section 13(c) specifying the election to exercise this option, the number of Shares for which it is being exercised and the form of payment and (ii) delivering payment, in a form permissible under
Section 5, for the full amount of the Purchase Price (together with any applicable withholding taxes under Subsection (b)). In the event that this option is being exercised by the representative of the Optionee, the notice shall be accompanied
by proof (satisfactory to the Company) of the representative’s right to exercise this option. In the event of a partial exercise of this option, Shares shall be deemed to have been purchased in the order in which they vest in accordance with
the Notice of Stock Option Grant. 
 (b) Withholding Taxes. In the event that the Company determines that it is required to withhold
any tax (including without limitation any income tax, social insurance contributions, payroll tax, payment on account or other tax-related items arising in connection with the Optionee’s participation in
the Plan and legally applicable to the Optionee (the “Tax-Related Items”)) as a result of the grant, vesting or exercise of this option, or as a result of the vesting or transfer of shares
acquired upon exercise of this option, the Optionee, as a condition of this option, shall make arrangements satisfactory to the Company to enable it to satisfy all Tax-Related Items. The Optionee acknowledges
that the responsibility for all Tax-Related Items is the Optionee’s and may exceed the amount actually withheld by the Company (or its affiliate or agent). 

(c) Issuance of Shares. After satisfying all requirements for exercise of this option, the Company shall cause to be issued one or more
certificates evidencing the Shares for which this option has been exercised. Such Shares shall be registered (i) in the name of the person exercising this option, (ii) in the names of such person and his or her spouse as community property
or as joint tenants with the right of survivorship or (iii) with the Company’s consent, in the name of a revocable trust. Until the issuance of the Shares has been entered into the books and records of the Company or a duly authorized
transfer agent of the Company, no right to vote, receive dividends or any other right as a stockholder will exist with respect to such Shares. In the case of Restricted Shares, the Company shall cause such certificates to be deposited in escrow
under Section 7(c). In the case of other Shares, the Company shall cause such certificates to be delivered to or upon the order of the person exercising this option. 

SECTION 5. PAYMENT FOR STOCK. 
 (a)
Cash. All or part of the Purchase Price may be paid in cash or cash equivalents. 
 (b) Surrender of Stock. At the discretion
of the Board of Directors, all or any part of the Purchase Price may be paid by surrendering, or attesting to the ownership of, Shares that are already owned by the Optionee. Such Shares shall be surrendered to the Company in good form for transfer
and shall be valued at their Fair Market Value as of the date when this option is exercised. 

  
 -3- 

 (c) Exercise/Sale. All or part of the Purchase Price and any withholding taxes may be
paid by the delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker approved by the Company to sell Shares and to deliver all or part of the sales proceeds to the Company. However, payment pursuant to this
Subsection (c) shall be permitted only if (i) Stock then is publicly traded and (ii) such payment does not violate applicable law. 

SECTION 6. TERM AND EXPIRATION. 
 (a)
Basic Term. This option shall in any event expire on the expiration date set forth in the Notice of Stock Option Grant, which date is 10 years after the Date of Grant (five years after the Date of Grant if this option is designated as an ISO
in the Notice of Stock Option Grant and Section 3(b) of the Plan applies). 
 (b) Termination of Service (Except by Death). If
the Optionee’s Service terminates for any reason other than death, then this option shall expire on the earliest of the following occasions: 

(i) The expiration date determined pursuant to Subsection (a) above; 

(ii) The date three months after the termination of the Optionee’s Service for any reason other than Disability; or 

(iii) The date six months after the termination of the Optionee’s Service by reason of Disability. 

The Optionee may exercise all or part of this option at any time before its expiration under the preceding sentence, but only to the extent that this option
is exercisable for vested Shares on or before the date when the Optionee’s Service terminates. When the Optionee’s Service terminates, this option shall expire immediately with respect to the number of Shares for which this option is not
yet exercisable and with respect to any Restricted Shares. In the event that the Optionee dies after termination of Service but before the expiration of this option, all or part of this option may be exercised (prior to expiration) by the executors
or administrators of the Optionee’s estate or by any person who has acquired this option directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that this option was exercisable for vested Shares on
or before the date when the Optionee’s Service terminated. Once this option (or portion thereof) has terminated, the Optionee shall have no further rights with respect to the option (or portion thereof) or to the underlying Shares. 

(c) Death of the Optionee. If the Optionee dies while in Service, then this option shall expire on the earlier of the following dates:

 (i) The expiration date determined pursuant to Subsection (a) above; or 

(ii) The date 12 months after the Optionee’s death. 

  
 -4- 

 All or part of this option may be exercised at any time before its expiration under the preceding sentence
by the executors or administrators of the Optionee’s estate or by any person who has acquired this option directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that this option is exercisable for
vested Shares on or before the date of the Optionee’s death. When the Optionee dies, this option shall expire immediately with respect to the number of Shares for which this option is not yet exercisable and with respect to any Restricted
Shares. Once this option (or portion thereof) has terminated, the Optionee shall have no further rights with respect to the option (or portion thereof) or to the underlying Shares. 

(d) Extension of Post-Termination Exercise Periods. Following the date on which the Company’s Stock is first listed for trading on
an established securities market, if during any part of the exercise period described in Subsections (b)(ii) or (iii) or Subsection (c)(ii) above the exercise of this option would be prohibited solely because the issuance of Shares upon such
exercise would violate the registration requirements under the Securities Act or a similar provision of other applicable law, then instead of terminating at the end of such prescribed period, the then-vested portion of this option will instead
remain outstanding and not expire until the earlier of (i) the expiration date determined pursuant to Section 6(a) above or (ii) the date on which the then-vested portion of this option has been exercisable without violation of
applicable law for the aggregate period (which need not be consecutive) after termination of the Optionee’s Service specified in the applicable Subsection above. 

(e) Part-Time Employment and Leaves of Absence. If the Optionee commences working on a part-time basis, then the Company may adjust the
vesting schedule set forth in the Notice of Stock Option Grant. If the Optionee goes on a leave of absence, then the Company may adjust the vesting schedule set forth in the Notice of Stock Option Grant in accordance with the Company’s leave of
absence policy or the terms of such leave. Except as provided in the preceding sentence, Service shall be deemed to continue for any purpose under this Agreement while the Optionee is on a bona fide leave of absence, if (i) such leave was
approved by the Company in writing and (ii) continued crediting of Service for such purpose is expressly required by the terms of such leave or by applicable law (as determined by the Company). Service shall be deemed to terminate when such
leave ends, unless the Optionee immediately returns to active work. 
 (f) Notice Concerning ISO Treatment. Even if this option is
designated as an ISO in the Notice of Stock Option Grant, it ceases to qualify for favorable tax treatment as an ISO to the extent that it is exercised: 

(i) More than three months after the date when the Optionee ceases to be an Employee for any reason other than death or permanent and total
disability (as defined in Section 22(e)(3) of the Code); 
 (ii) More than 12 months after the date when the Optionee ceases to be an
Employee by reason of permanent and total disability (as defined in Section 22(e)(3) of the Code); or 

  
 -5- 

 (iii) More than three months after the date when the Optionee has been on a leave of
absence for three months, unless the Optionee’s reemployment rights following such leave were guaranteed by statute or by contract. 
 SECTION 7.
RIGHT OF REPURCHASE. 
 (a) Scope of Repurchase Right. Until they vest in accordance with the Notice of Stock Option Grant and
Subsection (b) below, the Shares acquired under this Agreement shall be Restricted Shares and shall be subject to the Company’s Right of Repurchase. The Company, however, may decline to exercise its Right of Repurchase or may exercise its
Right of Repurchase only with respect to a portion of the Restricted Shares. The Company may exercise its Right of Repurchase only during the Repurchase Period following the termination of the Optionee’s Service, but the Right of Repurchase may
be exercised automatically under Subsection (d) below. If the Right of Repurchase is exercised, the Company shall pay the Optionee an amount equal to the lower of (i) the Exercise Price of each Restricted Share being repurchased or
(ii) the Fair Market Value of such Restricted Share at the time the Right of Repurchase is exercised. 
 (b) Lapse of Repurchase
Right. The Right of Repurchase shall lapse with respect to the Restricted Shares in accordance with the vesting schedule set forth in the Notice of Stock Option Grant. 

(c) Escrow. Upon issuance, the certificate(s) for Restricted Shares shall be deposited in escrow with the Company to be held in
accordance with the provisions of this Agreement. Any additional or exchanged securities or other property described in Subsection (f) below shall immediately be delivered to the Company to be held in escrow. All ordinary cash dividends on
Restricted Shares (or on other securities held in escrow) shall be paid directly to the Optionee and shall not be held in escrow. Restricted Shares, together with any other assets held in escrow under this Agreement, shall be (i) surrendered to
the Company for repurchase upon exercise of the Right of Repurchase or the Right of First Refusal or (ii) released to the Optionee upon his or her request to the extent that the Shares have ceased to be Restricted Shares (but not more
frequently than once every six months). In any event, all Shares that have ceased to be Restricted Shares, together with any other vested assets held in escrow under this Agreement, shall be released within 90 days after the earlier of (i) the
termination of the Optionee’s Service or (ii) the lapse of the Right of First Refusal. 
 (d) Exercise of Repurchase Right.
The Company shall be deemed to have exercised its Right of Repurchase automatically for all Restricted Shares as of the commencement of the Repurchase Period, unless the Company during the Repurchase Period notifies the holder of the Restricted
Shares pursuant to Section 13(c) that it will not exercise its Right of Repurchase for some or all of the Restricted Shares. The Company shall pay to the holder of the Restricted Shares the purchase price determined under Subsection
(a) above for the Restricted Shares being repurchased. Payment shall be made in cash or cash equivalents and/or by canceling indebtedness to the Company incurred by the Optionee in the purchase of the Restricted Shares. The certificate(s)
representing the Restricted Shares being repurchased shall be delivered to the Company. 

  
 -6- 

 (e) Termination of Rights as Stockholder. If the Right of Repurchase is exercised in
accordance with this Section 7 and the Company makes available the consideration for the Restricted Shares being repurchased, then the person from whom the Restricted Shares are repurchased shall no longer have any rights as a holder of the
Restricted Shares (other than the right to receive payment of such consideration). Such Restricted Shares shall be deemed to have been repurchased pursuant to this Section 7, whether or not the certificate(s) for such Restricted Shares have
been delivered to the Company or the consideration for such Restricted Shares has been accepted. 
 (f) Additional or Exchanged Securities
and Property. In the event of a merger or consolidation of the Company, a sale of all or substantially all of the Company’s stock or assets, any other corporate reorganization, a stock split, the declaration of a stock dividend, the
declaration of an extraordinary dividend payable in a form other than stock, a spin-off, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding
securities, any securities or other property (including cash or cash equivalents) that are by reason of such transaction exchanged for, or distributed with respect to, any Restricted Shares shall immediately be subject to the Right of Repurchase.
Appropriate adjustments to reflect the exchange or distribution of such securities or property shall be made to the number and/or class of the Restricted Shares. Appropriate adjustments shall also be made to the price per share to be paid upon the
exercise of the Right of Repurchase, provided that the aggregate purchase price payable for the Restricted Shares shall remain the same. In the event of any transaction described in Section 8(b) of the Plan or any other corporate
reorganization, the Right of Repurchase may be exercised by the Company’s successor. 
 (g) Transfer of Restricted Shares. The
Optionee shall not transfer, assign, encumber or otherwise dispose of any Restricted Shares without the Company’s written consent, except as provided in the following sentence. The Optionee may transfer Restricted Shares to one or more members
of the Optionee’s Immediate Family or to a trust established by the Optionee for the benefit of the Optionee and/or one or more members of the Optionee’s Immediate Family, provided in either case that the Transferee agrees in writing on a
form prescribed by the Company to be bound by all provisions of this Agreement. If the Optionee transfers any Restricted Shares, then this Agreement shall apply to the Transferee to the same extent as to the Optionee. 

(h) Assignment of Repurchase Right. The Board of Directors may freely assign the Company’s Right of Repurchase, in whole or in
part. Any person who accepts an assignment of the Right of Repurchase from the Company shall assume all of the Company’s rights and obligations under this Section 7. 

SECTION 8. RIGHT OF FIRST REFUSAL. 
 (a)
Right of First Refusal. In the event that the Optionee proposes to sell, pledge or otherwise transfer to a third party any Shares acquired under this Agreement, or any interest in such Shares, the Company shall have the Right of First Refusal
with respect to all (and not less than all) of such Shares. If the Optionee desires to transfer Shares acquired under this Agreement, the Optionee shall give a written Transfer Notice to the Company describing fully the proposed transfer, including
the number of Shares proposed to be transferred, the proposed transfer price, the name and 

  
 -7- 

 
address of the proposed Transferee and proof satisfactory to the Company that the proposed sale or transfer will not violate any applicable federal, State or foreign securities laws. The Transfer
Notice shall be signed both by the Optionee and by the proposed Transferee and must constitute a binding commitment of both parties to the transfer of the Shares. The Company shall have the right to purchase all, and not less than all, of the Shares
on the terms of the proposal described in the Transfer Notice (subject, however, to any change in such terms permitted under Subsection (b) below) by delivery of a notice of exercise of the Right of First Refusal within 30 days after the date
when the Transfer Notice was received by the Company. 
 (b) Transfer of Shares. If the Company fails to exercise its Right of First
Refusal within 30 days after the date when it received the Transfer Notice, the Optionee may, not later than 90 days following receipt of the Transfer Notice by the Company, conclude a transfer of the Shares subject to the Transfer Notice on the
terms and conditions described in the Transfer Notice, provided that any such sale is made in compliance with applicable federal, State and foreign securities laws and not in violation of any other contractual restrictions to which the Optionee is
bound. Any proposed transfer on terms and conditions different from those described in the Transfer Notice, as well as any subsequent proposed transfer by the Optionee, shall again be subject to the Right of First Refusal and shall require
compliance with the procedure described in Subsection (a) above. If the Company exercises its Right of First Refusal, the parties shall consummate the sale of the Shares on the terms set forth in the Transfer Notice within 60 days after the
date when the Company received the Transfer Notice (or within such longer period as may have been specified in the Transfer Notice); provided, however, that in the event the Transfer Notice provided that payment for the Shares was to be made in a
form other than cash or cash equivalents paid at the time of transfer, the Company shall have the option of paying for the Shares with cash or cash equivalents equal to the present value of the consideration described in the Transfer Notice. 

(c) Additional or Exchanged Securities and Property. In the event of a merger or consolidation of the Company, a sale of all or
substantially all of the Company’s stock or assets, any other corporate reorganization, a stock split, the declaration of a stock dividend, the declaration of an extraordinary dividend payable in a form other than stock, a spin-off, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities, any securities or other property (including cash or cash equivalents)
that are by reason of such transaction exchanged for, or distributed with respect to, any Shares subject to this Section 8 shall immediately be subject to the Right of First Refusal. Appropriate adjustments to reflect the exchange or
distribution of such securities or property shall be made to the number and/or class of the Shares subject to this Section 8. 
 (d)
Termination of Right of First Refusal. Any other provision of this Section 8 notwithstanding, in the event that the Stock is readily tradable on an established securities market when the Optionee desires to transfer Shares, the Company
shall have no Right of First Refusal, and the Optionee shall have no obligation to comply with the procedures prescribed by Subsections (a) and (b) above. 

  
 -8- 

 (e) Permitted Transfers. This Section 8 shall not apply to (i) a transfer
by beneficiary designation, will or intestate succession or (ii) a transfer to one or more members of the Optionee’s Immediate Family or to a trust established by the Optionee for the benefit of the Optionee and/or one or more members of
the Optionee’s Immediate Family, provided in either case that the Transferee agrees in writing on a form prescribed by the Company to be bound by all provisions of this Agreement. If the Optionee transfers any Shares acquired under this
Agreement, either under this Subsection (e) or after the Company has failed to exercise the Right of First Refusal, then this Agreement shall apply to the Transferee to the same extent as to the Optionee. 

(f) Termination of Rights as Stockholder. If the Company makes available, at the time and place and in the amount and form provided in
this Agreement, the consideration for the Shares to be purchased in accordance with this Section 8, then after such time the person from whom such Shares are to be purchased shall no longer have any rights as a holder of such Shares (other than
the right to receive payment of such consideration in accordance with this Agreement). Such Shares shall be deemed to have been purchased in accordance with the applicable provisions hereof, whether or not the certificate(s) therefor have been
delivered as required by this Agreement. 
 (g) Assignment of Right of First Refusal. The Board of Directors may freely assign the
Company’s Right of First Refusal, in whole or in part. Any person who accepts an assignment of the Right of First Refusal from the Company shall assume all of the Company’s rights and obligations under this Section 8. 

SECTION 9. LEGALITY OF INITIAL ISSUANCE. 

No Shares shall be issued upon the exercise of this option unless and until the Company has determined that: 

(a) It and the Optionee have taken any actions required to register the Shares under the Securities Act or to perfect an exemption from the
registration requirements thereof; 
 (b) Any applicable listing requirement of any stock exchange or other securities market on which Stock
is listed has been satisfied; and 
 (c) Any other applicable provision of federal, State or foreign law has been satisfied. 

SECTION 10. No REGISTRATION RIGHTS. 
 The
Company may, but shall not be obligated to, register or qualify the sale of Shares under the Securities Act or any other applicable law. The Company shall not be obligated to take any affirmative action in order to cause the sale of Shares under
this Agreement to comply with any law. 
 SECTION 11. RESTRICTIONS ON TRANSFER OF SHARES. 

(a) Bylaws Restrictions. The Shares acquired under this Agreement shall be subject to the transfer restrictions in Article IX of the
Company’s Amended and Restated Bylaws, as may be amended from time to time, in addition to, and not in limitation of, the provisions of Section 8 of this Agreement. 

  
 -9- 

 (b) Securities Law Restrictions. Regardless of whether the offer and sale of Shares
under the Plan have been registered under the Securities Act or have been registered or qualified under the securities laws of any State or other relevant jurisdiction, the Company at its discretion may impose restrictions upon the sale, pledge or
other transfer of such Shares (including the placement of appropriate legends on the stock certificates (or electronic equivalent) or the imposition of stop-transfer instructions) and may refuse (or may be required to refuse) to transfer Shares
acquired hereunder (or Shares proposed to be transferred in a subsequent transfer) if, in the judgment of the Company, such restrictions, legends or refusal are necessary or appropriate to achieve compliance with the Securities Act or other relevant
securities or other laws, including without limitation under Regulation S of the Securities Act or pursuant to another available exemption from registration. 

(c) Market Stand-Off. In connection with any underwritten public offering by the Company of its
equity securities pursuant to an effective registration statement filed under the Securities Act, including the Company’s initial public offering, the Optionee or a Transferee shall not directly or indirectly sell, make any short sale of, loan,
hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with
respect to, any Shares acquired under this Agreement without the prior written consent of the Company or its managing underwriter. Such restriction (the “Market Stand-Off”) shall be in effect for
such period of time following the date of the final prospectus for the offering as may be requested by the Company or such underwriter. In no event, however, shall such period exceed 180 days plus such additional period as may reasonably be
requested by the Company or such underwriter to accommodate regulatory restrictions on (i) the publication or other distribution of research reports or (ii) analyst recommendations and opinions, including (without limitation) the
restrictions set forth in Rule 2711(f)(4) of the National Association of Securities Dealers and Rule 472(f)(4) of the New York Stock Exchange, as amended, or any similar successor rules. The Market Stand-Off
shall in any event terminate two years after the date of the Company’s initial public offering. In the event of the declaration of a stock dividend, a spin-off, a stock split, an adjustment in conversion
ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities without receipt of consideration, any new, substituted or additional securities which are by reason of such transaction distributed with respect
to any Shares subject to the Market Stand-Off, or into which such Shares thereby become convertible, shall immediately be subject to the Market Stand-Off. In order to
enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the Shares acquired under this Agreement until the end of the applicable
stand-off period. The Company’s underwriters shall be beneficiaries of the agreement set forth in this Subsection (b). This Subsection (b) shall not apply to Shares registered in the public offering
under the Securities Act. 
 (d) Investment Intent at Grant. The Optionee represents and agrees that the Shares to be acquired upon
exercising this option will be acquired for investment, and not with a view to the sale or distribution thereof. 

  
 -10- 

 (e) Investment Intent at Exercise. In the event that the sale of Shares under the
Plan is not registered under the Securities Act but an exemption is available that requires an investment representation or other representation, the Optionee shall represent and agree at the time of exercise that the Shares being acquired upon
exercising this option are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations as are deemed necessary or appropriate by the Company and its counsel, including (if
applicable because the Company is relying on Regulation S under the Securities Act) that as of the date of exercise the Optionee is (i) not a U.S. Person; (ii) not acquiring the Shares on behalf, or for the account or benefit, of a U.S.
Person; and (iii) is not exercising the option in the United States. 
 (f) Legends. All certificates evidencing Shares purchased
under this Agreement shall bear the following legend: 
 “THE SHARES REPRESENTED HEREBY MAY NOT BE SOLD, ASSIGNED, TRANSFERRED,
ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE TERMS OF A WRITTEN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES). SUCH AGREEMENT GRANTS TO THE COMPANY
CERTAIN RIGHTS OF FIRST REFUSAL UPON AN ATTEMPTED TRANSFER OF THE SHARES AND CERTAIN REPURCHASE RIGHTS UPON TERMINATION OF SERVICE WITH THE COMPANY. IN ADDITION, THE SHARES ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR A LIMITED PERIOD FOLLOWING THE
EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY’S SECURITIES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. THE SECRETARY OF THE COMPANY WILL UPON
WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.” 
 All certificates evidencing Shares purchased under this
Agreement in an unregistered transaction shall bear the following legend (and such other restrictive legends as are required or deemed advisable under the provisions of any applicable law): 

“THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY
SECURITIES LAWS OF ANY U.S. STATE, AND MAY NOT BE SOLD, REOFFERED, PLEDGED, ASSIGNED, ENCUMBERED OR OTHERWISE TRANSFERRED OR DISPOSED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND
ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED. IN THE ABSENCE OF REGISTRATION OR THE AVAILABILITY (CONFIRMED BY OPINION OF COUNSEL) OF AN ALTERNATIVE EXEMPTION FROM REGISTRATION UNDER THE ACT (INCLUDING WITHOUT LIMITATION IN ACCORDANCE WITH
REGULATION S UNDER THE ACT), THESE SHARES MAY NOT BE SOLD, REOFFERED, PLEDGED, ASSIGNED, ENCUMBERED OR OTHERWISE TRANSFERRED OR DISPOSED OF. HEDGING TRANSACTIONS INVOLVING THESE SHARES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT.”

  
 -11- 

 (g) Removal of Legends. If, in the opinion of the Company and its counsel, any legend
placed on a stock certificate representing Shares sold under this Agreement is no longer required, the holder of such certificate shall be entitled to exchange such certificate for a certificate representing the same number of Shares but without
such legend. 
 (h) Administration. Any determination by the Company and its counsel in connection with any of the matters set forth
in this Section 11 shall be conclusive and binding on the Optionee and all other persons. 
 SECTION 12. ADJUSTMENT OF SHARES. 

In the event of any transaction described in Section 8(a) of the Plan, the terms of this option (including, without limitation, the number
and kind of Shares subject to this option and the Exercise Price) shall be adjusted as set forth in Section 8(a) of the Plan. In the event that the Company is a party to a merger or consolidation or in the event of a sale of all or
substantially all of the Company’s stock or assets, this option shall be subject to the treatment provided by the Board of Directors in its sole discretion, as provided in Section 8(b) of the Plan. 

SECTION 13. MISCELLANEOUS PROVISIONS. 

(a) Rights as a Stockholder. Neither the Optionee nor the Optionee’s representative shall have any rights as a stockholder with respect to
any Shares subject to this option until the Optionee or the Optionee’s representative becomes entitled to receive such Shares by filing a notice of exercise and paying the Purchase Price pursuant to Sections 4 and 5. 

(b) No Retention Rights. Nothing in this option or in the Plan shall confer upon the Optionee any right to continue in Service for any period
of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or retaining the Optionee) or of the Optionee, which rights are hereby expressly reserved by each, to terminate
his or her Service at any time and for any reason, with or without cause. 
 (c) Notice. Any notice required by the terms of this Agreement
shall be given in writing. It shall be deemed effective upon (i) personal delivery, (ii) deposit with the United States Postal Service, by registered or certified mail, with postage and fees prepaid, (iii) deposit with Federal Express
Corporation, with shipping charges prepaid or (iv) deposit with any internationally recognized express mail courier service. Notice shall be addressed to the Company at its principal executive office and to the Optionee at the address that he
or she most recently provided to the Company in accordance with this Subsection (c). 
 (d) Modifications and Waivers. No provision of this
Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by the Optionee and by an authorized officer of the Company (other than the Optionee). No waiver by either party of any
breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 

  
 -12- 

 (e) Entire Agreement. The Notice of Stock Option Grant, this Agreement and the Plan
constitute the entire contract between the parties hereto with regard to the subject matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the
subject matter hereof. 
 (f) Choice of Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of
Delaware, as such laws are applied to contracts entered into and performed in such State. 
 SECTION 14. ACKNOWLEDGEMENTS OF THE OPTIONEE. 

In addition to the other terms, conditions and restrictions imposed on this option and the Shares issuable under this option pursuant to this
Agreement and the Plan, the Optionee expressly acknowledges being subject to Sections 7 (Right of Repurchase), 8 (Right of First Refusal), 9 (Legality of Initial Issuance) and 11 (Restrictions on Transfer of Shares, including without limitation the
Market Stand-Off), as well as the following provisions: 
 (a) Tax Consequences. The Optionee
agrees that the Company does not have a duty to design or administer the Plan or its other compensation programs in a manner that minimizes the Optionee’s tax liabilities. The Optionee shall not make any claim against the Company or its Board
of Directors, officers or employees related to tax liabilities arising from this option or the Optionee’s other compensation. In particular, any Optionee subject to U.S. taxation acknowledges that this option is exempt from Section 409A of
the Code only if the Exercise Price is at least equal to the Fair Market Value per Share on the Date of Grant. Since Shares are not traded on an established securities market, the determination of their Fair Market Value is made by the Board of
Directors or by an independent valuation firm retained by the Company. The Optionee acknowledges that there is no guarantee in either case that the Internal Revenue Service will agree with the valuation, and the Optionee shall not make any claim
against the Company or its Board of Directors, officers or employees in the event that the Internal Revenue Service asserts that the valuation was too low. 

(b) Electronic Delivery of Documents. The Optionee agrees to accept by email all documents relating to the Company, the Plan or this
option and all other documents that the Company is required to deliver to its security holders (including, without limitation, disclosures that may be required by the Securities and Exchange Commission). The Optionee also agrees that the Company may
deliver these documents by posting them on a website maintained by the Company or by a third party under contract with the Company. If the Company posts these documents on a website, it shall notify the Optionee by email of their availability. The
Optionee acknowledges that he or she may incur costs in connection with electronic delivery, including the cost of accessing the internet and printing fees, and that an interruption of internet access may interfere with his or her ability to access
the documents. This consent shall remain in effect until this option expires or until the Optionee gives the Company written notice that it should deliver paper documents. 

  
 -13- 

 (c) No Notice of Expiration Date. The Optionee agrees that the Company and its
officers, employees, attorneys and agents do not have any obligation to notify him or her prior to the expiration of this option pursuant to Section 6, regardless of whether this option will expire at the end of its full term or on an earlier
date related to the termination of the Optionee’s Service. The Optionee further agrees that he or she has the sole responsibility for monitoring the expiration of this option and for exercising this option, if at all, before it expires. This
Subsection (c) shall supersede any contrary representation that may have been made, orally or in writing, by the Company or by an officer, employee, attorney or agent of the Company. 

(d) Waiver of Statutory Information Rights. The Optionee acknowledges and agrees that, upon exercise of this option and until the first
sale of the Company’s Stock to the general public pursuant to a registration statement filed under the Securities Act, he or she will be deemed to have waived any rights the Optionee might otherwise have had under Section 220 of the
Delaware General Corporation Law (or under similar rights under other applicable law) to inspect for any proper purpose and to make copies and extracts from the Company’s stock ledger, a list of its stockholders and its other books and records
or the books and records of any subsidiary. This waiver applies only in the Optionee’s capacity as a stockholder and does not affect any other inspection rights the Optionee may have under other law or pursuant to a written agreement with the
Company. 
 (e) Plan Discretionary. The Optionee understands and acknowledges that the Plan is entirely discretionary, (ii) the
Company and the Optionee’s employer have reserved the right to amend, suspend or terminate the Plan at any time, (iii) the grant of an option does not in any way create any contractual or other right to receive additional grants of options
(or benefits in lieu of options) at any time or in any amount and (iv) all determinations with respect to any additional grants, including (without limitation) the times when options will be granted, the number of Shares offered, the Exercise
Price and the vesting schedule, will be at the sole discretion of the Company. 
 (f) Termination of Service. The Optionee understands
and acknowledges that participation in the Plan ceases upon termination of his or her Service for any reason, except as may explicitly be provided otherwise in the Plan or this Agreement. 

(g) Extraordinary Compensation. The value of this option shall be an extraordinary item of compensation outside the scope of the
Optionee’s employment contract, if any, and shall not be considered a part of his or her normal or expected compensation for purposes of calculating severance, resignation, redundancy or end-of-service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. 

(h) Authorization to Disclose. The Optionee hereby authorizes and directs the Optionee’s employer to disclose to the Company or any
Subsidiary any information regarding the Optionee’s employment, the nature and amount of the Optionee’s compensation and the fact and conditions of the Optionee’s participation in the Plan, as the Optionee’s employer deems
necessary or appropriate to facilitate the administration of the Plan. 

  
 -14- 

 (i) Personal Data Authorization. The Optionee consents to the collection, use and
transfer of personal data as described in this Subsection (i). The Optionee understands and acknowledges that the Company, the Optionee’s employer and the Company’s other Subsidiaries hold certain personal information regarding the
Optionee for the purpose of managing and administering the Plan, including (without limitation) the Optionee’s name, home address, telephone number, date of birth, social insurance number, salary, nationality, job title, any Shares or
directorships held in the Company and details of all options or any other entitlements to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Optionee’s favor (the “Data”). The Optionee further
understands and acknowledges that the Company and/or its Subsidiaries will transfer Data among themselves as necessary for the purpose of implementation, administration and management of the Optionee’s participation in the Plan and that the
Company and/or any Subsidiary may each further transfer Data to any third party assisting the Company in the implementation, administration and management of the Plan. The Optionee understands and acknowledges that the recipients of Data may be
located in the United States or elsewhere. The Optionee authorizes such recipients to receive, possess, use, retain and transfer Data, in electronic or other form, for the purpose of administering the Optionee’s participation in the Plan,
including a transfer to any broker or other third party with whom the Optionee elects to deposit Shares acquired under the Plan of such Data as may be required for the administration of the Plan and/or the subsequent holding of Shares on the
Optionee’s behalf. The Optionee may, at any time, view the Data, require any necessary modifications of Data or withdraw the consents set forth in this Subsection (i) by contacting the Company in writing. 

SECTION 15. DEFINITIONS. 
 (a)
“Agreement” shall mean this Stock Option Agreement. 
 (b) “Board of Directors” shall mean the Board of
Directors of the Company, as constituted from time to time or, if a Committee has been appointed, such Committee. 
 (c)
“Company” shall mean DoorDash, Inc., a Delaware corporation. 
 (d) “Immediate Family” shall mean any
child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law
and shall include adoptive relationships. 
 (e) “Optionee” shall mean the person named in the Notice of Stock Option Grant.

 (f) “Plan” shall mean the DoorDash, Inc. 2014 Stock Plan, as in effect on the Date of Grant. 

(g) “Purchase Price” shall mean the Exercise Price multiplied by the number of Shares with respect to which this option is
being exercised. 
 (h) “Repurchase Period” shall mean a period of 90 consecutive days commencing on the date when the
Optionee’s Service terminates for any reason, including (without limitation) death or disability. 
 (i) “Restricted
Share” shall mean a Share that is subject to the Right of Repurchase. 

  
 -15- 

 (j) “Right of First Refusal” shall mean the Company’s right of first
refusal described in Section 8. 
 (k) “Right of Repurchase” shall mean the Company’s right of repurchase
described in Section 7. 
 (l) “Service” means service as an Employee, Outside Director or Consultant. 

(m) “Transferee” shall mean any person to whom the Optionee has directly or indirectly transferred any Share acquired under
this Agreement. 
 (n) “Transfer Notice” shall mean the notice of a proposed transfer of Shares described in Section 8.

 (o) “U.S. Person” shall mean a person described in Rule 902(k) of Regulation S of the Securities Act (or any successor
rule or provision), which generally defines a U.S. person as any natural person resident in the United States, any estate of which any executor or administrator is a U.S. Person, or any trust of which of any trustee is a U.S. Person. 

  
 -16- 

 DOORDASH, INC. 2014 

STOCK PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD 

You (“Recipient”) have been granted Restricted Stock Units (“RSUs”) representing shares of the Common Stock
of DoorDash, Inc. (the “Company”) on the following terms: 
  

			
		
	Name of Recipient:	 	<<Name>>
		
	Total Number of RSUs Granted:	 	<<TotalRSUs>>
		
	Date of Grant:	 	<<DateGrant>>
		
	Vesting Commencement Date:	 	<<VestComDate>>
		
	Expiration Date:	 	<<ExpirationDate>>1

 Vesting: You will receive a benefit with respect to an RSU only if it vests. Two vesting requirements must be
satisfied on or before the Expiration Date specified above in order for an RSU to vest: (i) a requirement that you provide Service over the period of time set forth in “Service-Based Requirement” below and (ii) a requirement that
the Company complete either an IPO or a Sale Event as set forth below in “Liquidity Event Requirement.” Your RSUs will not vest (in whole or in part) if only one (or if neither) of such requirements is satisfied on or before the Expiration
Date. The “Vesting Date” of an RSU will be the first date on or before the Expiration Date upon which both the Service-Based Requirement and the Liquidity Event Requirement are satisfied with respect to that particular RSU. 

Service-Based Requirement: The Service-Based Requirement will be satisfied in installments as to the RSUs as follows provided you remain in
Service through the applicable Company Vesting Date: (i) with respect to the first 25% of the RSUs subject to this award, on the first Company Vesting Date occurring on or after the 12 month anniversary of the Vesting Commencement Date
specified above and (ii) with respect to an additional 6.25% of the RSUs subject to this award on each Company Vesting Date thereafter. The “Company Vesting Dates” are February 20, May 20, August 20 and November 20.

 Liquidity Event Requirement: The Liquidity Event Requirement will be satisfied (as to any then-outstanding RSUs that have not previously
been terminated pursuant to Section 2 of the Restricted Stock Unit Agreement) on the earlier to occur of (i) an IPO or (ii) a Sale Event. 

Settlement: Settlement of RSUs refers to the issuance of Shares once the RSU is vested. If an RSU vests as a result of satisfaction of both
applicable vesting requirements as described above, the Company will deliver one Share for such RSU at the time of settlement specified in Section 4 of the Restricted Stock Unit Agreement. 

 
  

	1 	 Seven years from the date of grant. 

 By signing below or otherwise accepting this award in a manner acceptable to the Company,
you and the Company agree that these RSUs are granted under and governed by the terms and conditions of this Notice of Restricted Stock Unit Award, the 2014 Stock Plan (the “Plan”) and the Restricted Stock Unit Agreement. These latter two
documents are attached to, and made a part of, this Notice of Restricted Stock Unit Award. Capitalized terms not otherwise defined herein or in the Restricted Stock Unit Agreement shall have the meaning set forth in the Plan. You hereby acknowledge
that the vesting of the RSUs pursuant to this Notice of Restricted Stock Unit Award is conditioned on the satisfaction of the Service-Based Requirement and the occurrence, on or before the Expiration Date, of an IPO or Sale Event. You shall have no
right with respect to the RSUs to the extent an IPO or Sale Event does not occur on or before the Expiration Date (regardless of the extent to which the Service-Based Requirement was satisfied). Section 9 of the Restricted
Stock Unit Agreement also includes important acknowledgements. 
  

			
	RECIPIENT: DOORDASH, INC.
		
	By:	 	
                    

	
	Email Address:
		
	Title:	 	
	
	Address for Mailing Stock Certificate (only applicable if the Company has certificated shares):

 THE RSUS GRANTED PURSUANT TO THE NOTICE OF RESTRICTED STOCK UNIT AWARD AND THIS AGREEMENT AND THE SHARES ISSUABLE
THEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY
AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED. 

 DOORDASH, INC. 2014 STOCK PLAN 

RESTRICTED STOCK UNIT AGREEMENT 

SECTION 1    GRANT OF RESTRICTED STOCK UNITS. 

(a)    Grant. On the terms and conditions set forth in the Notice of Restricted Stock Unit Award and this
Agreement, the Company grants to you on the Date of Grant the number of RSUs set forth in the Notice of Restricted Stock Unit Award. Each RSU represents the right to receive one Share on the terms and conditions set forth in this Agreement. 

(b)    Consideration. No payment is required for the RSUs that have been granted to you. (c) Nature of
Units; No Rights as a Stockholder. Your RSUs are mere bookkeeping entries and represent only the Company’s unfunded and unsecured promise to issue Shares on a future date under specified conditions. As a holder of RSUs, you have no rights other
than the rights of a general creditor of the Company. Your RSUs carry neither voting rights nor rights to cash dividends. You have no rights as a stockholder of the Company unless and until your RSUs are settled pursuant to Section 4. 

(c)    Stock Plan and Defined Terms. Your RSUs are granted pursuant to the Plan, a copy of which you
acknowledge having received. The provisions of the Plan are incorporated into this Agreement by this reference. Certain capitalized terms are defined in Section 10 of this Agreement. Capitalized terms not otherwise defined herein or in the
Notice of Restricted Stock Unit Award shall have the meanings set forth in the Plan. 
 SECTION 2    VESTING. 

(a)    Generally. The RSUs vest in accordance with the vesting schedule set forth in the Notice of Restricted
Stock Unit Award. You will receive a benefit with respect to an RSU only if both the Service-Based Requirement and the Liquidity Event Requirement are satisfied on or before the Expiration Date. Your RSUs will not vest (in whole or in part) if only
one (or if neither) of such requirements is satisfied on or before the Expiration Date. 
 (b)    Termination
of Service. If your Service terminates for any reason, all RSUs as to which the Service-Based Requirement has not been satisfied as of your termination date shall automatically terminate and be cancelled on the date that is 30 days after your
termination date (such 30-day period, the “Post-Termination Period”). Except as provided in Subsection (c) below, you will not satisfy the Service-Based Requirement for any additional RSUs after
your Service has terminated for any reason. Upon your termination of Service, any RSUs as to which the Service-Based Requirement has been satisfied will (if an IPO or Sale Event had not yet occurred) remain outstanding until the first to occur of
the satisfaction of the Liquidity Event Requirement or the Expiration Date. 
 (c)    Additional Vesting
Credit After Termination of Service. To the extent the Service-Based Requirement is not fully satisfied when your Service terminates, the Board of Directors may, during the Post-Termination Period, take action to cause the Service-Based
Requirement to be satisfied with respect to additional RSUs. In no event will the Service-Based Requirement be satisfied after termination of your Service unless the Board of Directors takes affirmative action pursuant to the preceding sentence or
unless expressly provided in a written agreement between you and the Company. 

  
 -3- 

 (d)    Expiration of RSUs. If an IPO or Sale Event does
not occur on or before the Expiration Date set forth in the Notice of Restricted Stock Unit Award, all RSUs (regardless of whether or not, or the extent to which, the Service-Based Requirement had been satisfied as to such RSUs) shall automatically
terminate and be cancelled upon such date. Upon a termination of one or more RSUs pursuant to this Section 2, you will have no further right with respect to such RSUs or the Shares previously allocated thereto. 

(e)    Part-Time Employment and Leaves of Absence. If you commence working on a part-time basis, then the
Company may adjust the Service-Based Requirement set forth in the Notice of Restricted Stock Unit Award. If you go on a leave of absence, then, to the extent permitted by applicable law, the Company may adjust or suspend the Service-Based
Requirement set forth in the Notice of Restricted Stock Unit Award. Except as provided in the preceding sentence, Service shall be deemed to continue for any purpose under this Agreement while you are on a bona fide leave of absence approved
by the Company in writing. Service shall be deemed to terminate when such leave ends, unless you immediately return to active work when such leave ends. 

SECTION 3    RESTRICTIONS APPLICABLE TO RSUS. 

Except as otherwise provided in or pursuant to this Agreement or the Plan, these RSUs and the rights and privileges conferred hereby shall not be sold,
assigned, transferred, pledged, hypothecated, or otherwise disposed of by you prior to the settlement of the RSUs. However, you may designate a third party who, in the event of your death, shall thereafter be entitled to receive any distribution of
Shares to which you were entitled at the time of your death pursuant to this Agreement by delivering a written beneficiary designation to the Company’s headquarters on the prescribed form before your death. If you deliver no such beneficiary
designation or if your designated beneficiaries do not survive you, your estate will receive payments in respect of any vested RSUs. 
 SECTION
4    SETTLEMENT OF RSUS. 
 (a)    Settlement Date. Upon or following a
Vesting Date with respect to a particular RSU, the Company will settle the RSU by delivering one Share for that RSU. In connection with the satisfaction of the Liquidity Event Requirement, settlement of any vested RSUs will occur on the date
specified below (such date, the “Initial Settlement Date”): 
 (i)    Subject to Subsection
(b) below, if the Vesting Date involves an IPO, settlement shall occur 210 days after the IPO with respect to all RSUs vested on or before such settlement date; or 

(ii)    Settlement of any RSUs that vest upon a Sale Event will occur upon or as soon as practicable following the Sale
Event. 
 Any RSUs that vest after the Initial Settlement Date will be settled on or as soon as practicable after the Vesting Date applicable to the RSUs.

 (b)    Change in Initial Settlement Date. To the extent permitted by Code Section 409A, settlement
of any RSUs described in Section 4(a)(i) may occur up to 30 days earlier than the Initial Settlement Date, on a later date in the same calendar year as the Initial Settlement Date or, if later, by the 15th day of the third calendar month
following the Initial Settlement Date. In addition, settlement of any RSUs described in Section 4(a)(i) may be accelerated to the extent permitted by Treasury Regulation Sections 1.409A-3(j)(4)(vi) and
(xi). Any decision made pursuant to this Subsection (b) will be made by the Company’s Board of Directors in its sole discretion, and no Participant will be permitted, directly or indirectly, to select the calendar year of settlement. 

  
 -4- 

 (c)    Form of Delivery. The form of any delivery of
Shares (e.g., a stock certificate or electronic entry evidencing such shares) shall be determined by the Company. 

(d)    Legality of Issuance. No Shares shall be issued to you upon settlement of these RSUs unless and until
the Company has determined that (i) you and the Company have taken any actions required to register the Shares under the Securities Act or to perfect an exemption from the registration requirements thereof; (ii) any applicable listing
requirement of any stock exchange or other securities market on which Stock is listed has been satisfied; and (iii) any other applicable provision of federal, State or foreign law has been satisfied. The Company shall have no liability to issue
Shares in respect of the RSUs unless it is able to do so in compliance with applicable law. 
 SECTION 5    TAXES. 

(a)    Withholding Taxes. No consideration will be paid to you in respect of this award unless you have made
arrangements satisfactory to the Company and/or the Parent or Subsidiary employing you (your “ Employer ”) for the payment of all applicable federal, State, local and foreign income and employment withholding taxes which arise in
connection with the vesting and/or settlement of these RSUs (the “ Withholding Taxes ”). To the extent that you fail to make such arrangements with respect to these RSUs, then you will permanently forfeit such RSUs. At the
discretion of the Company, these arrangements may include (i) withholding from other compensation or amounts that are owed to you by your Employer, (ii) payment in cash, (iii) if the Stock is publicly traded, payment from the proceeds
of the sale of shares through a Company- approved broker, (iv) withholding a number of Shares that otherwise would be issued to you when the RSUs are settled, or (v) any other method permitted by the Company. If the Withholding Taxes are
satisfied pursuant to clause (iv), you will be deemed to have been issued the full number of Shares subject to the RSUs and the Fair Market Value of the withheld Shares, determined as of the date when taxes otherwise would have been withheld in
cash, will be applied to the Withholding Taxes and such amount will be remitted to appropriate tax authorities by the Company or your Employer. You acknowledge that the responsibility for all Withholding Taxes is yours and may exceed the amount
actually withheld by the Company or your Employer. 
 (b)    Section 409A. The settlement of these RSUs is
intended to comply with the requirements of Code Section 409A and shall be administered and interpreted in a manner that complies with such requirements so that this award is not subject to additional tax or interest under Code
Section 409A. To the extent that any provision of this Agreement is ambiguous as to its compliance with Code Section 409A, the provision shall be read in such a manner so that all payments hereunder comply with Code Section 409A. In
this regard, to the extent necessary to comply with Code Section 409A, any reference to your “termination of employment” or similar terms will mean your “separation from service” within the meaning of Code
Section 409A(a)(2)(A)(i) (a “Separation”). In addition, if this award is payable upon your Separation and you are a “specified employee” of the Company or any affiliate thereof within the meaning of Code
Section 409A(a)(2)(B)(i) on the day of your Separation, then no such payment shall be made prior to the date that is the earlier of (i) six months and one day after your Separation, or (ii) your death, but only to the extent such
delay is necessary so that this award is not subject to additional tax or interest under Code Section 409A. Each installment of your RSUs that vests is intended to constitute a separate payment for purposes of Code Section 409A. 

SECTION 6    RESTRICTIONS APPLICABLE TO SHARES. 

(a)    Bylaws Restrictions. The Shares acquired under this Agreement shall be subject to the transfer
restrictions in Article IX of the Company’s Amended and Restated Bylaws, as may be amended from time to time, in addition to, and not in limitation of, the provisions of this Agreement. 

  
 -5- 

 (b)    Securities Law Restrictions. Regardless of whether
the offering and sale of Shares under the Plan have been registered under the Securities Act or have been registered or qualified under the securities laws of any State or other relevant jurisdiction, the Company at its discretion may impose
restrictions upon the sale, pledge or other transfer of such Shares (including the placement of appropriate legends on the stock certificates (or electronic equivalent) or the imposition of stop-transfer instructions) and may refuse (or may be
required to refuse) to transfer Shares acquired hereunder (or Shares proposed to be transferred in a subsequent transfer) if, in the judgment of the Company, such restrictions, legends or refusal are necessary or appropriate to achieve compliance
with the Securities Act or other relevant securities or other laws, including without limitation under Regulation S of the Securities Act or pursuant to another available exemption from registration. You (or the beneficiary or your personal
representative in the event of your death or incapacity, as the case may be) shall deliver to the Company any representations or other documents or assurances as the Company may deem necessary or reasonably desirable to ensure compliance with all
applicable legal and regulatory requirements. 
 (c)    Market
Stand-Off. In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act, including the
Company’s initial public offering, you or a Transferee shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other
contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Agreement without the prior written consent of the Company or its managing
underwriter. Such restriction (the “Market Stand-Off”) shall be in effect for such period of time following the date of the final prospectus for the offering as may be requested by the Company
or such underwriter. In no event, however, shall such period exceed 180 days plus such additional period as may reasonably be requested by the Company or such underwriter to accommodate regulatory restrictions on (i) the publication or other
distribution of research reports or (ii) analyst recommendations and opinions, including (without limitation) the restrictions set forth in Rule 2711(f)(4) of the National Association of Securities Dealers and Rule 472(f)(4) of the New York
Stock Exchange, as amended, or any similar successor rules. The Market Stand-Off shall in any event terminate two years after the date of the Company’s initial public offering. In the event of the
declaration of a stock dividend, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities without receipt of
consideration, any new, substituted or additional securities which are by reason of such transaction distributed with respect to any Shares subject to the Market Stand-Off, or into which such Shares thereby
become convertible, shall immediately be subject to the Market Stand-Off. In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions
with respect to the Shares acquired under this Agreement until the end of the applicable stand-off period. The Company’s underwriters shall be beneficiaries of the agreement set forth in this
Section 6(c). This Section 6(c) shall not apply to Shares registered in the public offering under the Securities Act. 

(d)    Investment Intent at Grant. You represent and agree that the Shares to be acquired upon settlement of
these RSUs will be acquired for investment, and not with a view to the sale or distribution thereof. 

(e)    Investment Intent at Settlement. In the event that the sale of Shares under the Plan is not
registered under the Securities Act but an exemption is available that requires an investment representation or other representation, you shall represent and agree at the time of issuance that the Shares being acquired upon settlement of these RSUs
are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations as are deemed necessary or appropriate by the Company and its counsel, including, at the time of settlement, such
representations as required by Regulation S of the Securities Act (if the Company is relying on such exemption). 

  
 -6- 

 (f)    Rights of the Company. The Company shall not be
required to (i) transfer on its books any Shares that have been sold or transferred in contravention of this Agreement or (ii) treat as the owner of Shares, or otherwise to accord voting, dividend or liquidation rights to, any Transferee
to whom the Shares have been transferred in contravention of this Agreement. 
 (g)    Legends. All
certificates evidencing the Shares issued under this Agreement shall bear the following legend: 
 “THE SHARES REPRESENTED HEREBY (AND
ANY INTEREST THEREIN) MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE TERMS OF THE RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO WHICH SUCH SHARES WERE ACQUIRED. THE SHARES ARE SUBJECT TO
RESTRICTIONS ON TRANSFER AS SET FORTH IN SUCH RESTRICTED STOCK UNIT AGREEMENT. THE SECRETARY OF THE COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH RESTRICTED STOCK UNIT AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.” 

All certificates evidencing Shares issued under this Agreement in an unregistered transaction shall bear the following legend (and such other restrictive
legends as are required or deemed advisable under the provisions of any applicable law): 
 “THE SHARES REPRESENTED HEREBY HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY SECURITIES LAWS OF ANY U.S. STATE, AND MAY NOT BE SOLD, REOFFERED, PLEDGED, ASSIGNED, ENCUMBERED OR OTHERWISE TRANSFERRED OR DISPOSED OF WITHOUT AN EFFECTIVE
REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED. IN THE ABSENCE OF REGISTRATION OR THE AVAILABILITY (CONFIRMED BY OPINION OF COUNSEL) OF AN ALTERNATIVE
EXEMPTION FROM REGISTRATION UNDER THE ACT (INCLUDING WITHOUT LIMITATION IN ACCORDANCE WITH REGULATION S UNDER THE ACT), THESE SHARES MAY NOT BE SOLD, REOFFERED, PLEDGED, ASSIGNED, ENCUMBERED OR OTHERWISE TRANSFERRED OR DISPOSED OF. HEDGING
TRANSACTIONS INVOLVING THESE SHARES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT.” 

(h)    Removal of Legends. If, in the opinion of the Company and its counsel, any legend placed on a stock
certificate representing Shares issued under this Agreement is no longer required, the holder of such certificate shall be entitled to exchange such certificate for a certificate representing the same number of Shares but without such legend. 

  
 -7- 

 (i)    Administration. Any determination by the Company
and its counsel in connection with any of the matters set forth in this Section 6 shall be conclusive and binding on you and all other persons. 

SECTION 7    ADJUSTMENT OF SHARES. 

In the event of any transaction described in Section 9(a) of the Plan, the terms of these RSUs (including, without limitation, the number and kind of
shares subject to these RSUs) shall be adjusted as set forth in Section 9(a) of the Plan. In the event that the Company is a party to a merger or consolidation or in the event of a sale of all or substantially all of the Company’s stock or
assets, these RSUs shall be subject to the treatment provided by the Board of Directors in its sole discretion, as provided in Section 9(b) of the Plan; provided, however, that any action taken must either preserve the exemption of your RSUs
from Code Section 409A or comply with Code Section 409A. Any additional RSUs and any new, substituted or additional shares, cash or other property that become subject to this award as a result of any such transaction shall be subject to
the same conditions and restrictions as applicable to the RSUs to which they relate. 
 SECTION 8    MISCELLANEOUS
PROVISIONS. 
 (a)    No Retention Rights. Nothing in this Agreement or in the Plan shall confer upon
you the right to remain in Service in any capacity for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or retaining you) or you, which rights are
hereby expressly reserved by each, to terminate your Service at any time and for any reason, with or without cause. 

(b)    Notice. Any notice required by the terms of this Agreement shall be given in writing. It shall be
deemed effective upon (i) personal delivery, (ii) deposit with the United States Postal Service, by registered or certified mail, with postage and fees prepaid, (iii) deposit with Federal Express Corporation, with shipping charges
prepaid or (iv) deposit with any internationally recognized express mail courier service, with shipping charges prepaid. Notice shall be addressed to the Company at its principal executive office and to you at the address that you most recently
provided to the Company in accordance with this Section 8(b). In addition, to the extent required or permitted pursuant to rules established by the Company from time to time, notices may be delivered electronically. 

(c)    Modifications and Waivers. No provision of this Agreement shall be modified, waived or discharged
unless the modification, waiver or discharge is agreed to in writing and signed by you and by an authorized officer of the Company (other than you). No waiver by either party of any breach of, or of compliance with, any condition or provision of
this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 

(d)    Entire Agreement. The Notice of Restricted Stock Unit Award, this Agreement and the Plan constitute
the entire understanding between you and the Company regarding the subject matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject
matter hereof. 
 (e)    Choice of Law. This Agreement shall be governed by, and construed in accordance
with, the laws of the State of Delaware, as such laws are applied to contracts entered into and performed in such State. 

(f)    Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner
as to be effective and valid under applicable law, but if any provision of this Agreement shall be held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity,
without invalidating the remainder of such provision or the remaining provisions of this Agreement. 

  
 -8- 

 (g)    Successors and Assigns. Except as otherwise
expressly provided to the contrary, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the Company and its successors and assigns and be binding upon you and your legal representatives, heirs, legatees, distributes,
assigns and transferees by operation of law, whether or not any such person has become a party to this Agreement or has agreed in writing to join herein and to be bound by the terms, conditions and restrictions hereof. 

SECTION 9    ACKNOWLEDGEMENTS. 

In addition to the other terms, conditions and restrictions imposed on your RSUs and the Shares issuable upon settlement of your RSUs pursuant to this
Agreement and the Plan, you expressly acknowledge being subject to Section 6 (Restrictions Applicable to Shares, including without limitation the Bylaws Restrictions and Market Stand-Off), as well as the
following provisions: 
 (a)    Tax Consequences. You acknowledge that there will be tax consequences upon
vesting and/or settlement of the RSUs and/or disposition of the Shares, if any, received hereunder, and you should consult a tax adviser regarding your tax obligations prior to such event. You acknowledge that the Company is not providing any tax,
legal, or financial advice, nor is the Company making any recommendations regarding your participation in the Plan or acquisition or sale of Shares subject to this award. You are hereby advised to consult with your own personal tax, legal, and
financial advisors regarding your participation in the Plan. You further acknowledge that the Company (i) makes no representations or undertakings regarding the tax treatment of the award of RSUs, including, but not limited to the grant,
vesting, or settlement of the RSUs, the subsequent sale of Shares acquired pursuant to such RSUs, and the receipt of any dividends; and (ii) does not commit to and is under no obligation to structure the terms of the grant of the RSUs to reduce
or eliminate your tax liability or achieve any particular tax result. You agree that the Company does not have a duty to design or administer the RSUs, the Plan or its other compensation programs in a manner that minimizes your tax liability. You
shall not make any claim against the Company or its Board of Directors, officers, or employees related to tax matters arising from this award or your other compensation. 

(b)    Electronic Delivery of Documents. You acknowledge and agree that the Company may, in its sole
discretion, deliver all documents relating the Company, the Plan or these RSUs and all other documents that the Company is required to deliver to its security holders (including, without limitation, disclosures that may be required by the Securities
and Exchange Commission) by email or other means of electronic transmission (including by posting them on a website maintained by the Company or a third party under contract with the Company). You acknowledge that you may incur costs in connection
with any such delivery by means of electronic transmission, including the cost of accessing the internet and printing fees, and that an interruption of internet access may interfere with his or her ability to access the documents. 

(c)    Plan Discretionary. You understand and acknowledge that (i) the Plan is entirely discretionary,
(ii) the Company and your employer have reserved the right to amend, suspend or terminate the Plan at any time, (iii) the grant of the RSUs does not in any way create any contractual or other right to receive additional grants of RSUs (or
benefits in lieu of RSUs) at any time or in any amount and (iv) all determinations with respect to any additional grants, including (without limitation) the times when RSUs will be granted, the number of Shares offered, and the vesting
schedule, will be at the sole discretion of the Company. 
 (d)    Termination of Service. You understand
and acknowledge that participation in the Plan ceases upon termination of your Service for any reason, except as may explicitly be provided otherwise in the Plan or this Agreement. 

  
 -9- 

 (e)    Extraordinary Compensation. The value of your RSUs
and the Shares issuable thereunder shall be an extraordinary item of compensation outside the scope of your employment contract, if any, and shall not be considered a part of your normal or expected compensation for purposes of calculating
severance, resignation, redundancy or end-of-service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. 

(f)    Authorization to Disclose. You hereby authorize and direct your employer to disclose to the Company
or any Subsidiary any information regarding your employment, the nature and amount of your compensation and the fact and conditions of your participation in the Plan, as your employer deems necessary or appropriate to facilitate the administration
of the Plan. 
 (g)    Personal Data Authorization. You consent to the collection, use and transfer of
personal data as described in this Subsection (g). You understand and acknowledge that the Company, your employer and the Company’s other Subsidiaries hold certain personal information regarding you for the purpose of managing and administering
the Plan, including (without limitation) your name, home address, telephone number, date of birth, social insurance number, salary, nationality, job title, any Shares or directorships held in the Company and details of all RSUs or any other
entitlements to Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor (the “ Data ”). You further understand and acknowledge that the Company and/or its Subsidiaries will transfer Data among themselves
as necessary for the purpose of implementation, administration and management of your participation in the Plan and that the Company and/or any Subsidiary may each further transfer Data to any third party assisting the Company in the implementation,
administration and management of the Plan. You understand and acknowledge that the recipients of Data may be located in the United States or elsewhere. You authorize such recipients to receive, possess, use, retain and transfer Data, in electronic
or other form, for the purpose of administering your participation in the Plan, including a transfer to any broker or other third party with whom you elect to deposit Shares acquired under the Plan of such Data as may be required for the
administration of the Plan and/or the subsequent holding of Shares on your behalf. You may, at any time, view the Data, require any necessary modifications of Data or withdraw the consents set forth in this Subsection (g) by contacting the
Company in writing. 
 SECTION 10    DEFINITIONS. 

(a)    “Agreement” means this Restricted Stock Unit Agreement. 

(b)    “Board of Directors” means the Board of Directors of the Company, as constituted from time
to time or, if a Committee has been appointed, such Committee. 
 (c)    “Code” means the
Internal Revenue Code of 1986, as amended. 
 (d)    “Company” means DoorDash, Inc., a Delaware
corporation. 
 (e)    “Date of Grant” means the date specified in the Notice of Restricted
Stock Unit Award, which date shall be the later of (i) the date on which the Board of Directors resolved to grant these RSUs or (ii) your first date of Service. 

(f)    “Expiration Date” means the expiration date of the RSUs as set forth in the Notice of
Restricted Stock Unit Award. 
 (g)    “IPO” means the first firm commitment underwritten public
offering pursuant to an effective registration statement under the Securities Act covering the offer and sale by the Company of its equity securities, as a result of or following which the Shares shall be publicly held, and “IPO
Date” means the date on which the IPO occurs. 

  
 -10- 

 (h)    “Liquidity Event Requirement” means the
requirement that the Company complete an IPO or Sale Event as described in the Notice of Restricted Stock Unit Award. 

(i)    “Plan” means the DoorDash, Inc. 2014 Stock Plan, as in effect on the Date of Grant. 

(j)    “RSUs” means the Restricted Stock Units granted to you by the Company as set forth in the
Notice of Restricted Stock Unit Award. 
 (k)    “Sale Event” means the consummation of the
following transactions in which holders of Shares receive cash and/or marketable securities tradable on an established national or foreign securities exchange: (i) a sale of all or substantially all of the assets of the Company determined on a
consolidated basis to an unrelated person or entity; (ii) a merger, reorganization, or consolidation involving the Company in which the shares of voting stock of the Company outstanding immediately prior to such transaction represent or are
converted into or exchanged for securities of the surviving or resulting entity immediately upon completion of such transaction which represent less than 50% of the outstanding voting power of such surviving or resulting entity; or (iii) the
acquisition of all or a majority of the outstanding voting stock of the Company in a single transaction or series of related transactions by a person or group of persons. For the avoidance of doubt, an initial public offering, any subsequent public
offering, another capital raising event, and a merger effected solely to change the Company’s domicile shall not constitute a “Sale Event.” In addition, a transaction shall not constitute a Sale Event unless such transaction also
qualifies as an event under Treasury Regulation Section 1.409A-3(i)(5)(v) (change in the ownership of a corporation), Treasury Regulation
Section 1.409A-3(i)(5)(vi) (change in the effective control of a corporation) or Treasury Regulation Section 1.409A- 3(i)(5)(vii) (change in the ownership of a substantial portion of a
corporation’s assets). 
 (l)    “Service” means service as an Employee, Consultant or
Outside Director. In the event of any dispute over whether and when Service has terminated, the Board of Directors shall have sole discretion to determine whether such termination has occurred and the effective date of such termination. 

(m)    “Service-Based Requirement” means the requirement to provide Service over the period of
time set forth in the Notice of Restricted Stock Unit Award. 
 (n)    “Transferee” means any
person to whom you have directly or indirectly transferred any Shares acquired under this Agreement. 

  
 -11-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]